>DL071002.1 ENDOTHELIAL CELL EXPRESSION PATTERNS
AACACAGTGCC
>DL071001.1 ENDOTHELIAL CELL EXPRESSION PATTERNS
GAAACCCGGTA
>DL071000.1 ENDOTHELIAL CELL EXPRESSION PATTERNS
CTCTAAAAAAA
>DL070999.1 ENDOTHELIAL CELL EXPRESSION PATTERNS
GAGCAGTGCTG
>DL070998.1 ENDOTHELIAL CELL EXPRESSION PATTERNS
TCGTGCTTTGT
>DL070997.1 ENDOTHELIAL CELL EXPRESSION PATTERNS
CTTCTCACCTA
>DL070996.1 ENDOTHELIAL CELL EXPRESSION PATTERNS
ACTCCGGTGTG
>DL070995.1 ENDOTHELIAL CELL EXPRESSION PATTERNS
GACCGCGGCTT
>DL070994.1 ENDOTHELIAL CELL EXPRESSION PATTERNS
TAAAGGCACAG
>DL070993.1 ENDOTHELIAL CELL EXPRESSION PATTERNS
TGCATCTGTGC
>DL070992.1 ENDOTHELIAL CELL EXPRESSION PATTERNS
ATAACCTGCAG
>DL070991.1 ENDOTHELIAL CELL EXPRESSION PATTERNS
GTCACTAATTT
>DL070990.1 ENDOTHELIAL CELL EXPRESSION PATTERNS
TAAATACTTGT
>DL070989.1 ENDOTHELIAL CELL EXPRESSION PATTERNS
GCAAAGTGCCC
>DL070988.1 ENDOTHELIAL CELL EXPRESSION PATTERNS
TCAGTGACCAG
>DL070987.1 ENDOTHELIAL CELL EXPRESSION PATTERNS
AATATCTGACT
>DL070986.1 ENDOTHELIAL CELL EXPRESSION PATTERNS
AAGGAGAACTG
>DL070985.1 ENDOTHELIAL CELL EXPRESSION PATTERNS
GAATTCACCAG
>DL070984.1 ENDOTHELIAL CELL EXPRESSION PATTERNS
TATTAAAATAG
>DL070983.1 ENDOTHELIAL CELL EXPRESSION PATTERNS
CTCTTCAAAAA
>DL070982.1 ENDOTHELIAL CELL EXPRESSION PATTERNS
TTGTTCAAGGG
>DL070981.1 ENDOTHELIAL CELL EXPRESSION PATTERNS
GTAGAGGAAAA
>DL070980.1 ENDOTHELIAL CELL EXPRESSION PATTERNS
AAGATGCACAC
>DL070979.1 ENDOTHELIAL CELL EXPRESSION PATTERNS
ACAAAAAGGCC
>DL070978.1 ENDOTHELIAL CELL EXPRESSION PATTERNS
TGTTGAAAAAA
>DL070977.1 ENDOTHELIAL CELL EXPRESSION PATTERNS
ATTGCCAATCT
>DL070976.1 ENDOTHELIAL CELL EXPRESSION PATTERNS
CTTTGTTTTGC
>DL070975.1 ENDOTHELIAL CELL EXPRESSION PATTERNS
GTTTAAGGATG
>DL070974.1 ENDOTHELIAL CELL EXPRESSION PATTERNS
TGGGAAGAGGG
>DL070973.1 ENDOTHELIAL CELL EXPRESSION PATTERNS
CTCTTAAAAAA
>DL070972.1 ENDOTHELIAL CELL EXPRESSION PATTERNS
GTGGCTGACGC
>DL070971.1 ENDOTHELIAL CELL EXPRESSION PATTERNS
CTAGCGTTTTA
>DL070970.1 ENDOTHELIAL CELL EXPRESSION PATTERNS
TCTCACGTCTC
>DL070969.1 ENDOTHELIAL CELL EXPRESSION PATTERNS
ATCCCTTCCCG
>DL070968.1 ENDOTHELIAL CELL EXPRESSION PATTERNS
GGCTTGCCTTT
>DL070967.1 ENDOTHELIAL CELL EXPRESSION PATTERNS
CCCCACACGGG
>DL070966.1 ENDOTHELIAL CELL EXPRESSION PATTERNS
TTCGGTTGGTC
>DL070965.1 ENDOTHELIAL CELL EXPRESSION PATTERNS
AGTCACATAGT
>DL070964.1 ENDOTHELIAL CELL EXPRESSION PATTERNS
ATCAAAGGTTT
>DL070963.1 ENDOTHELIAL CELL EXPRESSION PATTERNS
GATGAGGAGAC
>DL070962.1 ENDOTHELIAL CELL EXPRESSION PATTERNS
TGCCACACAGT
>DL070961.1 ENDOTHELIAL CELL EXPRESSION PATTERNS
TGGAAATGACC
>DL070960.1 ENDOTHELIAL CELL EXPRESSION PATTERNS
TTATGTTTAAT
>DL070959.1 ENDOTHELIAL CELL EXPRESSION PATTERNS
TTTGTGTTGTA
>DL070958.1 ENDOTHELIAL CELL EXPRESSION PATTERNS
GTGGAGACGGA
>DL070955.1 ENDOTHELIAL CELL EXPRESSION PATTERNS
ACCAAAACCAC
>DL070954.1 ENDOTHELIAL CELL EXPRESSION PATTERNS
AGAAACCACGG
>DL070953.1 ENDOTHELIAL CELL EXPRESSION PATTERNS
CATTATCCAAA
>DL070952.1 ENDOTHELIAL CELL EXPRESSION PATTERNS
TTGGGTGAAAA
>DL070951.1 ENDOTHELIAL CELL EXPRESSION PATTERNS
TACAAATCGTT
>DL070950.1 ENDOTHELIAL CELL EXPRESSION PATTERNS
ACTACCATAAC
>DL070949.1 ENDOTHELIAL CELL EXPRESSION PATTERNS
AGCCCAAAGTG
>DL070948.1 ENDOTHELIAL CELL EXPRESSION PATTERNS
TCCCCCAGGAG
>DL070947.1 ENDOTHELIAL CELL EXPRESSION PATTERNS
AGACATACTGA
>DL070946.1 ENDOTHELIAL CELL EXPRESSION PATTERNS
TTAAATAGCAC
>DL070945.1 ENDOTHELIAL CELL EXPRESSION PATTERNS
GCCCTTTCTCT
>DL070944.1 ENDOTHELIAL CELL EXPRESSION PATTERNS
TACCACCTCCC
>DL070943.1 ENDOTHELIAL CELL EXPRESSION PATTERNS
GTTCCACAGAA
>DL070942.1 ENDOTHELIAL CELL EXPRESSION PATTERNS
CTATAGGAGAC
>DL070941.1 ENDOTHELIAL CELL EXPRESSION PATTERNS
CCACTGCAACC
>DL070940.1 ENDOTHELIAL CELL EXPRESSION PATTERNS
ACAGACTGTTA
>DL070939.1 ENDOTHELIAL CELL EXPRESSION PATTERNS
TTAAAAGTCAC
>DL070938.1 ENDOTHELIAL CELL EXPRESSION PATTERNS
CCACAGGGGAT
>DL070937.1 ENDOTHELIAL CELL EXPRESSION PATTERNS
GTACACACACC
>DL070936.1 ENDOTHELIAL CELL EXPRESSION PATTERNS
GAGTGAGACCC
>DL070935.1 ENDOTHELIAL CELL EXPRESSION PATTERNS
ACTTTAGATGG
>DL070934.1 ENDOTHELIAL CELL EXPRESSION PATTERNS
ATTTTGTATGA
>DL070933.1 ENDOTHELIAL CELL EXPRESSION PATTERNS
TTTGGTTTTCC
>DL070932.1 ENDOTHELIAL CELL EXPRESSION PATTERNS
TTTTTAAGAAC
>DL070931.1 ENDOTHELIAL CELL EXPRESSION PATTERNS
CCTGGTTCAGT
>DL070930.1 ENDOTHELIAL CELL EXPRESSION PATTERNS
GGAAATGTCAA
>DL070929.1 ENDOTHELIAL CELL EXPRESSION PATTERNS
CAGGAGACCCC
>DL070928.1 ENDOTHELIAL CELL EXPRESSION PATTERNS
TATTAACTCTC
>DL070927.1 ENDOTHELIAL CELL EXPRESSION PATTERNS
CTTTCTTTGAG
>DL070926.1 ENDOTHELIAL CELL EXPRESSION PATTERNS
CATTTTTATCT
>DL070925.1 ENDOTHELIAL CELL EXPRESSION PATTERNS
GATCTCCGTGT
>DL070924.1 ENDOTHELIAL CELL EXPRESSION PATTERNS
GGGGCTGCCCA
>DL070923.1 ENDOTHELIAL CELL EXPRESSION PATTERNS
CGTGGGGTGTA
>DL070922.1 ENDOTHELIAL CELL EXPRESSION PATTERNS
AGCGATGGAGA
>DL070921.1 ENDOTHELIAL CELL EXPRESSION PATTERNS
AGCAGAGACAA
>DL070920.1 ENDOTHELIAL CELL EXPRESSION PATTERNS
GTCAGTCACTT
>DL070919.1 ENDOTHELIAL CELL EXPRESSION PATTERNS
GTCAGGGTCCC
>DL070918.1 ENDOTHELIAL CELL EXPRESSION PATTERNS
GAGTGGCTACC
>DL070917.1 ENDOTHELIAL CELL EXPRESSION PATTERNS
TGGAACAGTGA
>DL070916.1 ENDOTHELIAL CELL EXPRESSION PATTERNS
GGGTAGGGTGA
>DL070915.1 ENDOTHELIAL CELL EXPRESSION PATTERNS
GAAGACACTTG
>DL070914.1 ENDOTHELIAL CELL EXPRESSION PATTERNS
TCAAGCAATCA
>DL070913.1 ENDOTHELIAL CELL EXPRESSION PATTERNS
TTAATGTGTAA
>DL070912.1 ENDOTHELIAL CELL EXPRESSION PATTERNS
CTCTCCAAACC
>DL070911.1 ENDOTHELIAL CELL EXPRESSION PATTERNS
GTCATTTTCTA
>DL070910.1 ENDOTHELIAL CELL EXPRESSION PATTERNS
AAATATGTGTT
>DL070909.1 ENDOTHELIAL CELL EXPRESSION PATTERNS
GGGCAGTGGCT
>DL070908.1 ENDOTHELIAL CELL EXPRESSION PATTERNS
TCCCCTCTCTC
>DL070907.1 ENDOTHELIAL CELL EXPRESSION PATTERNS
GTAGTTCTGGA
>DL070906.1 ENDOTHELIAL CELL EXPRESSION PATTERNS
GAATGCTCTTG
>DL070905.1 ENDOTHELIAL CELL EXPRESSION PATTERNS
TGACTGTATTA
>DL070904.1 ENDOTHELIAL CELL EXPRESSION PATTERNS
GCAGCAGCAGC
>DL070903.1 ENDOTHELIAL CELL EXPRESSION PATTERNS
CATCACGGATC
>DL070902.1 ENDOTHELIAL CELL EXPRESSION PATTERNS
TGTGCTTTTTT
>DL070901.1 ENDOTHELIAL CELL EXPRESSION PATTERNS
GCTAATAATGT
>DL070900.1 ENDOTHELIAL CELL EXPRESSION PATTERNS
CTTCTCTTGAG
>DL070899.1 ENDOTHELIAL CELL EXPRESSION PATTERNS
ACAAGTACCCA
>DL070898.1 ENDOTHELIAL CELL EXPRESSION PATTERNS
GGTTGTTGCGG
>DL070897.1 ENDOTHELIAL CELL EXPRESSION PATTERNS
GGCTTAGGATG
>DL070896.1 ENDOTHELIAL CELL EXPRESSION PATTERNS
TCTGCTTCTAG
>DL070895.1 ENDOTHELIAL CELL EXPRESSION PATTERNS
AGGCTCCTGGC
>DL070894.1 ENDOTHELIAL CELL EXPRESSION PATTERNS
CAGATGGAGGC
>DL070893.1 ENDOTHELIAL CELL EXPRESSION PATTERNS
CCCTGTTCAGC
>DL070892.1 ENDOTHELIAL CELL EXPRESSION PATTERNS
CGAGAGTGTGA
>DL070891.1 ENDOTHELIAL CELL EXPRESSION PATTERNS
TTGAATTTGTT
>DL070890.1 ENDOTHELIAL CELL EXPRESSION PATTERNS
CCGGCCCCTCC
>DL070889.1 ENDOTHELIAL CELL EXPRESSION PATTERNS
GTGCTACTTCT
>DL070888.1 ENDOTHELIAL CELL EXPRESSION PATTERNS
AATAGGGGAAA
>DL070887.1 ENDOTHELIAL CELL EXPRESSION PATTERNS
GTAATGACAGA
>DL070886.1 ENDOTHELIAL CELL EXPRESSION PATTERNS
TTTGTATAGAA
>DL070885.1 ENDOTHELIAL CELL EXPRESSION PATTERNS
ATACTATAATT
>DL070884.1 ENDOTHELIAL CELL EXPRESSION PATTERNS
ACCGTTCTGTA
>DL070883.1 ENDOTHELIAL CELL EXPRESSION PATTERNS
ACTGAAAGAAG
>DL070882.1 ENDOTHELIAL CELL EXPRESSION PATTERNS
AACAGGGGCCA
>DL070881.1 ENDOTHELIAL CELL EXPRESSION PATTERNS
TTTCATCCACT
>DL070880.1 ENDOTHELIAL CELL EXPRESSION PATTERNS
TGGGAAACCTG
>DL070879.1 ENDOTHELIAL CELL EXPRESSION PATTERNS
TGCCAGGTGCA
>DL070878.1 ENDOTHELIAL CELL EXPRESSION PATTERNS
TCACAGCCCCC
>DL070877.1 ENDOTHELIAL CELL EXPRESSION PATTERNS
GGCACTCCTGT
>DL070876.1 ENDOTHELIAL CELL EXPRESSION PATTERNS
GAGCCTGGATA
>DL070875.1 ENDOTHELIAL CELL EXPRESSION PATTERNS
ACATTCCAAGT
>DL070874.1 ENDOTHELIAL CELL EXPRESSION PATTERNS
TCACCGTGGAC
>DL070873.1 ENDOTHELIAL CELL EXPRESSION PATTERNS
ACAAGTACTGT
>DL070872.1 ENDOTHELIAL CELL EXPRESSION PATTERNS
ATCACACAGCT
>DL070871.1 ENDOTHELIAL CELL EXPRESSION PATTERNS
GCTAACCCCTG
>DL070870.1 ENDOTHELIAL CELL EXPRESSION PATTERNS
GGCCCTACAGT
>DL070869.1 ENDOTHELIAL CELL EXPRESSION PATTERNS
GAGCCATCATA
>DL070868.1 ENDOTHELIAL CELL EXPRESSION PATTERNS
GTCCCTGCCTT
>DL070867.1 ENDOTHELIAL CELL EXPRESSION PATTERNS
TGTTTAATACA
>DL070866.1 ENDOTHELIAL CELL EXPRESSION PATTERNS
TACTTTATAAG
>DL070865.1 ENDOTHELIAL CELL EXPRESSION PATTERNS
GCCTGTCCCTC
>DL070864.1 ENDOTHELIAL CELL EXPRESSION PATTERNS
ACAAAGCATTT
>DL070863.1 ENDOTHELIAL CELL EXPRESSION PATTERNS
CCCAGTAAGAT
>DL070862.1 ENDOTHELIAL CELL EXPRESSION PATTERNS
TTTACAAAGAG
>DL070861.1 ENDOTHELIAL CELL EXPRESSION PATTERNS
CCACGGGATTC
>DL070860.1 ENDOTHELIAL CELL EXPRESSION PATTERNS
TATGAGGGTAA
>DL070859.1 ENDOTHELIAL CELL EXPRESSION PATTERNS
GATAACTACAT
>DL070858.1 ENDOTHELIAL CELL EXPRESSION PATTERNS
GCAATTTAACC
>DL070857.1 ENDOTHELIAL CELL EXPRESSION PATTERNS
GGAAGCTAAGT
>DL070856.1 ENDOTHELIAL CELL EXPRESSION PATTERNS
ACCGGCGCCCG
>DL070855.1 ENDOTHELIAL CELL EXPRESSION PATTERNS
CAACAATAATA
>DL070854.1 ENDOTHELIAL CELL EXPRESSION PATTERNS
CTTCTGGATAA
>DL070853.1 ENDOTHELIAL CELL EXPRESSION PATTERNS
AGCTTGTGGCC
>DL070852.1 ENDOTHELIAL CELL EXPRESSION PATTERNS
GCACAAGTTCT
>DL070851.1 ENDOTHELIAL CELL EXPRESSION PATTERNS
CAGGTTTCATA
>DL070850.1 ENDOTHELIAL CELL EXPRESSION PATTERNS
TCTCTGAGCAT
>DL070849.1 ENDOTHELIAL CELL EXPRESSION PATTERNS
AAGATCAAGAT
>DL070848.1 ENDOTHELIAL CELL EXPRESSION PATTERNS
TGTTCTGGAGA
>DL070847.1 ENDOTHELIAL CELL EXPRESSION PATTERNS
CCCTTTCACAC
>DL070846.1 ENDOTHELIAL CELL EXPRESSION PATTERNS
GTTTATGGATA
>DL070845.1 ENDOTHELIAL CELL EXPRESSION PATTERNS
GTGCTAAGCGG
>DL070844.1 ENDOTHELIAL CELL EXPRESSION PATTERNS
TTCTCCCAAAT
>DL070843.1 ENDOTHELIAL CELL EXPRESSION PATTERNS
TTAGTGTCGTA
>DL070842.1 ENDOTHELIAL CELL EXPRESSION PATTERNS
GGGATTAAAGC
>DL070841.1 ENDOTHELIAL CELL EXPRESSION PATTERNS
ATGTCTTTTCT
>DL070840.1 ENDOTHELIAL CELL EXPRESSION PATTERNS
TAATCCTCAAG
>DL070839.1 ENDOTHELIAL CELL EXPRESSION PATTERNS
TCCCTGGCAGA
>DL070838.1 ENDOTHELIAL CELL EXPRESSION PATTERNS
TTCTGCTCTTG
>DL070837.1 ENDOTHELIAL CELL EXPRESSION PATTERNS
ACACTTCTTTC
>DL070836.1 ENDOTHELIAL CELL EXPRESSION PATTERNS
ACCATTGGATT
>DL070835.1 ENDOTHELIAL CELL EXPRESSION PATTERNS
TTGCTGACTTT
>DL070833.1 ENDOTHELIAL CELL EXPRESSION PATTERNS
TTTGCACCTTT
>DL070832.1 ENDOTHELIAL CELL EXPRESSION PATTERNS
TGCACTTCAAG
>DL070831.1 ENDOTHELIAL CELL EXPRESSION PATTERNS
CATATCATTAA
>DL069754.1 DETECTION OF NUCLEIC ACIDS BY TYPE-SPECIFIC HYBRID CAPTURE METHOD
CCCCAAAACCG
>DL069708.1 DETECTION OF NUCLEIC ACIDS BY TYPE-SPECIFIC HYBRID CAPTURE METHOD
TGCTGGCGGCG
>DL069715.1 DETECTION OF NUCLEIC ACIDS BY TYPE-SPECIFIC HYBRID CAPTURE METHOD
CCACGCGTCGG
>DL069690.1 DETECTION OF NUCLEIC ACIDS BY TYPE-SPECIFIC HYBRID CAPTURE METHOD
TCCAGAACCAC
>DL069677.1 DETECTION OF NUCLEIC ACIDS BY TYPE-SPECIFIC HYBRID CAPTURE METHOD
CGCCCCATCTT
>DL000080.1 UNNATURAL REACTIVE AMINO ACID GENETIC CODE ADDITIONS
GGTTCGANTCC
>DL007806.1 Method for Preparing Substrates Having Immobilized Molecules and Substrates
GGCGAGGAATA
>DL007799.1 Method for Preparing Substrates Having Immobilized Molecules and Substrates
AGGCAAGGAAT
>DL007798.1 Method for Preparing Substrates Having Immobilized Molecules and Substrates
GGCGAGGAATA
>DJ446520.1 GENE EXPRESSION FOR ANALYZING PHOTODAMAGE
CAATAAATGTT
>DJ446593.1 Herbicide metabolizing protein, DNA encoding said protein, and uses thereof
TAGCGGCCGCA
>DJ446523.1 GENE EXPRESSION FOR ANALYZING PHOTODAMAGE
TCAAAAATATA
>DJ446522.1 GENE EXPRESSION FOR ANALYZING PHOTODAMAGE
GGAAGTTTCGA
>DJ446521.1 GENE EXPRESSION FOR ANALYZING PHOTODAMAGE
GCTCCCAGACT
>DJ446519.1 GENE EXPRESSION FOR ANALYZING PHOTODAMAGE
AACTAACAAAA
>DJ446518.1 GENE EXPRESSION FOR ANALYZING PHOTODAMAGE
TTGGTGAAGGA
>DJ446517.1 GENE EXPRESSION FOR ANALYZING PHOTODAMAGE
TCAGACTTTTG
>DJ446516.1 GENE EXPRESSION FOR ANALYZING PHOTODAMAGE
TAAAAAAAAAA
>DJ446515.1 GENE EXPRESSION FOR ANALYZING PHOTODAMAGE
AAGAAGATAGA
>DJ446514.1 GENE EXPRESSION FOR ANALYZING PHOTODAMAGE
GAGCAGCGCCC
>DJ446513.1 GENE EXPRESSION FOR ANALYZING PHOTODAMAGE
AACGCGGCCAA
>DJ446512.1 GENE EXPRESSION FOR ANALYZING PHOTODAMAGE
ATCCGCGAGGC
>DJ446511.1 GENE EXPRESSION FOR ANALYZING PHOTODAMAGE
GGCCCCTCACC
>DJ446510.1 GENE EXPRESSION FOR ANALYZING PHOTODAMAGE
CAGCTATTTCA
>DJ446509.1 GENE EXPRESSION FOR ANALYZING PHOTODAMAGE
ACATTTCAAAG
>DJ446508.1 GENE EXPRESSION FOR ANALYZING PHOTODAMAGE
CGGGGTGGCCG
>DJ446507.1 GENE EXPRESSION FOR ANALYZING PHOTODAMAGE
TCTCCCACACC
>DJ446506.1 GENE EXPRESSION FOR ANALYZING PHOTODAMAGE
GTGCACTGAGC
>DJ446505.1 GENE EXPRESSION FOR ANALYZING PHOTODAMAGE
GGGGCAGGGCC
>DJ446504.1 GENE EXPRESSION FOR ANALYZING PHOTODAMAGE
GGAAAAAAAAA
>DJ446503.1 GENE EXPRESSION FOR ANALYZING PHOTODAMAGE
GCAAAACCCCG
>DJ446502.1 GENE EXPRESSION FOR ANALYZING PHOTODAMAGE
CTGCCAAGTTG
>DJ446501.1 GENE EXPRESSION FOR ANALYZING PHOTODAMAGE
CCCTGGCAATG
>DJ446500.1 GENE EXPRESSION FOR ANALYZING PHOTODAMAGE
CCCAACGCGCT
>DJ446499.1 GENE EXPRESSION FOR ANALYZING PHOTODAMAGE
CAGGACCTGGT
>DJ446498.1 GENE EXPRESSION FOR ANALYZING PHOTODAMAGE
CAGCTCACTGA
>DJ446497.1 GENE EXPRESSION FOR ANALYZING PHOTODAMAGE
CAATAAACTGA
>DJ446496.1 GENE EXPRESSION FOR ANALYZING PHOTODAMAGE
CTCCTCACCTG
>DJ446495.1 GENE EXPRESSION FOR ANALYZING PHOTODAMAGE
GCCAGGAGCTA
>DJ446494.1 GENE EXPRESSION FOR ANALYZING PHOTODAMAGE
GAAATACAGTT
>DJ446493.1 GENE EXPRESSION FOR ANALYZING PHOTODAMAGE
ACTCCAAAAAA
>DJ446492.1 GENE EXPRESSION FOR ANALYZING PHOTODAMAGE
ACATCATCGAT
>DJ446490.1 GENE EXPRESSION FOR ANALYZING PHOTODAMAGE
CAAAAAAAAAA
>DJ433211.1 Hairpin type polyamide and its constituent molecule
GCCTGTTAGCG
>DJ433210.1 Hairpin type polyamide and its constituent molecule
CGCTAACAGGC
>DJ432198.1 A method for detection of Listerar monocytogenes
GCATAACTACC
>DJ432195.1 A method for detection of Listerar monocytogenes
GAAGGACTAGC
>DJ436640.1 MODULATION OF IMMUNOSTIMULATORY PROPERTIES BY SMALL OLIGONUCLEOTIDE-BASED COMPOUNDS
TCTGTNGTTCT
>DJ436639.1 MODULATION OF IMMUNOSTIMULATORY PROPERTIES BY SMALL OLIGONUCLEOTIDE-BASED COMPOUNDS
CTGTCNTTCTC
>DJ436625.1 MODULATION OF IMMUNOSTIMULATORY PROPERTIES BY SMALL OLIGONUCLEOTIDE-BASED COMPOUNDS
CTATCTGACGT
>DJ436623.1 MODULATION OF IMMUNOSTIMULATORY PROPERTIES BY SMALL OLIGONUCLEOTIDE-BASED COMPOUNDS
ACGTTCTCTGT
>DJ436616.1 MODULATION OF IMMUNOSTIMULATORY PROPERTIES BY SMALL OLIGONUCLEOTIDE-BASED COMPOUNDS
CCTACTAGCGT
>DJ436613.1 MODULATION OF IMMUNOSTIMULATORY PROPERTIES BY SMALL OLIGONUCLEOTIDE-BASED COMPOUNDS
GCGTTCTCATC
>DJ436603.1 MODULATION OF IMMUNOSTIMULATORY PROPERTIES BY SMALL OLIGONUCLEOTIDE-BASED COMPOUNDS
TCTGANGTTCT
>DJ436602.1 MODULATION OF IMMUNOSTIMULATORY PROPERTIES BY SMALL OLIGONUCLEOTIDE-BASED COMPOUNDS
TCTGTNGTTCT
>DJ436601.1 MODULATION OF IMMUNOSTIMULATORY PROPERTIES BY SMALL OLIGONUCLEOTIDE-BASED COMPOUNDS
TCTTTCNTTCT
>DJ436600.1 MODULATION OF IMMUNOSTIMULATORY PROPERTIES BY SMALL OLIGONUCLEOTIDE-BASED COMPOUNDS
TCTTTNGTTCT
>DJ436596.1 MODULATION OF IMMUNOSTIMULATORY PROPERTIES BY SMALL OLIGONUCLEOTIDE-BASED COMPOUNDS
TCTGTCGTTCT
>DJ436590.1 MODULATION OF IMMUNOSTIMULATORY PROPERTIES BY SMALL OLIGONUCLEOTIDE-BASED COMPOUNDS
TCTGANNTTCT
>DJ436589.1 MODULATION OF IMMUNOSTIMULATORY PROPERTIES BY SMALL OLIGONUCLEOTIDE-BASED COMPOUNDS
TCTGACNTTCT
>DJ436587.1 MODULATION OF IMMUNOSTIMULATORY PROPERTIES BY SMALL OLIGONUCLEOTIDE-BASED COMPOUNDS
TCTGACNTTCT
>DJ436583.1 MODULATION OF IMMUNOSTIMULATORY PROPERTIES BY SMALL OLIGONUCLEOTIDE-BASED COMPOUNDS
TCTGTNNTTCT
>DJ436582.1 MODULATION OF IMMUNOSTIMULATORY PROPERTIES BY SMALL OLIGONUCLEOTIDE-BASED COMPOUNDS
TCTGTCNTTCT
>DJ436581.1 MODULATION OF IMMUNOSTIMULATORY PROPERTIES BY SMALL OLIGONUCLEOTIDE-BASED COMPOUNDS
TCTGTCNTTCT
>DJ436576.1 MODULATION OF IMMUNOSTIMULATORY PROPERTIES BY SMALL OLIGONUCLEOTIDE-BASED COMPOUNDS
TCTGACGTTCT
>DJ436468.1 Compositions and Methods Comprising a Ligand of ChemerinR
GGGGACTTTCC
>DJ445613.1 Quantitative Amplification With a Labeled Probe and 3' to 5' Exonuclease Activity
NCTGGTGCCAN
>DJ435277.1 SYNERGISTIC STIMULATION OF THE IMMUNE SYSTEM USING IMMUNOSTIMULATORY OLIGONUCLEOTIDES AND/OR IMMUNOMER COMPOUNDS IN CONJUNCTION WITH CYTOKINES AND/OR CHEMOTHERAPEUTIC AGENTS OR RADIATION THERAPY
TCNAANGTTCN
>DJ435276.1 SYNERGISTIC STIMULATION OF THE IMMUNE SYSTEM USING IMMUNOSTIMULATORY OLIGONUCLEOTIDES AND/OR IMMUNOMER COMPOUNDS IN CONJUNCTION WITH CYTOKINES AND/OR CHEMOTHERAPEUTIC AGENTS OR RADIATION THERAPY
TCNAACNTTCN
>DJ435275.1 SYNERGISTIC STIMULATION OF THE IMMUNE SYSTEM USING IMMUNOSTIMULATORY OLIGONUCLEOTIDES AND/OR IMMUNOMER COMPOUNDS IN CONJUNCTION WITH CYTOKINES AND/OR CHEMOTHERAPEUTIC AGENTS OR RADIATION THERAPY
TCNAACNTTCT
>DJ435274.1 SYNERGISTIC STIMULATION OF THE IMMUNE SYSTEM USING IMMUNOSTIMULATORY OLIGONUCLEOTIDES AND/OR IMMUNOMER COMPOUNDS IN CONJUNCTION WITH CYTOKINES AND/OR CHEMOTHERAPEUTIC AGENTS OR RADIATION THERAPY
TCNTTNCAACN
>DJ435273.1 SYNERGISTIC STIMULATION OF THE IMMUNE SYSTEM USING IMMUNOSTIMULATORY OLIGONUCLEOTIDES AND/OR IMMUNOMER COMPOUNDS IN CONJUNCTION WITH CYTOKINES AND/OR CHEMOTHERAPEUTIC AGENTS OR RADIATION THERAPY
TCCAACCTTCG
>DJ435272.1 SYNERGISTIC STIMULATION OF THE IMMUNE SYSTEM USING IMMUNOSTIMULATORY OLIGONUCLEOTIDES AND/OR IMMUNOMER COMPOUNDS IN CONJUNCTION WITH CYTOKINES AND/OR CHEMOTHERAPEUTIC AGENTS OR RADIATION THERAPY
TCNTTCNAACN
>DJ435264.1 SYNERGISTIC STIMULATION OF THE IMMUNE SYSTEM USING IMMUNOSTIMULATORY OLIGONUCLEOTIDES AND/OR IMMUNOMER COMPOUNDS IN CONJUNCTION WITH CYTOKINES AND/OR CHEMOTHERAPEUTIC AGENTS OR RADIATION THERAPY
TCNAACNTTCG
>DJ435263.1 SYNERGISTIC STIMULATION OF THE IMMUNE SYSTEM USING IMMUNOSTIMULATORY OLIGONUCLEOTIDES AND/OR IMMUNOMER COMPOUNDS IN CONJUNCTION WITH CYTOKINES AND/OR CHEMOTHERAPEUTIC AGENTS OR RADIATION THERAPY
TCNAACNTTCN
>DJ435262.1 SYNERGISTIC STIMULATION OF THE IMMUNE SYSTEM USING IMMUNOSTIMULATORY OLIGONUCLEOTIDES AND/OR IMMUNOMER COMPOUNDS IN CONJUNCTION WITH CYTOKINES AND/OR CHEMOTHERAPEUTIC AGENTS OR RADIATION THERAPY
TCTCACCTTCT
>DJ435261.1 SYNERGISTIC STIMULATION OF THE IMMUNE SYSTEM USING IMMUNOSTIMULATORY OLIGONUCLEOTIDES AND/OR IMMUNOMER COMPOUNDS IN CONJUNCTION WITH CYTOKINES AND/OR CHEMOTHERAPEUTIC AGENTS OR RADIATION THERAPY
TCNAACNTTCG
>DJ435260.1 SYNERGISTIC STIMULATION OF THE IMMUNE SYSTEM USING IMMUNOSTIMULATORY OLIGONUCLEOTIDES AND/OR IMMUNOMER COMPOUNDS IN CONJUNCTION WITH CYTOKINES AND/OR CHEMOTHERAPEUTIC AGENTS OR RADIATION THERAPY
TCNAACNTTCN
>DJ435182.1 SYNERGISTIC STIMULATION OF THE IMMUNE SYSTEM USING IMMUNOSTIMULATORY OLIGONUCLEOTIDES AND/OR IMMUNOMER COMPOUNDS IN CONJUNCTION WITH CYTOKINES AND/OR CHEMOTHERAPEUTIC AGENTS OR RADIATION THERAPY
TCTGACNTTCT
>DJ435181.1 SYNERGISTIC STIMULATION OF THE IMMUNE SYSTEM USING IMMUNOSTIMULATORY OLIGONUCLEOTIDES AND/OR IMMUNOMER COMPOUNDS IN CONJUNCTION WITH CYTOKINES AND/OR CHEMOTHERAPEUTIC AGENTS OR RADIATION THERAPY
TCTGANGTTCT
>DJ435174.1 SYNERGISTIC STIMULATION OF THE IMMUNE SYSTEM USING IMMUNOSTIMULATORY OLIGONUCLEOTIDES AND/OR IMMUNOMER COMPOUNDS IN CONJUNCTION WITH CYTOKINES AND/OR CHEMOTHERAPEUTIC AGENTS OR RADIATION THERAPY
TCTGTCNTTCT
>DJ435173.1 SYNERGISTIC STIMULATION OF THE IMMUNE SYSTEM USING IMMUNOSTIMULATORY OLIGONUCLEOTIDES AND/OR IMMUNOMER COMPOUNDS IN CONJUNCTION WITH CYTOKINES AND/OR CHEMOTHERAPEUTIC AGENTS OR RADIATION THERAPY
TCTGTNGTTCT
>DJ435170.1 SYNERGISTIC STIMULATION OF THE IMMUNE SYSTEM USING IMMUNOSTIMULATORY OLIGONUCLEOTIDES AND/OR IMMUNOMER COMPOUNDS IN CONJUNCTION WITH CYTOKINES AND/OR CHEMOTHERAPEUTIC AGENTS OR RADIATION THERAPY
TCTTTCNTTCT
>DJ435169.1 SYNERGISTIC STIMULATION OF THE IMMUNE SYSTEM USING IMMUNOSTIMULATORY OLIGONUCLEOTIDES AND/OR IMMUNOMER COMPOUNDS IN CONJUNCTION WITH CYTOKINES AND/OR CHEMOTHERAPEUTIC AGENTS OR RADIATION THERAPY
TCTTTNGTTCT
>DJ435160.1 SYNERGISTIC STIMULATION OF THE IMMUNE SYSTEM USING IMMUNOSTIMULATORY OLIGONUCLEOTIDES AND/OR IMMUNOMER COMPOUNDS IN CONJUNCTION WITH CYTOKINES AND/OR CHEMOTHERAPEUTIC AGENTS OR RADIATION THERAPY
TCTGTCNTTCT
>DJ435155.1 SYNERGISTIC STIMULATION OF THE IMMUNE SYSTEM USING IMMUNOSTIMULATORY OLIGONUCLEOTIDES AND/OR IMMUNOMER COMPOUNDS IN CONJUNCTION WITH CYTOKINES AND/OR CHEMOTHERAPEUTIC AGENTS OR RADIATION THERAPY
TCNTCNTTCTG
>DJ435153.1 SYNERGISTIC STIMULATION OF THE IMMUNE SYSTEM USING IMMUNOSTIMULATORY OLIGONUCLEOTIDES AND/OR IMMUNOMER COMPOUNDS IN CONJUNCTION WITH CYTOKINES AND/OR CHEMOTHERAPEUTIC AGENTS OR RADIATION THERAPY
CTGTCNTTCTC
>DJ435147.1 SYNERGISTIC STIMULATION OF THE IMMUNE SYSTEM USING IMMUNOSTIMULATORY OLIGONUCLEOTIDES AND/OR IMMUNOMER COMPOUNDS IN CONJUNCTION WITH CYTOKINES AND/OR CHEMOTHERAPEUTIC AGENTS OR RADIATION THERAPY
TCTGANNTTCT
>DJ435146.1 SYNERGISTIC STIMULATION OF THE IMMUNE SYSTEM USING IMMUNOSTIMULATORY OLIGONUCLEOTIDES AND/OR IMMUNOMER COMPOUNDS IN CONJUNCTION WITH CYTOKINES AND/OR CHEMOTHERAPEUTIC AGENTS OR RADIATION THERAPY
TCTGACNTTCT
>DJ435144.1 SYNERGISTIC STIMULATION OF THE IMMUNE SYSTEM USING IMMUNOSTIMULATORY OLIGONUCLEOTIDES AND/OR IMMUNOMER COMPOUNDS IN CONJUNCTION WITH CYTOKINES AND/OR CHEMOTHERAPEUTIC AGENTS OR RADIATION THERAPY
TCTGACNTTCT
>DJ435140.1 SYNERGISTIC STIMULATION OF THE IMMUNE SYSTEM USING IMMUNOSTIMULATORY OLIGONUCLEOTIDES AND/OR IMMUNOMER COMPOUNDS IN CONJUNCTION WITH CYTOKINES AND/OR CHEMOTHERAPEUTIC AGENTS OR RADIATION THERAPY
TCTGTNNTTCT
>DJ435139.1 SYNERGISTIC STIMULATION OF THE IMMUNE SYSTEM USING IMMUNOSTIMULATORY OLIGONUCLEOTIDES AND/OR IMMUNOMER COMPOUNDS IN CONJUNCTION WITH CYTOKINES AND/OR CHEMOTHERAPEUTIC AGENTS OR RADIATION THERAPY
TCTGTCNTTCT
>DJ435138.1 SYNERGISTIC STIMULATION OF THE IMMUNE SYSTEM USING IMMUNOSTIMULATORY OLIGONUCLEOTIDES AND/OR IMMUNOMER COMPOUNDS IN CONJUNCTION WITH CYTOKINES AND/OR CHEMOTHERAPEUTIC AGENTS OR RADIATION THERAPY
TCTGTCNTTCT
>DJ435133.1 SYNERGISTIC STIMULATION OF THE IMMUNE SYSTEM USING IMMUNOSTIMULATORY OLIGONUCLEOTIDES AND/OR IMMUNOMER COMPOUNDS IN CONJUNCTION WITH CYTOKINES AND/OR CHEMOTHERAPEUTIC AGENTS OR RADIATION THERAPY
TCTGACGTTCT
>DJ438993.1 A Novel Modular Type II Restriction Endonuclease, CspCI, and the Use of Modular Endonucleases for Generating Endonucleases with New Specificities
ACNNNNNCTCC
>DJ438992.1 A Novel Modular Type II Restriction Endonuclease, CspCI, and the Use of Modular Endonucleases for Generating Endonucleases with New Specificities
GAYNNNNNRTC
>DJ438990.1 A Novel Modular Type II Restriction Endonuclease, CspCI, and the Use of Modular Endonucleases for Generating Endonucleases with New Specificities
CCANNNNNNGT
>DJ438989.1 A Novel Modular Type II Restriction Endonuclease, CspCI, and the Use of Modular Endonucleases for Generating Endonucleases with New Specificities
GAGNNNNNCTC
>DJ438988.1 A Novel Modular Type II Restriction Endonuclease, CspCI, and the Use of Modular Endonucleases for Generating Endonucleases with New Specificities
ACNNNNGTAYC
>DJ438985.1 A Novel Modular Type II Restriction Endonuclease, CspCI, and the Use of Modular Endonucleases for Generating Endonucleases with New Specificities
CAANNNNNTGC
>DJ438984.1 A Novel Modular Type II Restriction Endonuclease, CspCI, and the Use of Modular Endonucleases for Generating Endonucleases with New Specificities
CGANNNNNTGC
>DJ438983.1 A Novel Modular Type II Restriction Endonuclease, CspCI, and the Use of Modular Endonucleases for Generating Endonucleases with New Specificities
CAANNNNNGTG
>DJ438980.1 A Novel Modular Type II Restriction Endonuclease, CspCI, and the Use of Modular Endonucleases for Generating Endonucleases with New Specificities
CAANNNNNTTG
>DJ438979.1 A Novel Modular Type II Restriction Endonuclease, CspCI, and the Use of Modular Endonucleases for Generating Endonucleases with New Specificities
CAANNNNGTGG
>DJ434489.1 Controlling DNA Hybridization
GCAATGGTTGC
>DJ434488.1 Controlling DNA Hybridization
CCTTTGGTCAG
>DJ434487.1 Controlling DNA Hybridization
CCCATGGTCCG
>DJ443015.1 METHOD FOR DETECTING ncRNA
CCGGTATTCCC
>DJ442998.1 METHOD FOR DETECTING ncRNA
ACCCAGCTTTT
>DJ442994.1 METHOD FOR DETECTING ncRNA
ACAAGTGCCCT
>DJ442989.1 METHOD FOR DETECTING ncRNA
GGCAATGTGAT
>DJ442985.1 METHOD FOR DETECTING ncRNA
CTGCCTGTCTG
>DJ442980.1 METHOD FOR DETECTING ncRNA
CTGATGCAGTA
>DJ442974.1 METHOD FOR DETECTING ncRNA
TAAGCACTTTA
>DJ442958.1 METHOD FOR DETECTING ncRNA
CTGGGACTTTG
>DJ442949.1 METHOD FOR DETECTING ncRNA
CCATCTTTACC
>DJ442946.1 METHOD FOR DETECTING ncRNA
GCATTATTACT
>DJ442938.1 METHOD FOR DETECTING ncRNA
ACAATGCTGCT
>DJ442932.1 METHOD FOR DETECTING ncRNA
ACAATGCTGCT
>DJ442925.1 METHOD FOR DETECTING ncRNA
ACAAAATCACA
>DJ442923.1 METHOD FOR DETECTING ncRNA
ACGGTAAACCA
>DJ442922.1 METHOD FOR DETECTING ncRNA
ATGTATGTGGG
>DJ442920.1 METHOD FOR DETECTING ncRNA
GTCACACTCCA
>EA780154.1 Sequence 5324 from patent US 7381816
GTGGTGAAGAC
>EA777491.1 Sequence 5324 from patent US 7381815
GTGGTGAAGAC
>EA774828.1 Sequence 5324 from patent US 7381814
GTGGTGAAGAC
>EA769204.1 Sequence 5324 from patent US 7378514
GTGGTGAAGAC
>EA766429.1 Sequence 63 from patent US 7378509
TCGATTTCCTC
>EA766420.1 Sequence 54 from patent US 7378509
AGGACTTTCCA
>EA766389.1 Sequence 7 from patent US 7378509
GGGGACTTTCC
>EA760015.1 Sequence 20 from patent US 7375198
NTTTTGTTTTT
>EA760014.1 Sequence 19 from patent US 7375198
AAAAANAAAAN
>EA760002.1 Sequence 2 from patent US 7375198
AAAAANAAAAA
>EA757627.1 Sequence 2 from patent US 7374885
ACGTAGCATCC
>EA756842.1 Sequence 101 from patent US 7371851
TTTTTTTTTTT
>EA756801.1 Sequence 60 from patent US 7371851
TTTTTTTTCGG
>EA756799.1 Sequence 58 from patent US 7371851
TTTTTTTTGCG
>EA756796.1 Sequence 55 from patent US 7371851
GGGGGGGGCCG
>EA756793.1 Sequence 52 from patent US 7371851
GGGGGGGGAAC
>EA756792.1 Sequence 51 from patent US 7371851
GGGGGGGGAAA
>EA756743.1 Sequence 2 from patent US 7371851
GGGGCCNNNCT
>EA756742.1 Sequence 1 from patent US 7371851
GGCCCCCNNAA
>EA752792.1 Sequence 5 from patent US 7368560
TCGACGTACTC
>EA752791.1 Sequence 4 from patent US 7368560
AGCTGCATGAG
>EA751998.1 Sequence 208 from patent US 7368548
CTCTCTGACCG
>EA751991.1 Sequence 200 from patent US 7368548
TGGAAGCAAAC
>EA751893.1 Sequence 100 from patent US 7368548
CTGAAGCTGAA
>EA731280.1 Sequence 62 from patent US 7368259
AAGGGAAGCAC
>EA731260.1 Sequence 42 from patent US 7368259
CGCCACCCCCA
>EA731244.1 Sequence 26 from patent US 7368259
CGGAGACTGCC
>EA731239.1 Sequence 21 from patent US 7368259
AGCCCAGGGAA
>EA731238.1 Sequence 20 from patent US 7368259
CCGCCACCCCA
>EA620963.1 Sequence 8 from patent US 7365186
CCATAAACCCC
>EA619500.1 Sequence 1113 from patent US 7364878
GCCNNNNNCCC
>EA619482.1 Sequence 1089 from patent US 7364878
CGCNNNNNGGC
>EA619473.1 Sequence 1080 from patent US 7364878
CAGNNNNNGGG
>EA619463.1 Sequence 1068 from patent US 7364878
GCGNNNNNGCC
>EA619405.1 Sequence 995 from patent US 7364878
CGGNNNNNCCC
>EA619380.1 Sequence 964 from patent US 7364878
CCCNNNNNCCA
>EA619378.1 Sequence 962 from patent US 7364878
ACGNNNNNGCA
>EA619358.1 Sequence 940 from patent US 7364878
CACNNNNNGGG
>EA619337.1 Sequence 914 from patent US 7364878
CCGNNNNNTCC
>EA619319.1 Sequence 892 from patent US 7364878
GGCNNNNNGGA
>EA619318.1 Sequence 891 from patent US 7364878
CCCNNNNNAGC
>EA619316.1 Sequence 888 from patent US 7364878
CAGNNNNNCCC
>EA619313.1 Sequence 885 from patent US 7364878
GCCNNNNNGGA
>EA619307.1 Sequence 879 from patent US 7364878
CGGNNNNNACG
>EA619301.1 Sequence 872 from patent US 7364878
AGCNNNNNCAG
>EA619299.1 Sequence 868 from patent US 7364878
CCANNNNNCCG
>EA619286.1 Sequence 847 from patent US 7364878
ACCNNNNNCCC
>EA619269.1 Sequence 824 from patent US 7364878
CCANNNNNGGG
>EA619266.1 Sequence 820 from patent US 7364878
CTGNNNNNCCC
>EA619258.1 Sequence 811 from patent US 7364878
CGCNNNNNGAG
>EA619236.1 Sequence 783 from patent US 7364878
CGGNNNNNGGC
>EA619219.1 Sequence 762 from patent US 7364878
CCCNNNNNAGG
>EA619212.1 Sequence 751 from patent US 7364878
GAGNNNNNCCC
>EA619181.1 Sequence 705 from patent US 7364878
CCTNNNNNGCC
>EA619163.1 Sequence 682 from patent US 7364878
CCCNNNNNCGG
>EA619155.1 Sequence 673 from patent US 7364878
CCGNNNNNCCC
>EA619133.1 Sequence 645 from patent US 7364878
CTGNNNNNCGC
>EA619131.1 Sequence 643 from patent US 7364878
GCGNNNNNGAC
>EA619089.1 Sequence 589 from patent US 7364878
CTCNNNNNCGC
>EA619077.1 Sequence 574 from patent US 7364878
GACNNNNNCGC
>EA619073.1 Sequence 569 from patent US 7364878
CCCNNNNNCCG
>EA619061.1 Sequence 547 from patent US 7364878
CAGNNNNNCCG
>EA619026.1 Sequence 504 from patent US 7364878
CCGNNNNNGAC
>EA619016.1 Sequence 489 from patent US 7364878
GCGNNNNNGGA
>EA619010.1 Sequence 481 from patent US 7364878
CGGNNNNNCTC
>EA618986.1 Sequence 450 from patent US 7364878
GCCNNNNNCGC
>EA618965.1 Sequence 424 from patent US 7364878
GGGNNNNNGGA
>EA618961.1 Sequence 417 from patent US 7364878
CCTNNNNNGCG
>EA618958.1 Sequence 414 from patent US 7364878
CACNNNNNGCG
>EA618953.1 Sequence 401 from patent US 7364878
CCCNNNNNGCC
>EA618948.1 Sequence 396 from patent US 7364878
CGCNNNNNGCA
>EA618207.1 Sequence 10 from patent US 7364855
GTCCGCCCCAC
>EA618204.1 Sequence 7 from patent US 7364855
CGCCCCACATA
>EA618202.1 Sequence 5 from patent US 7364855
CCGCCCCACAT
>EA618200.1 Sequence 3 from patent US 7364855
GTCCGCCCCAC
>EA618050.1 Sequence 2 from patent US 7364847
GCTGCTACAAG
>EA617935.1 Sequence 135 from patent US 7364740
ACTCTTGGAGT
>EA617934.1 Sequence 134 from patent US 7364740
ACTCTTGGAGT
>EA498733.1 Sequence 172 from patent US 7358351
AACACAGTGCC
>EA498732.1 Sequence 171 from patent US 7358351
GAAACCCGGTA
>EA498731.1 Sequence 170 from patent US 7358351
CTCTAAAAAAA
>EA498730.1 Sequence 169 from patent US 7358351
GAGCAGTGCTG
>EA498729.1 Sequence 168 from patent US 7358351
TCGTGCTTTGT
>EA498728.1 Sequence 167 from patent US 7358351
CTTCTCACCTA
>EA498727.1 Sequence 166 from patent US 7358351
ACTCCGGTGTG
>EA498726.1 Sequence 165 from patent US 7358351
GACCGCGGCTT
>EA498725.1 Sequence 164 from patent US 7358351
TAAAGGCACAG
>EA498724.1 Sequence 163 from patent US 7358351
TGCATCTGTGC
>EA498723.1 Sequence 162 from patent US 7358351
ATAACCTGCAG
>EA498722.1 Sequence 161 from patent US 7358351
GTCACTAATTT
>EA498721.1 Sequence 160 from patent US 7358351
TAAATACTTGT
>EA498720.1 Sequence 159 from patent US 7358351
GCAAAGTGCCC
>EA498719.1 Sequence 158 from patent US 7358351
TCAGTGACCAG
>EA498718.1 Sequence 157 from patent US 7358351
AATATCTGACT
>EA498717.1 Sequence 156 from patent US 7358351
AAGGAGAACTG
>EA498716.1 Sequence 155 from patent US 7358351
GAATTCACCAG
>EA498715.1 Sequence 154 from patent US 7358351
TATTAAAATAG
>EA498714.1 Sequence 153 from patent US 7358351
CTCTTCAAAAA
>EA498713.1 Sequence 152 from patent US 7358351
TTGTTCAAGGG
>EA498712.1 Sequence 151 from patent US 7358351
GTAGAGGAAAA
>EA498711.1 Sequence 150 from patent US 7358351
AAGATGCACAC
>EA498710.1 Sequence 149 from patent US 7358351
ACAAAAAGGCC
>EA498709.1 Sequence 148 from patent US 7358351
TGTTGAAAAAA
>EA498708.1 Sequence 147 from patent US 7358351
ATTGCCAATCT
>EA498707.1 Sequence 146 from patent US 7358351
CTTTGTTTTGC
>EA498706.1 Sequence 145 from patent US 7358351
GTTTAAGGATG
>EA498705.1 Sequence 144 from patent US 7358351
TGGGAAGAGGG
>EA498704.1 Sequence 143 from patent US 7358351
CTCTTAAAAAA
>EA498703.1 Sequence 142 from patent US 7358351
GTGGCTGACGC
>EA498702.1 Sequence 141 from patent US 7358351
CTAGCGTTTTA
>EA498701.1 Sequence 140 from patent US 7358351
TCTCACGTCTC
>EA498700.1 Sequence 139 from patent US 7358351
ATCCCTTCCCG
>EA498699.1 Sequence 138 from patent US 7358351
GGCTTGCCTTT
>EA498698.1 Sequence 137 from patent US 7358351
CCCCACACGGG
>EA498697.1 Sequence 136 from patent US 7358351
TTCGGTTGGTC
>EA498696.1 Sequence 135 from patent US 7358351
AGTCACATAGT
>EA498695.1 Sequence 134 from patent US 7358351
ATCAAAGGTTT
>EA498694.1 Sequence 133 from patent US 7358351
GATGAGGAGAC
>EA498693.1 Sequence 132 from patent US 7358351
TGCCACACAGT
>EA498692.1 Sequence 131 from patent US 7358351
TGGAAATGACC
>EA498691.1 Sequence 130 from patent US 7358351
TTATGTTTAAT
>EA498690.1 Sequence 129 from patent US 7358351
TTTGTGTTGTA
>EA498689.1 Sequence 128 from patent US 7358351
GTGGAGACGGA
>EA498686.1 Sequence 125 from patent US 7358351
ACCAAAACCAC
>EA498685.1 Sequence 124 from patent US 7358351
AGAAACCACGG
>EA498684.1 Sequence 123 from patent US 7358351
CATTATCCAAA
>EA498683.1 Sequence 122 from patent US 7358351
TTGGGTGAAAA
>EA498682.1 Sequence 121 from patent US 7358351
TACAAATCGTT
>EA498681.1 Sequence 120 from patent US 7358351
ACTACCATAAC
>EA498680.1 Sequence 119 from patent US 7358351
AGCCCAAAGTG
>EA498679.1 Sequence 118 from patent US 7358351
TCCCCCAGGAG
>EA498678.1 Sequence 117 from patent US 7358351
AGACATACTGA
>EA498677.1 Sequence 116 from patent US 7358351
TTAAATAGCAC
>EA498676.1 Sequence 115 from patent US 7358351
GCCCTTTCTCT
>EA498675.1 Sequence 114 from patent US 7358351
TACCACCTCCC
>EA498674.1 Sequence 113 from patent US 7358351
GTTCCACAGAA
>EA498673.1 Sequence 112 from patent US 7358351
CTATAGGAGAC
>EA498672.1 Sequence 111 from patent US 7358351
CCACTGCAACC
>EA498671.1 Sequence 110 from patent US 7358351
ACAGACTGTTA
>EA498670.1 Sequence 109 from patent US 7358351
TTAAAAGTCAC
>EA498669.1 Sequence 108 from patent US 7358351
CCACAGGGGAT
>EA498668.1 Sequence 107 from patent US 7358351
GTACACACACC
>EA498667.1 Sequence 106 from patent US 7358351
GAGTGAGACCC
>EA498666.1 Sequence 105 from patent US 7358351
ACTTTAGATGG
>EA498665.1 Sequence 104 from patent US 7358351
ATTTTGTATGA
>EA498664.1 Sequence 103 from patent US 7358351
TTTGGTTTTCC
>EA498663.1 Sequence 102 from patent US 7358351
TTTTTAAGAAC
>EA498662.1 Sequence 101 from patent US 7358351
CCTGGTTCAGT
>EA498661.1 Sequence 100 from patent US 7358351
GGAAATGTCAA
>EA498660.1 Sequence 99 from patent US 7358351
CAGGAGACCCC
>EA498659.1 Sequence 98 from patent US 7358351
TATTAACTCTC
>EA498658.1 Sequence 97 from patent US 7358351
CTTTCTTTGAG
>EA498657.1 Sequence 96 from patent US 7358351
CATTTTTATCT
>EA498656.1 Sequence 95 from patent US 7358351
GATCTCCGTGT
>EA498655.1 Sequence 94 from patent US 7358351
GGGGCTGCCCA
>EA498654.1 Sequence 93 from patent US 7358351
CGTGGGGTGTA
>EA498653.1 Sequence 92 from patent US 7358351
AGCGATGGAGA
>EA498652.1 Sequence 91 from patent US 7358351
AGCAGAGACAA
>EA498651.1 Sequence 90 from patent US 7358351
GTCAGTCACTT
>EA498650.1 Sequence 89 from patent US 7358351
GTCAGGGTCCC
>EA498649.1 Sequence 88 from patent US 7358351
GAGTGGCTACC
>EA498648.1 Sequence 87 from patent US 7358351
TGGAACAGTGA
>EA498647.1 Sequence 86 from patent US 7358351
GGGTAGGGTGA
>EA498646.1 Sequence 85 from patent US 7358351
GAAGACACTTG
>EA498645.1 Sequence 84 from patent US 7358351
TCAAGCAATCA
>EA498644.1 Sequence 83 from patent US 7358351
TTAATGTGTAA
>EA498643.1 Sequence 82 from patent US 7358351
CTCTCCAAACC
>EA498642.1 Sequence 81 from patent US 7358351
GTCATTTTCTA
>EA498641.1 Sequence 80 from patent US 7358351
AAATATGTGTT
>EA498640.1 Sequence 79 from patent US 7358351
GGGCAGTGGCT
>EA498639.1 Sequence 78 from patent US 7358351
TCCCCTCTCTC
>EA498638.1 Sequence 77 from patent US 7358351
GTAGTTCTGGA
>EA498637.1 Sequence 76 from patent US 7358351
GAATGCTCTTG
>EA498636.1 Sequence 75 from patent US 7358351
TGACTGTATTA
>EA498635.1 Sequence 74 from patent US 7358351
GCAGCAGCAGC
>EA498634.1 Sequence 73 from patent US 7358351
CATCACGGATC
>EA498633.1 Sequence 72 from patent US 7358351
TGTGCTTTTTT
>EA498632.1 Sequence 71 from patent US 7358351
GCTAATAATGT
>EA498631.1 Sequence 70 from patent US 7358351
CTTCTCTTGAG
>EA498630.1 Sequence 69 from patent US 7358351
ACAAGTACCCA
>EA498629.1 Sequence 68 from patent US 7358351
GGTTGTTGCGG
>EA498628.1 Sequence 67 from patent US 7358351
GGCTTAGGATG
>EA498627.1 Sequence 66 from patent US 7358351
TCTGCTTCTAG
>EA498626.1 Sequence 65 from patent US 7358351
AGGCTCCTGGC
>EA498625.1 Sequence 64 from patent US 7358351
CAGATGGAGGC
>EA498624.1 Sequence 63 from patent US 7358351
CCCTGTTCAGC
>EA498623.1 Sequence 62 from patent US 7358351
CGAGAGTGTGA
>EA498622.1 Sequence 61 from patent US 7358351
TTGAATTTGTT
>EA498621.1 Sequence 60 from patent US 7358351
CCGGCCCCTCC
>EA498620.1 Sequence 59 from patent US 7358351
GTGCTACTTCT
>EA498619.1 Sequence 58 from patent US 7358351
AATAGGGGAAA
>EA498618.1 Sequence 57 from patent US 7358351
GTAATGACAGA
>EA498617.1 Sequence 56 from patent US 7358351
TTTGTATAGAA
>EA498616.1 Sequence 55 from patent US 7358351
ATACTATAATT
>EA498615.1 Sequence 54 from patent US 7358351
ACCGTTCTGTA
>EA498614.1 Sequence 53 from patent US 7358351
ACTGAAAGAAG
>EA498613.1 Sequence 52 from patent US 7358351
AACAGGGGCCA
>EA498612.1 Sequence 51 from patent US 7358351
TTTCATCCACT
>EA498611.1 Sequence 50 from patent US 7358351
TGGGAAACCTG
>EA498610.1 Sequence 49 from patent US 7358351
TGCCAGGTGCA
>EA498609.1 Sequence 48 from patent US 7358351
TCACAGCCCCC
>EA498608.1 Sequence 47 from patent US 7358351
GGCACTCCTGT
>EA498607.1 Sequence 46 from patent US 7358351
GAGCCTGGATA
>EA498606.1 Sequence 45 from patent US 7358351
ACATTCCAAGT
>EA498605.1 Sequence 44 from patent US 7358351
TCACCGTGGAC
>EA498604.1 Sequence 43 from patent US 7358351
ACAAGTACTGT
>EA498603.1 Sequence 42 from patent US 7358351
ATCACACAGCT
>EA498602.1 Sequence 41 from patent US 7358351
GCTAACCCCTG
>EA498601.1 Sequence 40 from patent US 7358351
GGCCCTACAGT
>EA498600.1 Sequence 39 from patent US 7358351
GAGCCATCATA
>EA498599.1 Sequence 38 from patent US 7358351
GTCCCTGCCTT
>EA498598.1 Sequence 37 from patent US 7358351
TGTTTAATACA
>EA498597.1 Sequence 36 from patent US 7358351
TACTTTATAAG
>EA498596.1 Sequence 35 from patent US 7358351
GCCTGTCCCTC
>EA498595.1 Sequence 34 from patent US 7358351
ACAAAGCATTT
>EA498594.1 Sequence 33 from patent US 7358351
CCCAGTAAGAT
>EA498593.1 Sequence 32 from patent US 7358351
TTTACAAAGAG
>EA498592.1 Sequence 31 from patent US 7358351
CCACGGGATTC
>EA498591.1 Sequence 30 from patent US 7358351
TATGAGGGTAA
>EA498590.1 Sequence 29 from patent US 7358351
GATAACTACAT
>EA498589.1 Sequence 28 from patent US 7358351
GCAATTTAACC
>EA498588.1 Sequence 27 from patent US 7358351
GGAAGCTAAGT
>EA498587.1 Sequence 26 from patent US 7358351
ACCGGCGCCCG
>EA498586.1 Sequence 25 from patent US 7358351
CAACAATAATA
>EA498585.1 Sequence 24 from patent US 7358351
CTTCTGGATAA
>EA498584.1 Sequence 23 from patent US 7358351
AGCTTGTGGCC
>EA498583.1 Sequence 22 from patent US 7358351
GCACAAGTTCT
>EA498582.1 Sequence 21 from patent US 7358351
CAGGTTTCATA
>EA498581.1 Sequence 20 from patent US 7358351
TCTCTGAGCAT
>EA498580.1 Sequence 19 from patent US 7358351
AAGATCAAGAT
>EA498579.1 Sequence 18 from patent US 7358351
TGTTCTGGAGA
>EA498578.1 Sequence 17 from patent US 7358351
CCCTTTCACAC
>EA498577.1 Sequence 16 from patent US 7358351
GTTTATGGATA
>EA498576.1 Sequence 15 from patent US 7358351
GTGCTAAGCGG
>EA498575.1 Sequence 14 from patent US 7358351
TTCTCCCAAAT
>EA498574.1 Sequence 13 from patent US 7358351
TTAGTGTCGTA
>EA498573.1 Sequence 12 from patent US 7358351
GGGATTAAAGC
>EA498572.1 Sequence 11 from patent US 7358351
ATGTCTTTTCT
>EA498571.1 Sequence 10 from patent US 7358351
TAATCCTCAAG
>EA498570.1 Sequence 9 from patent US 7358351
TCCCTGGCAGA
>EA498569.1 Sequence 8 from patent US 7358351
TTCTGCTCTTG
>EA498568.1 Sequence 7 from patent US 7358351
ACACTTCTTTC
>EA498567.1 Sequence 6 from patent US 7358351
ACCATTGGATT
>EA498566.1 Sequence 5 from patent US 7358351
TTGCTGACTTT
>EA498564.1 Sequence 3 from patent US 7358351
TTTGCACCTTT
>EA498563.1 Sequence 2 from patent US 7358351
TGCACTTCAAG
>EA498562.1 Sequence 1 from patent US 7358351
CATATCATTAA
>EA497065.1 Sequence 36 from patent US 7357928
GCGGTTTGCGG
>EA497051.1 Sequence 20 from patent US 7357928
GGTGGTGGTGG
>DJ418119.1 Tissue Products From Animals Lacking Functional Alpha 1,3 Galactosyltransferase
GCTGTCGGAAG
>DJ390574.1 Aptamer
CACTACCAGTG
>DJ387637.1 Polyamide nucleic acid derivatives with a negative charge, agents and methods for preparing them
GTTAGGGTTAG
>DJ387632.1 Polyamide nucleic acid derivatives with a negative charge, agents and methods for preparing them
TATTCCGTCAT
>DJ387580.1 Polyamide nucleic acid derivatives with a negative charge, agents and methods for preparing them
TATTCCGTCAT
>DJ380468.1 Segment synthesis
CGCACCCGCAT
>DJ380467.1 Segment synthesis
AGCGTGGGCGT
>DJ380203.1 Gene chip for neonate screening
GGACAAATCTG
>DJ379562.1 Methods for isolating and characterizing endogenous mRNA-protein (mRNP) complexes
NNTTTATTTNN
>CS725962.1 Sequence 36 from Patent EP1840209
GGATCCCCGGG
>CS725918.1 Sequence 6 from Patent WO2007105041
CCTGCAGCAGA
>CS723920.1 Sequence 178 from Patent WO2007100584
GAATTTCCAAA
>CS723919.1 Sequence 177 from Patent WO2007100584
TAAATGGCGGG
>CS723916.1 Sequence 174 from Patent WO2007100584
GGGAATTTCCA
>DJ358710.1 TRANSITION STATE ANALOG INHIBITORS OF RICIN A-CHAIN
CGCNNNGAGCG
>DJ347959.1 Detection method and detection kit of 5-methylcytosine in gene
CTGGGAGAGAC
>DJ347489.1 ssDNA oligomer modified with Deoxyguanosine Hybrid Compound
GCCAATTTGCG
>DJ347488.1 ssDNA oligomer modified with Deoxyguanosine Hybrid Compound
CGCAAATTGGC
>DJ347487.1 ssDNA oligomer modified with Deoxyguanosine Hybrid Compound
GCCAGACTCCG
>DJ347486.1 ssDNA oligomer modified with Deoxyguanosine Hybrid Compound
CGGAATTCGGC
>DJ347485.1 ssDNA oligomer modified with Deoxyguanosine Hybrid Compound
GCCGAATTCCG
>DJ347484.1 ssDNA oligomer modified with Deoxyguanosine Hybrid Compound
CGGAATGTGGC
>DJ347483.1 ssDNA oligomer modified with Deoxyguanosine Hybrid Compound
GCCAGATTCCG
>DJ347482.1 ssDNA oligomer modified with Deoxyguanosine Hybrid Compound
CGGAACTTGGC
>DJ347481.1 ssDNA oligomer modified with Deoxyguanosine Hybrid Compound
GCCAAGTTCCG
>DJ347480.1 ssDNA oligomer modified with Deoxyguanosine Hybrid Compound
CGGACTTTGGC
>DJ347479.1 ssDNA oligomer modified with Deoxyguanosine Hybrid Compound
GCCAAAGTCCG
>DJ347478.1 ssDNA oligomer modified with Deoxyguanosine Hybrid Compound
CGGCATTTGGC
>DJ347477.1 ssDNA oligomer modified with Deoxyguanosine Hybrid Compound
GCCAAATGCCG
>DJ347476.1 ssDNA oligomer modified with Deoxyguanosine Hybrid Compound
CGGAATTTGGC
>DJ347475.1 ssDNA oligomer modified with Deoxyguanosine Hybrid Compound
GCCAAATTCCG
>DJ347474.1 ssDNA oligomer modified with Deoxyguanosine Hybrid Compound
CGMAGTCTGGC
>DJ347473.1 ssDNA oligomer modified with Deoxyguanosine Hybrid Compound
CGMAATTCGGC
>DJ347472.1 ssDNA oligomer modified with Deoxyguanosine Hybrid Compound
CGMAATCTGGC
>DJ347471.1 ssDNA oligomer modified with Deoxyguanosine Hybrid Compound
CGMAACTTGGC
>DJ347470.1 ssDNA oligomer modified with Deoxyguanosine Hybrid Compound
CGMACTTTGGC
>DJ347469.1 ssDNA oligomer modified with Deoxyguanosine Hybrid Compound
CGMCATTTGGC
>DJ347468.1 ssDNA oligomer modified with Deoxyguanosine Hybrid Compound
CGMAATTTGGC
>DJ359507.1 OLIGONUCLEOTIDE ANALOG AND METHOD FOR TREATING FLAVIVIRUS INFECTIONS
TCTTGTTCTCC
>DJ359505.1 OLIGONUCLEOTIDE ANALOG AND METHOD FOR TREATING FLAVIVIRUS INFECTIONS
GGAGAACAAGA
>DJ357437.1 ANTIBODIES AGAINST T CELL IMMUNOGLOBULIN DOMAIN AND MUCIN DOMAIN 1 (TIM-1) ANTIGEN AND USES THEREOF
TTACTATGATA
>DJ357157.1 RECOMBINANT INFLUENZA VIRUSES HOLDING A MUTATION IN A TRANSMEMBRANE PROTEIN GENE
CTTAAATTTTA
>DJ357155.1 RECOMBINANT INFLUENZA VIRUSES HOLDING A MUTATION IN A TRANSMEMBRANE PROTEIN GENE
CTTAAATTTTA
>DJ357153.1 RECOMBINANT INFLUENZA VIRUSES HOLDING A MUTATION IN A TRANSMEMBRANE PROTEIN GENE
CTTAAATTTTA
>DJ357151.1 RECOMBINANT INFLUENZA VIRUSES HOLDING A MUTATION IN A TRANSMEMBRANE PROTEIN GENE
CTAAAATTTTA
>DJ357144.1 RECOMBINANT INFLUENZA VIRUSES HOLDING A MUTATION IN A TRANSMEMBRANE PROTEIN GENE
TATTAGTAGAA
>DJ350948.1 Stabilized Aptamers to Platelet Derived Growth Factor and Their Use as Oncology Therapeutics
CCCAGGCTACG
>DJ350946.1 Stabilized Aptamers to Platelet Derived Growth Factor and Their Use as Oncology Therapeutics
CACAGGCTACG
>DJ350943.1 Stabilized Aptamers to Platelet Derived Growth Factor and Their Use as Oncology Therapeutics
CACAGGCTACG
>DJ350929.1 Stabilized Aptamers to Platelet Derived Growth Factor and Their Use as Oncology Therapeutics
CACAGGCTACG
>DJ362937.1 THAP PROTEINS AS NUCLEAR RECEPTORS FOR CHEMOKINES AND ROLES IN TRANSCRIPTIONAL REGULATION, CELL PROLIFERATION AND CELL DIFFERENTIATION
AGTGTGGGCAT
>DJ362931.1 THAP PROTEINS AS NUCLEAR RECEPTORS FOR CHEMOKINES AND ROLES IN TRANSCRIPTIONAL REGULATION, CELL PROLIFERATION AND CELL DIFFERENTIATION
AGTAAGGGAAA
>DJ362930.1 THAP PROTEINS AS NUCLEAR RECEPTORS FOR CHEMOKINES AND ROLES IN TRANSCRIPTIONAL REGULATION, CELL PROLIFERATION AND CELL DIFFERENTIATION
AGTAAGGGCCA
>DJ362929.1 THAP PROTEINS AS NUCLEAR RECEPTORS FOR CHEMOKINES AND ROLES IN TRANSCRIPTIONAL REGULATION, CELL PROLIFERATION AND CELL DIFFERENTIATION
AGTAAGTGCAA
>DJ362928.1 THAP PROTEINS AS NUCLEAR RECEPTORS FOR CHEMOKINES AND ROLES IN TRANSCRIPTIONAL REGULATION, CELL PROLIFERATION AND CELL DIFFERENTIATION
AGTAAGGTCAA
>DJ362927.1 THAP PROTEINS AS NUCLEAR RECEPTORS FOR CHEMOKINES AND ROLES IN TRANSCRIPTIONAL REGULATION, CELL PROLIFERATION AND CELL DIFFERENTIATION
AGTAATTTCAA
>DJ362926.1 THAP PROTEINS AS NUCLEAR RECEPTORS FOR CHEMOKINES AND ROLES IN TRANSCRIPTIONAL REGULATION, CELL PROLIFERATION AND CELL DIFFERENTIATION
AGTAAGGGCAA
>DJ362925.1 THAP PROTEINS AS NUCLEAR RECEPTORS FOR CHEMOKINES AND ROLES IN TRANSCRIPTIONAL REGULATION, CELL PROLIFERATION AND CELL DIFFERENTIATION
NNTNNNGGCAN
>DJ350128.1 EXPANDING THE EUKARYOTIC GENETIC CODE
GGTTCGANTCC
>DJ350056.1 MODULATION OF TELOMERE-INITIATED CELL SIGNALING
GATCGATCGAT
>DJ350055.1 MODULATION OF TELOMERE-INITIATED CELL SIGNALING
CTAACCCTAAC
>DJ350054.1 MODULATION OF TELOMERE-INITIATED CELL SIGNALING
GTTAGGGTTAG
>DJ349934.1 Methods for Selecting Medications
GAAGGAGCTGA
>DJ349924.1 Methods for Selecting Medications
GCATTCCTCAC
>DJ349923.1 Methods for Selecting Medications
GCATTCCTCAG
>DJ349909.1 Methods for Selecting Medications
AAAGGGAGCCA
>DJ349898.1 Methods for Selecting Medications
ACGTCGGAGAT
>DJ349884.1 Methods for Selecting Medications
GCACAGAGCAT
>DJ349883.1 Methods for Selecting Medications
GCACAGAGCAC
>DJ349844.1 Methods for Selecting Medications
GGACGAGTAGC
>DJ349843.1 Methods for Selecting Medications
GGACGAGTAGA
>DJ362383.1 BIOLOGICALLY-ACTIVE DNA-BINDING SITES AND RELATED METHODS
GYGWCASWAAW
>DJ362380.1 BIOLOGICALLY-ACTIVE DNA-BINDING SITES AND RELATED METHODS
YMTGTMTYTAW
>DJ362379.1 BIOLOGICALLY-ACTIVE DNA-BINDING SITES AND RELATED METHODS
YGGCGCTAYCA
>DJ362365.1 BIOLOGICALLY-ACTIVE DNA-BINDING SITES AND RELATED METHODS
SGTGCGSYGYG
>DJ362355.1 BIOLOGICALLY-ACTIVE DNA-BINDING SITES AND RELATED METHODS
AAKGAAANKWA
>DJ362349.1 BIOLOGICALLY-ACTIVE DNA-BINDING SITES AND RELATED METHODS
GGNNATANCGS
>DJ362348.1 BIOLOGICALLY-ACTIVE DNA-BINDING SITES AND RELATED METHODS
GATAAGATAAG
>DJ349838.1 Methods for Selecting Medications
TTCAGGTGGCT
>DJ349804.1 Methods for Selecting Medications
GGTGTCGGAAA
>DJ349803.1 Methods for Selecting Medications
GGTGTCGGAAC
>DJ349792.1 Methods for Selecting Medications
GAGCTGGTGAA
>DJ349791.1 Methods for Selecting Medications
GAGCTGGTGAG
>DJ361002.1 COMPOSITIONS FOR USE IN IDENTIFICATION OF BACTERIA
TATTCTTCGTT
>DJ361001.1 COMPOSITIONS FOR USE IN IDENTIFICATION OF BACTERIA
TACTCATGCCA
>DJ360647.1 COMPOSITIONS FOR USE IN IDENTIFICATION OF BACTERIA
TCCACCCTCAA
>DJ343155.1 Modulators of body weight, corresponding nucleic acids and proteins, and diagnostic and therapeutic uses thereof
AGCAGTCGGTA
>DJ348077.1 Anti-cancer agent comprising PGK-alpha inhibitor
GGGGACTTTCC
>EA496531.1 Sequence 28 from patent US 7355033
GATCTCTAGAT
>EA496123.1 Sequence 453 from patent US 7355024
TGAATGTTCCT
>EA496101.1 Sequence 431 from patent US 7355024
AAAACAAAGAT
>EA496090.1 Sequence 420 from patent US 7355024
TTTACATAAAT
>EA496062.1 Sequence 392 from patent US 7355024
GCAACCACTGA
>EA496056.1 Sequence 386 from patent US 7355024
TAAGGAAAAAC
>EA496055.1 Sequence 385 from patent US 7355024
GGAAAAACAGA
>EA496053.1 Sequence 383 from patent US 7355024
ATCTATTCATC
>EA496045.1 Sequence 375 from patent US 7355024
TGTGGAAAACA
>EA496040.1 Sequence 369 from patent US 7355024
GGAAAAAAAGC
>EA496039.1 Sequence 368 from patent US 7355024
AAAGGAAAAAA
>EA496022.1 Sequence 351 from patent US 7355024
ATTAACTGCTG
>EA496013.1 Sequence 342 from patent US 7355024
AGTGGAAACAG
>EA496001.1 Sequence 330 from patent US 7355024
CTTGAACTCAA
>EA495999.1 Sequence 328 from patent US 7355024
AGAGCCATTGA
>EA495996.1 Sequence 325 from patent US 7355024
TTTACCTCAGT
>EA495966.1 Sequence 295 from patent US 7355024
CTTACATTTTT
>EA495964.1 Sequence 293 from patent US 7355024
AGTGATTCATA
>EA495956.1 Sequence 285 from patent US 7355024
AGAAAAAATCC
>EA495908.1 Sequence 237 from patent US 7355024
TTTACATATTT
>EA495896.1 Sequence 224 from patent US 7355024
GCAATAGCCAG
>EA495889.1 Sequence 216 from patent US 7355024
ATTACACAATG
>EA495878.1 Sequence 205 from patent US 7355024
GTTACCTCACT
>EA495874.1 Sequence 200 from patent US 7355024
ACTCATTCATA
>EA495850.1 Sequence 175 from patent US 7355024
CTAGCCATTAA
>EA495843.1 Sequence 167 from patent US 7355024
TAATAATTAAG
>EA495818.1 Sequence 140 from patent US 7355024
CCCACCTATCT
>EA495810.1 Sequence 132 from patent US 7355024
TCAACCAATAA
>EA495789.1 Sequence 111 from patent US 7355024
GGAGGAAAAAG
>EA495788.1 Sequence 110 from patent US 7355024
GGAAAAAGAGA
>EA495785.1 Sequence 107 from patent US 7355024
AGAAAAACTGA
>EA495784.1 Sequence 106 from patent US 7355024
AAAAACTGAAT
>EA495782.1 Sequence 104 from patent US 7355024
ACTGATTCAGT
>EA495779.1 Sequence 101 from patent US 7355024
GCAAAAAATGA
>EA492334.1 Sequence 16 from patent US 7354710
GCCCACTACAG
>EA492333.1 Sequence 15 from patent US 7354710
CGCCCACTACA
>EA491469.1 Sequence 12 from patent US 7351813
TATTGAYTTWG
>EA489383.1 Sequence 56 from patent US 7351578
GAAAGCTGGGT
>EA489382.1 Sequence 55 from patent US 7351578
AAAAGCAGGCT
>EA482805.1 Sequence 1 from patent US 7345159
ACGTACGACGT
>EA481708.1 Sequence 128 from patent US 7345142
GTGGTTTGAAA
>EA480762.1 Sequence 39 from patent US 7344841
CTTATTTCCCT
>EA480677.1 Sequence 3 from patent US 7344834
TACTACGTTCT
>EA480675.1 Sequence 1 from patent US 7344834
ATGATGCAAGA
>EA479811.1 Sequence 4 from patent US 7342109
AGTAAGTCCAT
>EA479810.1 Sequence 3 from patent US 7342109
ATGGACTTACT
>EA478440.1 Sequence 33 from patent US 7341871
TCGAGGAAGGA
>EA478090.1 Sequence 3 from patent US 7341848
CCAATTAGAAG
>EA478088.1 Sequence 1 from patent US 7341848
CCAATNNNNNN
>EA447741.1 Sequence 1 from patent US 7339045
AAAAAAGGGGG
>EA446084.1 Sequence 17 from patent US 7338800
CCANNNNNTGG
>EA446083.1 Sequence 16 from patent US 7338800
GCNNNNNNNGC
>EA446078.1 Sequence 10 from patent US 7338800
CCTNNNNNAGG
>EA446075.1 Sequence 7 from patent US 7338800
GCANNNNNTGC
>EA446074.1 Sequence 6 from patent US 7338800
CCNNNNNNNGG
>EA446072.1 Sequence 4 from patent US 7338800
GCCNNNNNGGC
>EA446069.1 Sequence 1 from patent US 7338800
GACNNNNNGTC
>EA445836.1 Sequence 5324 from patent US 7338786
GTGGTGAAGAC
>EA442974.1 Sequence 22 from patent US 7338764
GGAAGTCCTGC
>EA442973.1 Sequence 21 from patent US 7338764
GGGAGTCCTGC
>EA442404.1 Sequence 45 from patent US 7338656
CCANNNNNTGG
>EA442403.1 Sequence 43 from patent US 7338656
GCNNNNNNNGC
>EA442400.1 Sequence 39 from patent US 7338656
CCTNNNNNAGG
>EA442397.1 Sequence 35 from patent US 7338656
GCANNNNNTGC
>EA442396.1 Sequence 34 from patent US 7338656
CCNNNNNNNGG
>EA442394.1 Sequence 32 from patent US 7338656
GCCNNNNNGGC
>EA442391.1 Sequence 28 from patent US 7338656
GACNNNNNGTC
>EA436516.1 Sequence 5324 from patent US 7335493
GTGGTGAAGAC
>EA431989.1 Sequence 2 from patent US 7332322
TCTAGGTGAGC
>EA427979.1 Sequence 81 from patent US 7332291
GGGGACTTTCC
>EA426808.1 Sequence 7 from patent US 7332277
CCTNNNNNAGG
>EA426435.1 Sequence 90 from patent US 7332169
CGCGAGSCTCG
>DJ336262.1 Albumin Fusion Proteins
CCGCCACCATG
>DJ330620.1 Direct Nucleic Acid Detection in Bodily Fluids
CGCGCCGAGGN
>DJ330569.1 Direct Nucleic Acid Detection in Bodily Fluids
TCCGCGCGTCC
>DJ327660.1 GENETIC DIAGNOSIS USING MULTIPLE SEQUENCE VARIANT ANALYSIS
ATACGCTGNCN
>DJ327659.1 GENETIC DIAGNOSIS USING MULTIPLE SEQUENCE VARIANT ANALYSIS
ATNCGCTGTCC
>DJ327658.1 GENETIC DIAGNOSIS USING MULTIPLE SEQUENCE VARIANT ANALYSIS
ATACNCTGNCC
>DJ327657.1 GENETIC DIAGNOSIS USING MULTIPLE SEQUENCE VARIANT ANALYSIS
NTACGCTGTCC
>DJ327656.1 GENETIC DIAGNOSIS USING MULTIPLE SEQUENCE VARIANT ANALYSIS
ATANGCTGTCC
>DJ327655.1 GENETIC DIAGNOSIS USING MULTIPLE SEQUENCE VARIANT ANALYSIS
ATACGNTCTCN
>DJ327654.1 GENETIC DIAGNOSIS USING MULTIPLE SEQUENCE VARIANT ANALYSIS
ANACGCTCTNC
>DJ327653.1 GENETIC DIAGNOSIS USING MULTIPLE SEQUENCE VARIANT ANALYSIS
NTACGCTNTCC
>DJ327652.1 GENETIC DIAGNOSIS USING MULTIPLE SEQUENCE VARIANT ANALYSIS
ATACGCTGTCC
>DJ327651.1 GENETIC DIAGNOSIS USING MULTIPLE SEQUENCE VARIANT ANALYSIS
ATACGCTGTCN
>DJ327650.1 GENETIC DIAGNOSIS USING MULTIPLE SEQUENCE VARIANT ANALYSIS
GNNAANCCATA
>DJ327649.1 GENETIC DIAGNOSIS USING MULTIPLE SEQUENCE VARIANT ANALYSIS
GGTAATCCTTA
>DJ327648.1 GENETIC DIAGNOSIS USING MULTIPLE SEQUENCE VARIANT ANALYSIS
GGTAATCCATA
>DJ326589.1 A method of synthesizing a suppressor tRNA, DNA construct and use thereof for producing an unnatural amino acid incorparated protein
GGTTCGANTCC
>DI011895.1 Replicons derived from positive strand RNA virusgenomes useful for the production of heterologousproteins
CGAAGCTAGCC
>DI008368.1 CHIMERIC IMMUNOMODULATORY COMPOUNDS AND METHODS OF USING THE SAME
TNGAANGTTCG
>DI008343.1 Adenoviral transfer vector for the gene transfort of a DNA sequence
AGGAGGCCTGA
>DI008271.1 TROVAC FOWLPOX VIRUS RECOMBINANTS AND USES THEREOF
AATTCAACCGC
>DI006378.1 POLYMORPHIC LOCI THAT DIFFERENTIATE ESCHERICHIA COLI 0157:H7 FROMOTHER STRAINS
AGCTTGCCCTG
>DI023397.1 ALVAC CANARYPOX VIRUS RECOMBINANTS AND USES THEREOF
GATCTCCCGGG
>DI023392.1 DNA sequences comprising gene transcription regulatory qualities and
CGCNNNNNGAG
>DJ089849.1 Mutated DNA polymerases with increased mispairing discrimination
TAAGGAYCGGA
>DJ089848.1 Mutated DNA polymerases with increased mispairing discrimination
GTGAATRCAAC
>DJ089847.1 Mutated DNA polymerases with increased mispairing discrimination
CTAAAGWGACA
>DJ089793.1 Promoter
ACGCTACTTCT
>DJ089037.1 Test system and method for the detection of analytes
GATACCGAGCG
>DJ087236.1 High Titer Recombinant Influenza Viruses for Vaccines and Gene Therapy
TATTAGTAGAA
>DJ086447.1 siRNA expression system
GTCCCCTATTT
>DI167005.1 SEMI-SOFT C-CLASS IMMUNOSTIMULATORY OLIGONUCLEOTIDES
CCGTTTTGTGG
>DI166926.1 SEMI-SOFT C-CLASS IMMUNOSTIMULATORY OLIGONUCLEOTIDES
TCGTCGTTTTA
>DI166913.1 SEMI-SOFT C-CLASS IMMUNOSTIMULATORY OLIGONUCLEOTIDES
GTCGAGGAGGT
>DI165622.1 c-Met Kinase Binding Proteins
CGCCGTCGCAA
>DI164482.1 c-Met Kinase Binding Proteins
TTGCGACGGCG
>DI164038.1 IMMUNOSTIMULATORY OLIGONUCLEOTIDE MULTIMERS
TCNAACNTTCN
>DI163885.1 IMMUNOSTIMULATORY OLIGONUCLEOTIDE MULTIMERS
TCNAACNTTCG
>DI163855.1 IMMUNOSTIMULATORY OLIGONUCLEOTIDE MULTIMERS
TCNAANGTTCN
>DI163798.1 IMMUNOSTIMULATORY OLIGONUCLEOTIDE MULTIMERS
TCCAACCTTCG
>DI163774.1 IMMUNOSTIMULATORY OLIGONUCLEOTIDE MULTIMERS
TCTGTCNTTCT
>DI163718.1 IMMUNOSTIMULATORY OLIGONUCLEOTIDE MULTIMERS
TCGAACGTTCG
>DI163527.1 IMMUNOSTIMULATORY OLIGONUCLEOTIDE MULTIMERS
TCTCACCTTCT
>DI163479.1 IMMUNOSTIMULATORY OLIGONUCLEOTIDE MULTIMERS
TNCAANCTTNC
>DI163341.1 IMMUNOSTIMULATORY OLIGONUCLEOTIDE MULTIMERS
TCNTTNCAACN
>DI163126.1 IMMUNOSTIMULATORY OLIGONUCLEOTIDE MULTIMERS
TCNAACNTTCN
>DI162962.1 IMMUNOSTIMULATORY OLIGONUCLEOTIDE MULTIMERS
TCTGTCNTTCT
>DI162861.1 IMMUNOSTIMULATORY OLIGONUCLEOTIDE MULTIMERS
TCNAACNTTCN
>DI162658.1 IMMUNOSTIMULATORY OLIGONUCLEOTIDE MULTIMERS
TCNAACNTTCN
>DI162614.1 IMMUNOSTIMULATORY OLIGONUCLEOTIDE MULTIMERS
TCNAACNTTCN
>DI162172.1 IMMUNOSTIMULATORY OLIGONUCLEOTIDE MULTIMERS
TCNAACNTTCG
>DI161840.1 IMMUNOSTIMULATORY OLIGONUCLEOTIDE MULTIMERS
TCTGTCNACAG
>DI161605.1 IMMUNOSTIMULATORY OLIGONUCLEOTIDE MULTIMERS
TCTCACCTTCT
>DI161511.1 IMMUNOSTIMULATORY OLIGONUCLEOTIDE MULTIMERS
TCNAANGTTCN
>DI161426.1 IMMUNOSTIMULATORY OLIGONUCLEOTIDE MULTIMERS
TCNTTCNAACN
>DI161113.1 IMMUNOSTIMULATORY OLIGONUCLEOTIDE MULTIMERS
TCNTGTCNTTT
>DI161007.1 IMMUNOSTIMULATORY OLIGONUCLEOTIDE MULTIMERS
TNCAANCTTNC
>DI160934.1 IMMUNOSTIMULATORY OLIGONUCLEOTIDE MULTIMERS
TNCAANCTTNC
>DI160925.1 IMMUNOSTIMULATORY OLIGONUCLEOTIDE MULTIMERS
TCTGTNGTTCT
>DI160557.1 IMMUNOSTIMULATORY OLIGONUCLEOTIDE MULTIMERS
TCNAACNTTCN
>DI159988.1 Albumin Fusion Proteins
CCGCCACCATG
>DI158890.1 A kit for discriminating genetical identification among Cervusspecies by pyrosequencing methods
CAGTTCATGGG
>DI158030.1 METHOD OF DETECTING ncRNA
ACAAGTGCCCT
>DI157946.1 METHOD OF DETECTING ncRNA
CTGGGACTTTG
>DI157753.1 METHOD OF DETECTING ncRNA
CCATCTTTACC
>DI157737.1 METHOD OF DETECTING ncRNA
CCGGTATTCCC
>DI157665.1 METHOD OF DETECTING ncRNA
ACCCAGCTTTT
>DI157660.1 METHOD OF DETECTING ncRNA
ACAATGCTGCT
>DI157472.1 METHOD OF DETECTING ncRNA
CTGATGCAGTA
>DI157372.1 METHOD OF DETECTING ncRNA
GGCAATGTGAT
>DI157264.1 A kit for discriminating genetical identification among Cervusspecies by pyrosequencing methods
CGGTTTATGGG
>DI157250.1 A kit for discriminating genetical identification among Cervusspecies by pyrosequencing methods
CGATTCATGGG
>DI157213.1 METHOD OF DETECTING ncRNA
TAAGCACTTTA
>DI157106.1 METHOD OF DETECTING ncRNA
ATGTATGTGGG
>DI156829.1 METHOD OF DETECTING ncRNA
ACGGTAAACCA
>DI156623.1 METHOD OF DETECTING ncRNA
CTGCCTGTCTG
>DI156577.1 METHOD OF DETECTING ncRNA
ACAATGCTGCT
>DI156485.1 METHOD OF DETECTING ncRNA
ACAAAATCACA
>DI156084.1 A kit for discriminating genetical identification among Cervusspecies by pyrosequencing methods
CGATCTATGGG
>DI155491.1 MODULATION OF IMMUNOSTIMULATORY PROPERTIES BYSMALL OLIGONUCLEOTIDE-BASED COMPOUNDS
TCTTTNGTTCT
>DI154930.1 MODULATION OF IMMUNOSTIMULATORY PROPERTIES BYSMALL OLIGONUCLEOTIDE-BASED COMPOUNDS
TCTGACNTTCT
>DI154521.1 Humanized Antibodies that RecognizeBeta-Amyloid Peptide
GGACGGGACAG
>DI154235.1 NOVEL VECTORS AND USE THEREOF
GACNNTNNGTC
>DI153984.1 NOVEL VECTORS AND USE THEREOF
GACNNANNGTC
>DI153972.1 MODULATION OF IMMUNOSTIMULATORY PROPERTIES BYSMALL OLIGONUCLEOTIDE-BASED COMPOUNDS
CTGTCNTTCTC
>DI153823.1 Decoy nucleic acid against syobiolin promoter
GCCGGAAGTGA
>DI153748.1 MODULATION OF IMMUNOSTIMULATORY PROPERTIES BYSMALL OLIGONUCLEOTIDE-BASED COMPOUNDS
TCTGTCNTTCT
>DI153371.1 NOVEL VECTORS AND USE THEREOF
GACNNTNNGTC
>DI153130.1 MODULATION OF IMMUNOSTIMULATORY PROPERTIES BYSMALL OLIGONUCLEOTIDE-BASED COMPOUNDS
TCTGTNGTTCT
>DI153112.1 MODULATION OF IMMUNOSTIMULATORY PROPERTIES BYSMALL OLIGONUCLEOTIDE-BASED COMPOUNDS
TCTGANGTTCT
>DI152795.1 MODULATION OF IMMUNOSTIMULATORY PROPERTIES BYSMALL OLIGONUCLEOTIDE-BASED COMPOUNDS
CCTACTAGCGT
>DI152645.1 MODULATION OF IMMUNOSTIMULATORY PROPERTIES BYSMALL OLIGONUCLEOTIDE-BASED COMPOUNDS
TCTTTCNTTCT
>DI152050.1 MODULATION OF IMMUNOSTIMULATORY PROPERTIES BYSMALL OLIGONUCLEOTIDE-BASED COMPOUNDS
TCTGTNNTTCT
>DI151924.1 MODULATION OF IMMUNOSTIMULATORY PROPERTIES BYSMALL OLIGONUCLEOTIDE-BASED COMPOUNDS
ACGTTCTCTGT
>DI151750.1 MODULATION OF IMMUNOSTIMULATORY PROPERTIES BYSMALL OLIGONUCLEOTIDE-BASED COMPOUNDS
GCGTTCTCATC
>DI151543.1 NOVEL VECTORS AND USE THEREOF
GACNNANNGTC
>DI151511.1 MODULATION OF IMMUNOSTIMULATORY PROPERTIES BYSMALL OLIGONUCLEOTIDE-BASED COMPOUNDS
CTATCTGACGT
>DI151235.1 MODULATION OF IMMUNOSTIMULATORY PROPERTIES BYSMALL OLIGONUCLEOTIDE-BASED COMPOUNDS
TCTGTCGTTCT
>DI147326.1 NUCLEOTIDES FOR PREVENTION AND TREATMENT OF BACTERIALAND FUNGAL PATHOLOGIES
TGGGGAGTGAG
>DI145722.1 NUCLEOTIDES FOR PREVENTION AND TREATMENT OF BACTERIALAND FUNGAL PATHOLOGIES
TGATGACCTTT
>DI144785.1 NUCLEOTIDES FOR PREVENTION AND TREATMENT OF BACTERIALAND FUNGAL PATHOLOGIES
CTTTCAACAGT
>DI143269.1 NUCLEOTIDES FOR PREVENTION AND TREATMENT OF BACTERIALAND FUNGAL PATHOLOGIES
TTTTGATGACC
>DI140933.1 OLIGONUCLEOTIDE ANALOG AND METHOD FOR TREATING FLAVIVIRUSINFECTIONS
GGAGAACAAGA
>DI139711.1 A microarray having probe polynucleotide spots binding to a sametarget polynucleotide fragment maximally apart therebetween and amethod of producing the same
GCCCAGCCCCT
>DI139710.1 A HERBICIDE METABOLIZING PROTEIN, A GENE THEREOF AND USE THEREOF
TAGCGGCCGCA
>DI139686.1 Polyamide nucleic acid derivatives, agents andmethods for producing them
TATTCCGTCAT
>DI139029.1 A microarray having probe polynucleotide spots binding to a sametarget polynucleotide fragment maximally apart therebetween and amethod of producing the same
GAAGCGGGCCG
>DI138374.1 MODULATION OF IMMUNOSTIMULATORY PROPERTIES OFOLIGONUCLEOTIDE-BASED COMPOUNDS BY UTILIZING MODIFIEDIMMUNOSTIMULATORY DINUCLEOTIDES
TCTGTNGTTCT
>DI138326.1 MODULATION OF IMMUNOSTIMULATORY PROPERTIES OFOLIGONUCLEOTIDE-BASED COMPOUNDS BY UTILIZING MODIFIEDIMMUNOSTIMULATORY DINUCLEOTIDES
TCTGTNGTTCT
>DI138081.1 MODULATION OF IMMUNOSTIMULATORY PROPERTIES OFOLIGONUCLEOTIDE-BASED COMPOUNDS BY UTILIZING MODIFIEDIMMUNOSTIMULATORY DINUCLEOTIDES
TCTTTNGTTCT
>DI137950.1 MODULATION OF IMMUNOSTIMULATORY PROPERTIES OFOLIGONUCLEOTIDE-BASED COMPOUNDS BY UTILIZING MODIFIEDIMMUNOSTIMULATORY DINUCLEOTIDES
TNNTNNTTCTG
>DI137776.1 A microarray having probe polynucleotide spots binding to a sametarget polynucleotide fragment maximally apart therebetween and amethod of producing the same
GACCGGCACAC
>DI137515.1 MODULATION OF IMMUNOSTIMULATORY PROPERTIES OFOLIGONUCLEOTIDE-BASED COMPOUNDS BY UTILIZING MODIFIEDIMMUNOSTIMULATORY DINUCLEOTIDES
CTGTCNTTCTC
>DI136968.1 MODULATION OF IMMUNOSTIMULATORY PROPERTIES OFOLIGONUCLEOTIDE-BASED COMPOUNDS BY UTILIZING MODIFIEDIMMUNOSTIMULATORY DINUCLEOTIDES
TCTGANNTTCT
>DI136850.1 MODULATION OF IMMUNOSTIMULATORY PROPERTIES OFOLIGONUCLEOTIDE-BASED COMPOUNDS BY UTILIZING MODIFIEDIMMUNOSTIMULATORY DINUCLEOTIDES
CTATCTGACGT
>DI136846.1 MODULATION OF IMMUNOSTIMULATORY PROPERTIES OFOLIGONUCLEOTIDE-BASED COMPOUNDS BY UTILIZING MODIFIEDIMMUNOSTIMULATORY DINUCLEOTIDES
CTGTCNTTCTC
>DI136372.1 MODULATION OF IMMUNOSTIMULATORY PROPERTIES OFOLIGONUCLEOTIDE-BASED COMPOUNDS BY UTILIZING MODIFIEDIMMUNOSTIMULATORY DINUCLEOTIDES
TCTGTCGTTCT
>DI136043.1 Peptide nucleic acid derivatives with a negative charge,agents and methods for producing them
GTTAGGGTTAG
>DI135765.1 Height-related gene
ATATTCTCCCC
>DI135750.1 MODULATION OF IMMUNOSTIMULATORY PROPERTIES OFOLIGONUCLEOTIDE-BASED COMPOUNDS BY UTILIZING MODIFIEDIMMUNOSTIMULATORY DINUCLEOTIDES
TNGTNGTTCTG
>DI135295.1 MODULATION OF IMMUNOSTIMULATORY PROPERTIES OFOLIGONUCLEOTIDE-BASED COMPOUNDS BY UTILIZING MODIFIEDIMMUNOSTIMULATORY DINUCLEOTIDES
CTGTNGTTCTC
>DI135278.1 MODULATION OF IMMUNOSTIMULATORY PROPERTIES OFOLIGONUCLEOTIDE-BASED COMPOUNDS BY UTILIZING MODIFIEDIMMUNOSTIMULATORY DINUCLEOTIDES
TCTGACGTTCT
>DI135244.1 MODULATION OF IMMUNOSTIMULATORY PROPERTIES OFOLIGONUCLEOTIDE-BASED COMPOUNDS BY UTILIZING MODIFIEDIMMUNOSTIMULATORY DINUCLEOTIDES
TCTGTNNTTCT
>DI134751.1 Screening system of reassortant influenza viruses using primerdependent multiplex RT-PCR
AGCAAAGCAGG
>DI134492.1 Polyamide nucleic acid derivatives, agents andmethods for producing them
TATTCCGTCAT
>DI134234.1 MODULATION OF IMMUNOSTIMULATORY PROPERTIES OFOLIGONUCLEOTIDE-BASED COMPOUNDS BY UTILIZING MODIFIEDIMMUNOSTIMULATORY DINUCLEOTIDES
CTATCTGACGT
>DI133667.1 Peptide nucleic acid derivatives with a negative charge,agents and methods for producing them
TATTCCGTCAT
>DI133411.1 MODULATION OF IMMUNOSTIMULATORY PROPERTIES OFOLIGONUCLEOTIDE-BASED COMPOUNDS BY UTILIZING MODIFIEDIMMUNOSTIMULATORY DINUCLEOTIDES
TCTGACNTTCT
>DI133076.1 MODULATION OF IMMUNOSTIMULATORY PROPERTIES OFOLIGONUCLEOTIDE-BASED COMPOUNDS BY UTILIZING MODIFIEDIMMUNOSTIMULATORY DINUCLEOTIDES
TNGTNGTTCTG
>DI132806.1 IMMUNOSTIMULATORY NUCLEIC ACIDS
TCGTCGTTTTG
>DI132174.1 MODULATION OF IMMUNOSTIMULATORY PROPERTIES OFOLIGONUCLEOTIDE-BASED COMPOUNDS BY UTILIZING MODIFIEDIMMUNOSTIMULATORY DINUCLEOTIDES
CTGTNGTTCTC
>DI131843.1 Humanized Antibodies that RecognizeBeta-Amyloid Peptide
GGACGGTTGGG
>DI131409.1 MODULATION OF IMMUNOSTIMULATORY PROPERTIES OFOLIGONUCLEOTIDE-BASED COMPOUNDS BY UTILIZING MODIFIEDIMMUNOSTIMULATORY DINUCLEOTIDES
ACGTTCTCTGT
>DI131063.1 Humanized Antibodies that RecognizeBeta-Amyloid Peptide
GGACGGGACAG
>DI130352.1 MODULATION OF IMMUNOSTIMULATORY PROPERTIES OFOLIGONUCLEOTIDE-BASED COMPOUNDS BY UTILIZING MODIFIEDIMMUNOSTIMULATORY DINUCLEOTIDES
CTGTNGTTCTC
>DI130255.1 IMMUNOSTIMULATORY NUCLEIC ACIDS
GTTTTGTCGTT
>DI130059.1 MODULATION OF IMMUNOSTIMULATORY PROPERTIES OFOLIGONUCLEOTIDE-BASED COMPOUNDS BY UTILIZING MODIFIEDIMMUNOSTIMULATORY DINUCLEOTIDES
TCTGACGTTCT
>DI129580.1 MODULATION OF IMMUNOSTIMULATORY PROPERTIES OFOLIGONUCLEOTIDE-BASED COMPOUNDS BY UTILIZING MODIFIEDIMMUNOSTIMULATORY DINUCLEOTIDES
TCTGACGTTCT
>DI129523.1 MODULATION OF IMMUNOSTIMULATORY PROPERTIES OFOLIGONUCLEOTIDE-BASED COMPOUNDS BY UTILIZING MODIFIEDIMMUNOSTIMULATORY DINUCLEOTIDES
TNGTNGTTCTG
>DI129345.1 A microarray having probe polynucleotide spots binding to a sametarget polynucleotide fragment maximally apart therebetween and amethod of producing the same
GGGAGTCCTGC
>DI128994.1 MODULATION OF IMMUNOSTIMULATORY PROPERTIES OFOLIGONUCLEOTIDE-BASED COMPOUNDS BY UTILIZING MODIFIEDIMMUNOSTIMULATORY DINUCLEOTIDES
TCTGACNTTCT
>DI128852.1 MODULATION OF IMMUNOSTIMULATORY PROPERTIES OFOLIGONUCLEOTIDE-BASED COMPOUNDS BY UTILIZING MODIFIEDIMMUNOSTIMULATORY DINUCLEOTIDES
TCTGTCGTTCT
>DI128716.1 MODULATION OF IMMUNOSTIMULATORY PROPERTIES OFOLIGONUCLEOTIDE-BASED COMPOUNDS BY UTILIZING MODIFIEDIMMUNOSTIMULATORY DINUCLEOTIDES
TCTGACNTTCT
>DI128713.1 MODULATION OF IMMUNOSTIMULATORY PROPERTIES OFOLIGONUCLEOTIDE-BASED COMPOUNDS BY UTILIZING MODIFIEDIMMUNOSTIMULATORY DINUCLEOTIDES
TCTGTCNTTCT
>DI128680.1 MODULATION OF IMMUNOSTIMULATORY PROPERTIES OFOLIGONUCLEOTIDE-BASED COMPOUNDS BY UTILIZING MODIFIEDIMMUNOSTIMULATORY DINUCLEOTIDES
TCTGTNGTTCT
>DI128216.1 COLD-INDUCIBLE EXPRESSION VECTOR
CCGGGGATCCG
>DI126693.1 MODULATION OF IMMUNOSTIMULATORY PROPERTIES OFOLIGONUCLEOTIDE-BASED COMPOUNDS BY UTILIZING MODIFIEDIMMUNOSTIMULATORY DINUCLEOTIDES
ACGTTCTCTGT
>DI125579.1 MODULATION OF IMMUNOSTIMULATORY PROPERTIES OFOLIGONUCLEOTIDE-BASED COMPOUNDS BY UTILIZING MODIFIEDIMMUNOSTIMULATORY DINUCLEOTIDES
TCTGTCGTTCT
>DI125200.1 MODULATION OF IMMUNOSTIMULATORY PROPERTIES OFOLIGONUCLEOTIDE-BASED COMPOUNDS BY UTILIZING MODIFIEDIMMUNOSTIMULATORY DINUCLEOTIDES
TCTGTCNTTCT
>DI125194.1 MODULATION OF IMMUNOSTIMULATORY PROPERTIES OFOLIGONUCLEOTIDE-BASED COMPOUNDS BY UTILIZING MODIFIEDIMMUNOSTIMULATORY DINUCLEOTIDES
TCTGTNGTTCT
>DI123761.1 A substrate having an oxide layer, method for detecting a targetsubstance using the same and optical sensor containing the same
GACCGGCACAC
>DI123748.1 Recombinant Influenza Vectors with A PolII Promoter and Ribozymesfor Vaccines and Gene Therapy
TATTAGTAGAA
>DI123384.1 A substrate having an oxide layer, method for detecting a targetsubstance using the same and optical sensor containing the same
GGGAGTCCTGC
>DI121651.1 A MINUS STRAND RNA VIRUS VECTOR CARRING A GENE IN WHICHA MUTAGENIC REGION HAS BEEN ALTERED
AGAAAAAACTT
>DI121306.1 GENOMIC PROFILING OF REGULATORY FACTORBINDING SITES
TATTTGTTTAT
>DI120912.1 GENOMIC PROFILING OF REGULATORY FACTORBINDING SITES
TATTTGTTTAT
>DI120791.1 High Titer Recombinant Influenza Viruses for Vaccines and GeneTherapy
TATTAGTAGAA
>DI120731.1 METHOD FOR INHIBITING IRES-DEPENDENT TRANSLATION BY USING ANOLIGO DNA
GTACCGCAATT
>DI120582.1 A METHOD OF ANALYSING A MARKER NUCLEIC ACID MOLECULE
TGACTACGGTG
>DI119783.1 GENOMIC PROFILING OF REGULATORY FACTORBINDING SITES
TGTTTATTTCA
>DI119649.1 Viruses Encoding Mutant Membrane Protein
CTAAAATTTTA
>DI119307.1 Viruses Encoding Mutant Membrane Protein
CTTAAATTTTA
>DI119230.1 Viruses Encoding Mutant Membrane Protein
TATTAGTAGAA
>DI118903.1 Viruses Encoding Mutant Membrane Protein
CTTAAATTTTA
>DI109271.1 C-CLASS OLIGONUCLEOTIDE ANALOGS WITH ENHANCED IMMUNOSTIMULATORYPOTENCY
CCGTTTTGTGG
>DI109038.1 C-CLASS OLIGONUCLEOTIDE ANALOGS WITH ENHANCED IMMUNOSTIMULATORYPOTENCY
GTCGAGGAGGT
>DI108703.1 C-CLASS OLIGONUCLEOTIDE ANALOGS WITH ENHANCED IMMUNOSTIMULATORYPOTENCY
TCGTCGTTTTA
>DI103806.1 Polynucleotide microarray comprising 2 or more groups of probepolynucleotide immobilized on a substrate in accordance with Tmand method for detecting a target polynucleotide
GGAAGTCCTGC
>DI101985.1 Gene and Polypeptide Sequences
TTAGGCTTATA
>DI100238.1 Method for identification and analysis of specific moleculesusing single strand nucleic acid ligands
CTTCCTACTCT
>DI100019.1 Method for identification and analysis of specific moleculesusing single strand nucleic acid ligands
CTAAACTTTCT
>DI099996.1 Method for identification and analysis of specific moleculesusing single strand nucleic acid ligands
CCTTGTACTGG
>DI099954.1 Method for identification and analysis of specific moleculesusing single strand nucleic acid ligands
GGAACATCGAG
>DI099897.1 Method to Inhibit Cell Growth Using Oligonucleotides
GATCGATCGAT
>DI099875.1 Method for detecting a target nucleic acid by using labelledcontrol nucleic acid
GAAGTGGGCCG
>DI099584.1 Method for identification and analysis of specific moleculesusing single strand nucleic acid ligands
AGAAAGTTTAG
>DI099404.1 Method for identification and analysis of specific moleculesusing single strand nucleic acid ligands
CTCGATGTTCC
>DI099355.1 Method for identification and analysis of specific moleculesusing single strand nucleic acid ligands
GGGATGGTTGG
>DI099302.1 Method for identification and analysis of specific moleculesusing single strand nucleic acid ligands
AGAGTAGGAAG
>DI099101.1 Method for identification and analysis of specific moleculesusing single strand nucleic acid ligands
CCAGTACAAGG
>DI099094.1 Method for identification and analysis of specific moleculesusing single strand nucleic acid ligands
GCTGTAAACGT
>DI099052.1 Method for identification and analysis of specific moleculesusing single strand nucleic acid ligands
ACGTTTACAGC
>DI099002.1 Method for identification and analysis of specific moleculesusing single strand nucleic acid ligands
GCGCTGGAGCG
>DI098730.1 Method to Inhibit Cell Growth Using Oligonucleotides
CGGGCTTATTG
>DI098640.1 Method to Inhibit Cell Growth Using Oligonucleotides
GTTAGGGTTAG
>DI098492.1 Method for identification and analysis of specific moleculesusing single strand nucleic acid ligands
GGTAAATTCGG
>DI098485.1 Method for identification and analysis of specific moleculesusing single strand nucleic acid ligands
GTAGACGCCGG
>DI098265.1 Method for identification and analysis of specific moleculesusing single strand nucleic acid ligands
CGCTCCAGCGC
>DI095948.1 Immunostimulatory sequence oligonucleotidesand methods of using the same
TCGAACGTTCG
>DI095197.1 FUNCTIONAL POLYMORPHISMS OF THE INTERLEUKIN-1 LOCUSAFFECTING TRANSCRIPTION AND SUSCEPTIBILITY TOIMFLAMMATORY AND INFECTIOUS DISEASES
TGCATAGGGTT
>DI095157.1 FUNCTIONAL POLYMORPHISMS OF THE INTERLEUKIN-1 LOCUSAFFECTING TRANSCRIPTION AND SUSCEPTIBILITY TOIMFLAMMATORY AND INFECTIOUS DISEASES
CGCATAGGGTC
>DI095000.1 FUNCTIONAL POLYMORPHISMS OF THE INTERLEUKIN-1 LOCUSAFFECTING TRANSCRIPTION AND SUSCEPTIBILITY TOIMFLAMMATORY AND INFECTIOUS DISEASES
TGCATAGGGTT
>DI094937.1 FUNCTIONAL POLYMORPHISMS OF THE INTERLEUKIN-1 LOCUSAFFECTING TRANSCRIPTION AND SUSCEPTIBILITY TOIMFLAMMATORY AND INFECTIOUS DISEASES
TACATAGGGTC
>DI094905.1 FUNCTIONAL POLYMORPHISMS OF THE INTERLEUKIN-1 LOCUSAFFECTING TRANSCRIPTION AND SUSCEPTIBILITY TOIMFLAMMATORY AND INFECTIOUS DISEASES
TGCATAGGGTC
>DI094830.1 FUNCTIONAL POLYMORPHISMS OF THE INTERLEUKIN-1 LOCUSAFFECTING TRANSCRIPTION AND SUSCEPTIBILITY TOIMFLAMMATORY AND INFECTIOUS DISEASES
TGCATAGGGTT
>DI094716.1 FUNCTIONAL POLYMORPHISMS OF THE INTERLEUKIN-1 LOCUSAFFECTING TRANSCRIPTION AND SUSCEPTIBILITY TOIMFLAMMATORY AND INFECTIOUS DISEASES
TGCATGGGGTC
>DI094637.1 FUNCTIONAL POLYMORPHISMS OF THE INTERLEUKIN-1 LOCUSAFFECTING TRANSCRIPTION AND SUSCEPTIBILITY TOIMFLAMMATORY AND INFECTIOUS DISEASES
TGCATAGAGTC
>DI094597.1 FUNCTIONAL POLYMORPHISMS OF THE INTERLEUKIN-1 LOCUSAFFECTING TRANSCRIPTION AND SUSCEPTIBILITY TOIMFLAMMATORY AND INFECTIOUS DISEASES
TACATAGGGTC
>DI094589.1 FUNCTIONAL POLYMORPHISMS OF THE INTERLEUKIN-1 LOCUSAFFECTING TRANSCRIPTION AND SUSCEPTIBILITY TOIMFLAMMATORY AND INFECTIOUS DISEASES
TGCACAGGGTC
>DI094381.1 FUNCTIONAL POLYMORPHISMS OF THE INTERLEUKIN-1 LOCUSAFFECTING TRANSCRIPTION AND SUSCEPTIBILITY TOIMFLAMMATORY AND INFECTIOUS DISEASES
TGCATAGGCCT
>DI094354.1 FUNCTIONAL POLYMORPHISMS OF THE INTERLEUKIN-1 LOCUSAFFECTING TRANSCRIPTION AND SUSCEPTIBILITY TOIMFLAMMATORY AND INFECTIOUS DISEASES
TGCATAGGGTC
>DI094352.1 PHOSPHORAMIDITE COMPOUNDS
AAAAAAAAAAA
>DI094300.1 FUNCTIONAL POLYMORPHISMS OF THE INTERLEUKIN-1 LOCUSAFFECTING TRANSCRIPTION AND SUSCEPTIBILITY TOIMFLAMMATORY AND INFECTIOUS DISEASES
TGCATAGGGCC
>DI094286.1 FUNCTIONAL POLYMORPHISMS OF THE INTERLEUKIN-1 LOCUSAFFECTING TRANSCRIPTION AND SUSCEPTIBILITY TOIMFLAMMATORY AND INFECTIOUS DISEASES
CGCATAGGGTC
>DI094075.1 FUNCTIONAL POLYMORPHISMS OF THE INTERLEUKIN-1 LOCUSAFFECTING TRANSCRIPTION AND SUSCEPTIBILITY TOIMFLAMMATORY AND INFECTIOUS DISEASES
TGCATGGGGTC
>DI094018.1 FUNCTIONAL POLYMORPHISMS OF THE INTERLEUKIN-1 LOCUSAFFECTING TRANSCRIPTION AND SUSCEPTIBILITY TOIMFLAMMATORY AND INFECTIOUS DISEASES
TGCATAGGGTC
>DI093972.1 FUNCTIONAL POLYMORPHISMS OF THE INTERLEUKIN-1 LOCUSAFFECTING TRANSCRIPTION AND SUSCEPTIBILITY TOIMFLAMMATORY AND INFECTIOUS DISEASES
TGCATAGGGTC
>DI093829.1 FUNCTIONAL POLYMORPHISMS OF THE INTERLEUKIN-1 LOCUSAFFECTING TRANSCRIPTION AND SUSCEPTIBILITY TOIMFLAMMATORY AND INFECTIOUS DISEASES
TGCATAGGGTC
>DI093799.1 FUNCTIONAL POLYMORPHISMS OF THE INTERLEUKIN-1 LOCUSAFFECTING TRANSCRIPTION AND SUSCEPTIBILITY TOIMFLAMMATORY AND INFECTIOUS DISEASES
TGCATGGGGTC
>DI093775.1 FUNCTIONAL POLYMORPHISMS OF THE INTERLEUKIN-1 LOCUSAFFECTING TRANSCRIPTION AND SUSCEPTIBILITY TOIMFLAMMATORY AND INFECTIOUS DISEASES
TACATAGGGTC
>DI093769.1 PHOSPHORAMIDITE COMPOUNDS
TTTTTTTTTTT
>DI093717.1 FUNCTIONAL POLYMORPHISMS OF THE INTERLEUKIN-1 LOCUSAFFECTING TRANSCRIPTION AND SUSCEPTIBILITY TOIMFLAMMATORY AND INFECTIOUS DISEASES
TGCATAGGGTC
>DI093704.1 FUNCTIONAL POLYMORPHISMS OF THE INTERLEUKIN-1 LOCUSAFFECTING TRANSCRIPTION AND SUSCEPTIBILITY TOIMFLAMMATORY AND INFECTIOUS DISEASES
TGCATAGGGTT
>DI093658.1 FUNCTIONAL POLYMORPHISMS OF THE INTERLEUKIN-1 LOCUSAFFECTING TRANSCRIPTION AND SUSCEPTIBILITY TOIMFLAMMATORY AND INFECTIOUS DISEASES
TGCATAGAGTC
>DI093585.1 FUNCTIONAL POLYMORPHISMS OF THE INTERLEUKIN-1 LOCUSAFFECTING TRANSCRIPTION AND SUSCEPTIBILITY TOIMFLAMMATORY AND INFECTIOUS DISEASES
TGCATAGGGCC
>DI093555.1 FUNCTIONAL POLYMORPHISMS OF THE INTERLEUKIN-1 LOCUSAFFECTING TRANSCRIPTION AND SUSCEPTIBILITY TOIMFLAMMATORY AND INFECTIOUS DISEASES
TGCATGGGGTC
>DI093549.1 FUNCTIONAL POLYMORPHISMS OF THE INTERLEUKIN-1 LOCUSAFFECTING TRANSCRIPTION AND SUSCEPTIBILITY TOIMFLAMMATORY AND INFECTIOUS DISEASES
TGTATAGGGTC
>DI093502.1 FUNCTIONAL POLYMORPHISMS OF THE INTERLEUKIN-1 LOCUSAFFECTING TRANSCRIPTION AND SUSCEPTIBILITY TOIMFLAMMATORY AND INFECTIOUS DISEASES
TGCATAGGGTC
>DI093462.1 FUNCTIONAL POLYMORPHISMS OF THE INTERLEUKIN-1 LOCUSAFFECTING TRANSCRIPTION AND SUSCEPTIBILITY TOIMFLAMMATORY AND INFECTIOUS DISEASES
TGTATAGGGTC
>DI093369.1 FUNCTIONAL POLYMORPHISMS OF THE INTERLEUKIN-1 LOCUSAFFECTING TRANSCRIPTION AND SUSCEPTIBILITY TOIMFLAMMATORY AND INFECTIOUS DISEASES
TACATAGGGTC
>DI090935.1 Genomic DNA and Promoter of lipoxygenase gene and theirapplication
TGGGGTCGCGC
>DI090166.1 DNA sequences comprising gene transcription regulatory qualities and
ACGNNNNNGCA
>DI089082.1 Expression and Export of Anti-Obesity Proteins as FcFusion Proteins
AATTCGATATC
>DI088855.1 AMPLIFICATION OF NUCLEIC ACID FRAGMENTSUSING NICKING AGENTS
CCAGTCGTAGG
>DI087722.1 CHIMERIC IMMUNOMODULATORY COMPOUNDS AND METHODS OF USING THE SAME
TCGACCGTTCG
>DI086818.1 DNA sequences comprising gene transcription regulatory qualities and
CGGNNNNNGGC
>DI086707.1 DNA sequences comprising gene transcription regulatory qualities and
CACNNNNNGCG
>DI084563.1 DNA sequences comprising gene transcription regulatory qualities and
CAGNNNNNGGG
>DI082452.1 CHEMICALLY REGULATABLE DNA SEQUENCES AND GENES AND USES THEREOF
GGGATCCTGCA
>DI081299.1 METHOD OF AMPLIFYING TARGET NUCLEIC ACIDS APPLICABLE TO LIGASE CHAIN REACTIONS
CTGTTAATGGA
>DI080021.1 Recombinant baculovirus and Method of MACELISA using the recombinan
TAATTAATTAA
>DI077819.1 Peptide Acceptor Ligation Methods
AAAAAAAAAAA
>DI077728.1 ALVAC CANARYPOX VIRUS RECOMBINANTS AND USES THEREOF
GGTTCCCCGGG
>DI076564.1 METHOD FOR AMPLIFYING SPECIFIC NUCLEIC ACID SEQUENCES
CCNNNNNNNGG
>DI074848.1 DNA sequences comprising gene transcription regulatory qualities and
CCCNNNNNAGG
>DI074149.1 Expression and secretion vector for human interferon alpha and process for producing human interferon alpha by employing same
GAGGTGATTTT
>DI070953.1 METHODS FOR PURIFYING AND DETECTING DOUBLE STRANDED DNA TARGETSEQUENCES BY TRIPLE HELIX INTERACTION
TCCTCTCCCTC
>DI068861.1 DNA sequences comprising gene transcription regulatory qualities and
CCGNNNNNTCC
>DI067601.1 Therapeutically Useful Synthetic Oligonucleotides
GGTTTTGTTTG
>DI066799.1 FUSION PROTEIN OF HCV CORE PROTEIN AND PROCESS FOR THE PREPARATION THEREOF
CGCTTAAGAAT
>DI064170.1 DNA sequences comprising gene transcription regulatory qualities and
GGCNNNNNGGA
>DI064153.1 ALVAC CANARYPOX VIRUS RECOMBINANTS AND USES THEREOF
GGGTGACTGCA
>DI063275.1 DNA sequences comprising gene transcription regulatory qualities and
GCCNNNNNCGC
>DI063014.1 TROVAC FOWLPOX VIRUS RECOMBINANTS AND USES THEREOF
AATTCAACCGC
>DI061646.1 DNA sequences comprising gene transcription regulatory qualities and
AGCNNNNNCAG
>DI060585.1 DNA sequences comprising gene transcription regulatory qualities and
CCTNNNNNGCG
>DI060048.1 ALVAC CANARYPOX VIRUS RECOMBINANTS AND USES THEREOF
GATCCCCGGGA
>DI059934.1 Antisense Oligonucleotide Inhibition of ras
CACCGACGGCG
>DI058526.1 CHIMERIC IMMUNOMODULATORY COMPOUNDS AND METHODS OF USING THE SAME
TCGAACGTTCG
>DI058258.1 Therapeutically Useful Synthetic Oligonucleotides
GTGTGTTTGGT
>DI058221.1 DNA sequences comprising gene transcription regulatory qualities and
CGGNNNNNCCC
>DI056928.1 Compositions and methods for the treatment and diagnosis of breast cancer
TTCCGTTATGC
>DI052763.1 COMPOSITIONS AND METHODS RELATING TO THE DAPTOMYCINBIOSYNTHETIC GENE CLUSTER
GTGGTGAAGAC
>DI051597.1 Single nucleotide polymorphism in the promoter region of MxA gene and use thereof
TTCTGCCCCCG
>DI050927.1 DNA sequences comprising gene transcription regulatory qualities and
CCCNNNNNCCA
>DI050569.1 Single nucleotide polymorphism in the promoter region of MxA gene and use thereof
TTCTGCACCCG
>DI050279.1 DNA sequences comprising gene transcription regulatory qualities and
CTGNNNNNCGC
>DI049245.1 SCREENING ASSAY FOR THE DETECTION OF DNA-BINDING MOLECULES
TGCTCGCACTT
>DI048955.1 DNA sequences comprising gene transcription regulatory qualities and
CCCNNNNNCCG
>DI048783.1 Oligonucleotide Compositions and Methods for the Modulation of the Expression of B7 Proteins
GCTCCCCGTAC
>DI047081.1 METHOD OF AMPLIFYING TARGET NUCLEIC ACIDS APPLICABLE TO LIGASE CHAIN REACTIONS
TCCATTAACAG
>DI046172.1 RECOMBINANT DNA WHICH CODING RNA OF ROSPOVIRUS, AND PLANT TRNSFORMED WITH THE GENE
AACATATGTCT
>DI045866.1 METHOD FOR PURIFYING INTERFERON
AATTCATGCAG
>DI045048.1 DNA sequences comprising gene transcription regulatory qualities and
CGCNNNNNGCA
>DI043767.1 Adenoviral transfer vector for the gene transfort of a DNA sequence
GTCAGGCCTCC
>DI042550.1 Single nucleotide polymorphism in the promoter region of MxA gene and use thereof
CGGGAGCAGAA
>DI041675.1 DNA sequences comprising gene transcription regulatory qualities and
CCCNNNNNCGG
>DI040230.1 ALVAC CANARYPOX VIRUS RECOMBINANTS AND USES THEREOF
AATTCAACCGC
>DI039676.1 FUSION PROTEIN OF HCV CORE PROTEIN AND PROCESS FOR THE PREPARATION THEREOF
GCGGATCCATG
>DI038983.1 CHIMERIC IMMUNOMODULATORY COMPOUNDS AND METHODS OF USING THE SAME
TCGAANGTTCG
>DI036720.1 DNA sequences comprising gene transcription regulatory qualities and
CTGNNNNNCCC
>DI036517.1 SCREENING ASSAY FOR THE DETECTION OF DNA-BINDING MOLECULES
CGTTCGCACTT
>DI035072.1 TROVAC FOWLPOX VIRUS RECOMBINANTS AND USES THEREOF
GATCCCCGGGA
>DI032981.1 A HERBICIDE METABOLIZING PROTEIN, A GENE THEREOF AND USE THEREOF
TAGCGGCCGCA
>DI031774.1 DNA sequences comprising gene transcription regulatory qualities and
CACNNNNNGGG
>DI030190.1 A detecting method of hepatitis C virus using recombinant mixed antigens derived from HCV and a diagnostic kit thereof
TGCTCCGGTTC
>DI029633.1 DNA sequences comprising gene transcription regulatory qualities and
CCGNNNNNGAC
>DI028036.1 Compositions and methods for the therapy and diagnosisof breast cancer
TTCCGTTATGC
>DI027411.1 DNA sequences comprising gene transcription regulatory qualities and
CGCNNNNNGGC
>DI027299.1 DNA sequences comprising gene transcription regulatory qualities and
CCCNNNNNAGC
>DI025554.1 DNA sequences comprising gene transcription regulatory qualities and
GACNNNNNCGC
>DI024191.1 Compositions and methods for the treatment anddiagnosis of breast cancer
TTCCGTTATGC
>DI023895.1 Infectious Bovine Rhinotracheitis Virus Neutralization Test
TAATTAATTAA
>DI023183.1 DNA sequences comprising gene transcription regulatory qualities and
CTCNNNNNCGC
>DI023093.1 Immunostimulatory Nucleic Acids
GATGTATCGTC
>DI023075.1 DNA sequences comprising gene transcription regulatory qualities and
CCGNNNNNCCC
>DI021495.1 Single nucleotide polymorphism in the promoter region of MxA gene and use thereof
TTCTGCTCCCG
>DI021425.1 DNA sequences comprising gene transcription regulatory qualities and
GCGNNNNNGCC
>DI021269.1 ANTISENSE OLIGONUCLEOTIDE INHIBITION OF THE RAS GENE
CACCGACGGCG
>DI018170.1 CHIMERIC IMMUNOMODULATORY COMPOUNDS AND METHODS OF USING THE SAME
TNGACCGTTCG
>DI015641.1 COLD-INDUCIBLE EXPRESSION VECTOR
CCGGGGATCCG
>DI015389.1 Conjugates and methods for the production thereof, andtheir use for transporting molecules via biologicalmembranes
TATTCCGTCAT
>DI009159.1 Nucleotide Sequences for Gene Regulation and Methods ofUse Thereof
TCGAGGAAGGA
>DI003519.1 CHIMERIC ANTAGONIST ANTH1
CCCATATGATG
>DI005982.1 METHOD OF PREPARING FUSION PROTEINS
TTGCCCATGGC
>DI009924.1 PURIFICATION OF A TRIPLE HELIX FORMATION WITH AN IMMOBILIZEDOLIGONUCLEOTIDE
TTTTTTTTCCT
>DI005752.1 METHODS FOR PURIFYING AND DETECTING DOUBLE STRANDED DNA TARGETSEQUENCES BY TRIPLE HELIX INTERACTION
AGGAGCGGGAG
>DI006696.1 DNA sequences comprising gene transcription regulatory qualities and
ACCNNNNNCCC
>DI007976.1 DNA sequences comprising gene transcription regulatory qualities and
GCCNNNNNGGA
>DJ082773.1 Method of Eliminating Inhibitory/Instability Regions of mRNA
TACATGTAATG
>DJ084368.1 A conserved domain detection system considering evolutive process
ACCTATTGCTG
>DJ086760.1 IDENTIFICATION, ISOLATION AND ELIMINATION OF CANCER STEM CELLS
GCTTTGATCTT
>DI005514.1 CHIMERIC IMMUNOMODULATORY COMPOUNDS AND METHODS OF USING THE SAME
TNGAACGTTCG
>DI164314.1 IMMUNOSTIMULATORY OLIGONUCLEOTIDE MULTIMERS
TCNAACNTTCT
>DI164293.1 IMMUNOSTIMULATORY OLIGONUCLEOTIDE MULTIMERS
TCNAACNTTCN
>DI163971.1 IMMUNOSTIMULATORY OLIGONUCLEOTIDE MULTIMERS
CTGTCNTTCTC
>DI162804.1 IMMUNOSTIMULATORY OLIGONUCLEOTIDE MULTIMERS
CTGTCNTTCTC
>DI162504.1 IMMUNOSTIMULATORY OLIGONUCLEOTIDE MULTIMERS
TCTGTNCACAG
>DI162244.1 IMMUNOSTIMULATORY OLIGONUCLEOTIDE MULTIMERS
TCNAACNTTCN
>DI162011.1 IMMUNOSTIMULATORY OLIGONUCLEOTIDE MULTIMERS
TNCTGTNCTTT
>DI160772.1 IMMUNOSTIMULATORY OLIGONUCLEOTIDE MULTIMERS
TCNAACNTTCN
>DI160528.1 IMMUNOSTIMULATORY OLIGONUCLEOTIDE MULTIMERS
TCNAACNTTCT
>DI158380.1 METHOD OF DETECTING ncRNA
GCATTATTACT
>DI157807.1 METHOD OF DETECTING ncRNA
GTCACACTCCA
>DI156370.1 A kit for discriminating genetical identification among Cervusspecies by pyrosequencing methods
CAGTATATGGG
>DI155881.1 MODULATION OF IMMUNOSTIMULATORY PROPERTIES BYSMALL OLIGONUCLEOTIDE-BASED COMPOUNDS
TCTGTNGTTCT
>DI155570.1 MODULATION OF IMMUNOSTIMULATORY PROPERTIES BYSMALL OLIGONUCLEOTIDE-BASED COMPOUNDS
TCTGACNTTCT
>DI154128.1 Humanized Antibodies that RecognizeBeta-Amyloid Peptide
GGACGGTTGGG
>DI153049.1 MODULATION OF IMMUNOSTIMULATORY PROPERTIES BYSMALL OLIGONUCLEOTIDE-BASED COMPOUNDS
TCTGTCNTTCT
>DI150765.1 MODULATION OF IMMUNOSTIMULATORY PROPERTIES BYSMALL OLIGONUCLEOTIDE-BASED COMPOUNDS
TCTGACGTTCT
>DI150733.1 MODULATION OF IMMUNOSTIMULATORY PROPERTIES BYSMALL OLIGONUCLEOTIDE-BASED COMPOUNDS
TCTGANNTTCT
>DI144085.1 NUCLEOTIDES FOR PREVENTION AND TREATMENT OF BACTERIALAND FUNGAL PATHOLOGIES
TTGCTGACCAT
>DI141070.1 Method for selecting a cold adapted attenuated reassortedInfluenza virus from a cold adapted attenuated Influenza virusand a infectious Influenza virus
AGCAAAGCAGG
>DI139005.1 Newcastle disease virus infectious clones, vaccines anddiagnostic assays
CGCGAGSCTCG
>DI138204.1 MODULATION OF IMMUNOSTIMULATORY PROPERTIES OFOLIGONUCLEOTIDE-BASED COMPOUNDS BY UTILIZING MODIFIEDIMMUNOSTIMULATORY DINUCLEOTIDES
TCTGTNGTTCT
>DI138142.1 Peptide nucleic acid derivatives with a negative charge,agents and methods for producing them
TATTCCGTCAT
>DI138141.1 Height-related gene
ATATTCTCCCC
>DI133955.1 MODULATION OF IMMUNOSTIMULATORY PROPERTIES OFOLIGONUCLEOTIDE-BASED COMPOUNDS BY UTILIZING MODIFIEDIMMUNOSTIMULATORY DINUCLEOTIDES
TCNTCNTTCTG
>DI132645.1 MODULATION OF IMMUNOSTIMULATORY PROPERTIES OFOLIGONUCLEOTIDE-BASED COMPOUNDS BY UTILIZING MODIFIEDIMMUNOSTIMULATORY DINUCLEOTIDES
TCTTTCNTTCT
>DI132590.1 ALBUMIN-FUSED KUNITZ DOMAIN PEPTIDES
CCANNNNNTGG
>DI131001.1 MODULATION OF IMMUNOSTIMULATORY PROPERTIES OFOLIGONUCLEOTIDE-BASED COMPOUNDS BY UTILIZING MODIFIEDIMMUNOSTIMULATORY DINUCLEOTIDES
TCTGANGTTCT
>DI130427.1 MODULATION OF IMMUNOSTIMULATORY PROPERTIES OFOLIGONUCLEOTIDE-BASED COMPOUNDS BY UTILIZING MODIFIEDIMMUNOSTIMULATORY DINUCLEOTIDES
TCNTCNTTCTG
>DI126911.1 CPG FORMULATIONS AND RELATED METHODS
GGGNGGGNGGG
>DI126274.1 MODULATION OF IMMUNOSTIMULATORY PROPERTIES OFOLIGONUCLEOTIDE-BASED COMPOUNDS BY UTILIZING MODIFIEDIMMUNOSTIMULATORY DINUCLEOTIDES
CCTACTAGCGT
>DI126041.1 MODULATION OF IMMUNOSTIMULATORY PROPERTIES OFOLIGONUCLEOTIDE-BASED COMPOUNDS BY UTILIZING MODIFIEDIMMUNOSTIMULATORY DINUCLEOTIDES
GCGTTCTCATC
>DI124681.1 MODULATION OF IMMUNOSTIMULATORY PROPERTIES OFOLIGONUCLEOTIDE-BASED COMPOUNDS BY UTILIZING MODIFIEDIMMUNOSTIMULATORY DINUCLEOTIDES
TCTGANGTTCT
>DI124668.1 IMMUNOSTIMULATORY NUCLEIC ACIDS
GTTTTGTCGTT
>DI124362.1 MODULATION OF IMMUNOSTIMULATORY PROPERTIES OFOLIGONUCLEOTIDE-BASED COMPOUNDS BY UTILIZING MODIFIEDIMMUNOSTIMULATORY DINUCLEOTIDES
TCTGTCNTTCT
>DI123544.1 A substrate having an oxide layer, method for detecting a targetsubstance using the same and optical sensor containing the same
GCCCAGCCCCT
>DI123529.1 A substrate having an oxide layer, method for detecting a targetsubstance using the same and optical sensor containing the same
GAAGCGGGCCG
>DI121754.1 A MINUS STRAND RNA VIRUS VECTOR CARRING A GENE IN WHICHA MUTAGENIC REGION HAS BEEN ALTERED
AGAAAAAACYY
>DI121497.1 A METHOD OF ANALYSING A MARKER NUCLEIC ACID MOLECULE
TGACTACAGTA
>DI119164.1 Viruses Encoding Mutant Membrane Protein
CTTAAATTTTA
>DI117965.1 EXPANDING THE EUKARYOTIC GENETIC CODE
GGTTCGANTCC
>DI102156.1 Polynucleotide microarray comprising 2 or more groups of probepolynucleotide immobilized on a substrate in accordance with Tmand method for detecting a target polynucleotide
GGGAGTCCTGC
>DI100110.1 Method for identification and analysis of specific moleculesusing single strand nucleic acid ligands
CCAACCATCCC
>DI099810.1 Method for identification and analysis of specific moleculesusing single strand nucleic acid ligands
TTAGCTTCGAC
>DI099798.1 Method for identification and analysis of specific moleculesusing single strand nucleic acid ligands
GTCGAAGCTAA
>DI099734.1 Method for identification and analysis of specific moleculesusing single strand nucleic acid ligands
GGGGCGCCACA
>DI099474.1 Method to Inhibit Cell Growth Using Oligonucleotides
CTAACCCTAAC
>DI099217.1 Method for identification and analysis of specific moleculesusing single strand nucleic acid ligands
CCGGCGTCTAC
>DI098725.1 Method for identification and analysis of specific moleculesusing single strand nucleic acid ligands
TGTGGCGCCCC
>DI098361.1 Method for identification and analysis of specific moleculesusing single strand nucleic acid ligands
CCGAATTTACC
>DI098317.1 Method to Inhibit Cell Growth Using Oligonucleotides
TAGATGTGGTG
>DI095139.1 FUNCTIONAL POLYMORPHISMS OF THE INTERLEUKIN-1 LOCUSAFFECTING TRANSCRIPTION AND SUSCEPTIBILITY TOIMFLAMMATORY AND INFECTIOUS DISEASES
TGCATAAGGTC
>DI095137.1 FUNCTIONAL POLYMORPHISMS OF THE INTERLEUKIN-1 LOCUSAFFECTING TRANSCRIPTION AND SUSCEPTIBILITY TOIMFLAMMATORY AND INFECTIOUS DISEASES
TGCGTAGGGTC
>DI095131.1 FUNCTIONAL POLYMORPHISMS OF THE INTERLEUKIN-1 LOCUSAFFECTING TRANSCRIPTION AND SUSCEPTIBILITY TOIMFLAMMATORY AND INFECTIOUS DISEASES
TGTATAGGGTC
>DI095074.1 FUNCTIONAL POLYMORPHISMS OF THE INTERLEUKIN-1 LOCUSAFFECTING TRANSCRIPTION AND SUSCEPTIBILITY TOIMFLAMMATORY AND INFECTIOUS DISEASES
TGCATAAGGTC
>DI094753.1 FUNCTIONAL POLYMORPHISMS OF THE INTERLEUKIN-1 LOCUSAFFECTING TRANSCRIPTION AND SUSCEPTIBILITY TOIMFLAMMATORY AND INFECTIOUS DISEASES
TGCACAGGGTC
>DI094752.1 FUNCTIONAL POLYMORPHISMS OF THE INTERLEUKIN-1 LOCUSAFFECTING TRANSCRIPTION AND SUSCEPTIBILITY TOIMFLAMMATORY AND INFECTIOUS DISEASES
TGCATAGGGTC
>DI094535.1 FUNCTIONAL POLYMORPHISMS OF THE INTERLEUKIN-1 LOCUSAFFECTING TRANSCRIPTION AND SUSCEPTIBILITY TOIMFLAMMATORY AND INFECTIOUS DISEASES
TGCATAGGGTC
>DI094512.1 FUNCTIONAL POLYMORPHISMS OF THE INTERLEUKIN-1 LOCUSAFFECTING TRANSCRIPTION AND SUSCEPTIBILITY TOIMFLAMMATORY AND INFECTIOUS DISEASES
TGCATAGGCTC
>DI094508.1 FUNCTIONAL POLYMORPHISMS OF THE INTERLEUKIN-1 LOCUSAFFECTING TRANSCRIPTION AND SUSCEPTIBILITY TOIMFLAMMATORY AND INFECTIOUS DISEASES
TGCATAGGGTC
>DI094499.1 FUNCTIONAL POLYMORPHISMS OF THE INTERLEUKIN-1 LOCUSAFFECTING TRANSCRIPTION AND SUSCEPTIBILITY TOIMFLAMMATORY AND INFECTIOUS DISEASES
TGCATAGGGTC
>DI093870.1 FUNCTIONAL POLYMORPHISMS OF THE INTERLEUKIN-1 LOCUSAFFECTING TRANSCRIPTION AND SUSCEPTIBILITY TOIMFLAMMATORY AND INFECTIOUS DISEASES
TGCGTAGGGTC
>DI093869.1 FUNCTIONAL POLYMORPHISMS OF THE INTERLEUKIN-1 LOCUSAFFECTING TRANSCRIPTION AND SUSCEPTIBILITY TOIMFLAMMATORY AND INFECTIOUS DISEASES
TGTATAGGGTC
>DI092982.1 Single nucleotide polymorphism in the promoter region of MxA gene and use thereof
CGGGTGCAGAA
>DI092600.1 FUSION PROTEIN CONTAINING N-TERMINAL FRAGMENTS OF HUMAN SERUM ALBUMIN
CTCGAGATGCA
>DI089282.1 DNA sequences comprising gene transcription regulatory qualities and
GGGNNNNNGGA
>DI083941.1 Single nucleotide polymorphism in the promoter region of MxA gene and use thereof
CGGGGGCAGAA
>DI080762.1 Technetium-99M labelled peptides for imaging
GDCGGCGCGGC
>DI080153.1 DNA sequences comprising gene transcription regulatory qualities and
CAGNNNNNCCG
>DI074679.1 High expression recombinant vector of E. coli and preparing method of human granulocyte colony stimulating factor
GTAATATCGAT
>DI073301.1 Production Of Attenuated Negative Stranded RNA Virus Vaccines From Cloned tt
AAAAAAGGGGG
>DI072749.1 Single nucleotide polymorphism in the promoter region of MxA gene and use thereof
CGGGCGCAGAA
>DI071488.1 DNA sequences comprising gene transcription regulatory qualities and
GCGNNNNNGAC
>DI067213.1 DNA sequences comprising gene transcription regulatory qualities and
CCTNNNNNGCC
>DI065234.1 Antisense Compositions and Cancer-Treatment Methods
GGGGGGGGGGG
>DI064380.1 DNA sequences comprising gene transcription regulatory qualities and
CAGNNNNNCCC
>DI062617.1 POLYPEPTIDE
CTCGAGATGCA
>DI059130.1 DNA sequences comprising gene transcription regulatory qualities and
GAGNNNNNCCC
>DI056211.1 DNA sequences comprising gene transcription regulatory qualities and
CCANNNNNGGG
>DI054120.1 DNA sequences comprising gene transcription regulatory qualities and
CGGNNNNNCTC
>DI048159.1 Modified phosphodiester CpG oligonucleotides conjugated with a dG run which have improved immunomodulatory activity and safety
CTTAACGTTCT
>DI045945.1 DNA sequences comprising gene transcription regulatory qualities and
GCGNNNNNGGA
>DI041447.1 Expression and Export of Anti-Obesity Proteins as FcFusion Proteins
TTAAGATATCG
>DI041157.1 TROVAC FOWLPOX VIRUS RECOMBINANTS AND USES THEREOF
GGTTCCCCGGG
>DI040537.1 DNA sequences comprising gene transcription regulatory qualities and
CGGNNNNNACG
>DI038422.1 TROVAC FOWLPOX VIRUS RECOMBINANTS AND USES THEREOF
GGGTGACTGCA
>DI036349.1 TROVAC FOWLPOX VIRUS RECOMBINANTS AND USES THEREOF
GATCTCCCGGG
>DI033433.1 Manipulation of negative stranded RNA viruses by rearrangementof their genes and uses thereof
NNNNNGAGACC
>DI023787.1 DNA sequences comprising gene transcription regulatory qualities and
CCANNNNNCCG
>DI020456.1 DNA sequences comprising gene transcription regulatory qualities and
CCCNNNNNGCC
>DI020420.1 ALVAC CANARYPOX VIRUS RECOMBINANTS AND USES THEREOF
AATTCAACCGC
>DI020080.1 Single nucleotide polymorphism in the promoter region of MxA gene and use thereof
TTCTGCGCCCG
>DI016956.1 DNA sequences comprising gene transcription regulatory qualities and
GCCNNNNNCCC
>DI015755.1 SCREENING ASSAY FOR THE DETECTION OF DNA-BINDING MOLECULES
CGTTCTCACTT
>DI013862.1 Antisense Inhibition of ras Gene with Chimeric and Alternating Oligonucleotides
CACCGACGGCG
>DJ071787.1 WNT-1 INDUCED SECRETED POLYPEPTIDES: WISP-1, -2 AND -3
ACCGCCCTCCG
>DJ080363.1 MULTIPLEX METHOD FOR NUCLEIC ACID DETECTION
TGCCGAGACGT
>DJ080304.1 Nucleic Acid Detection
AGTGACTGGGG
>DJ080280.1 Nucleic Acid Detection
TGCCGAGACGT
>DJ081368.1 Method of cloning and producing fragment chains with readable information content
TTTTTTTTTTT
>DJ081327.1 Method of cloning and producing fragment chains with readable information content
TTTTTTTTCGG
>DJ081325.1 Method of cloning and producing fragment chains with readable information content
TTTTTTTTGCG
>DJ081322.1 Method of cloning and producing fragment chains with readable information content
GGGGGGGGCCG
>DJ081319.1 Method of cloning and producing fragment chains with readable information content
GGGGGGGGAAC
>DJ081318.1 Method of cloning and producing fragment chains with readable information content
GGGGGGGGAAA
>DJ081269.1 Method of cloning and producing fragment chains with readable information content
GGGGCCNNNCT
>DJ081268.1 Method of cloning and producing fragment chains with readable information content
GGCCCCCNNAA
>EA423104.1 Sequence 5324 from patent US 7326544
GTGGTGAAGAC
>EA416716.1 Sequence 21 from patent US 7321029
GTTGAGTGTAG
>EA416715.1 Sequence 20 from patent US 7321029
GTTAGGGTTAG
>EA416712.1 Sequence 17 from patent US 7321029
GTTGAGTGTAG
>EA416711.1 Sequence 16 from patent US 7321029
GTTAGGGTTAG
>EA415636.1 Sequence 16 from patent US 7320964
GTTCCCGGAAC
>EA415635.1 Sequence 15 from patent US 7320964
GTTCCGGGAAC
>EA415634.1 Sequence 14 from patent US 7320964
CTTCCGGGAAC
>EA415633.1 Sequence 13 from patent US 7320964
GTTCCCGGAAG
>EA415632.1 Sequence 12 from patent US 7320964
GTTCCTGGAAC
>EA415631.1 Sequence 11 from patent US 7320964
GTTCCAGGAAC
>EA415630.1 Sequence 10 from patent US 7320964
CTTACAGGAAT
>EA415629.1 Sequence 9 from patent US 7320964
ATTCCTGTAAG
>EA415628.1 Sequence 8 from patent US 7320964
CTTCCAGGAAT
>EA415627.1 Sequence 7 from patent US 7320964
ATTCCTGGAAG
>EA415626.1 Sequence 6 from patent US 7320964
CTTACCGGAAT
>EA415625.1 Sequence 5 from patent US 7320964
ATTCCGGTAAG
>EA415624.1 Sequence 4 from patent US 7320964
CTTCCGGTAAT
>EA415623.1 Sequence 3 from patent US 7320964
ATTACCGGAAG
>EA415622.1 Sequence 2 from patent US 7320964
NTTHCVGNAAN
>EA415621.1 Sequence 1 from patent US 7320964
NTTNCBGDAAN
>EA402533.1 Sequence 50 from patent US 7319003
CCANNNNNTGG
>EA402532.1 Sequence 49 from patent US 7319003
CCANNNNNTGG
>EA402525.1 Sequence 40 from patent US 7319003
GCCNNNNNGGC
>EA402524.1 Sequence 39 from patent US 7319003
GCCNNNNNGGC
>EA401825.1 Sequence 68 from patent US 7317098
TAAGAGCCGCC
>EA398814.1 Sequence 6 from patent US 7316931
CAATGTCCTTT
>EA398679.1 Sequence 2 from patent US 7316914
GGAAGGTATTA
>EA398678.1 Sequence 1 from patent US 7316914
GGYCGGTWYGK
>EA374790.1 Sequence 4 from patent US 7314928
TACGTAAGGCS
>EA374748.1 Sequence 10 from patent US 7314926
GGTGGTGGTGG
>EA369258.1 Sequence 28 from patent US 7312202
TGTGGGCGGGG
>EA369252.1 Sequence 17 from patent US 7312202
AGGGACTTTCC
>EA369251.1 Sequence 14 from patent US 7312202
ATTTGACGTCA
>EA369244.1 Sequence 4 from patent US 7312202
GCAGGCAGTTG
>EA368551.1 Sequence 1 from patent US 7312038
AAAAAAGGGGG
>EA360371.1 Sequence 6 from patent US 7309605
AATGCTTTCCA
>DJ069070.1 Identification of Clonal Cells by Repeats in (Eg.) T-Cell Receptor V/D/J Genes
TGACTACGGTG
>DJ069068.1 Identification of Clonal Cells by Repeats in (Eg.) T-Cell Receptor V/D/J Genes
TGACTACAGTA
>DJ063264.1 Method, apparatus, and computer program for searching miRNA, and recording medium
TGATCCTGCCA
>DJ065512.1 gene fragment comprising mutation in S. aureus with reduced susceptibility to glycopeptide and its use
CAACCGATGAT
>DJ058377.1 NF-kB Oligonucleotide Decoy Molecules
TCGATTTCCTC
>DJ058368.1 NF-kB Oligonucleotide Decoy Molecules
AGGACTTTCCA
>DJ058321.1 NF-kB Oligonucleotide Decoy Molecules
GGGGACTTTCC
>DJ054950.1 MN Gene and Protein
ACACAGAAGGG
>DJ054948.1 MN Gene and Protein
CTCCAGTCCAG
>DJ054947.1 MN Gene and Protein
CCCTAGCTCCA
>DJ054946.1 MN Gene and Protein
TCACAGGCTCA
>DJ054945.1 MN Gene and Protein
CCCCAGGAGGG
>DJ054944.1 MN Gene and Protein
TTTCAGATCCA
>DJ054943.1 MN Gene and Protein
ACGCAGTGCAA
>DJ054942.1 MN Gene and Protein
CCCCAGGCGAC
>DJ054941.1 MN Gene and Protein
ATACAGGGGAT
>DJ054940.1 MN Gene and Protein
CACAGGTATTA
>DJ054939.1 MN Gene and Protein
TGCTGGTGAGT
>DJ054938.1 MN Gene and Protein
GCCAGGTACAG
>DJ054937.1 MN Gene and Protein
AGCAGGTGGGC
>DJ054936.1 MN Gene and Protein
GGAAGGTCAGT
>DJ054935.1 MN Gene and Protein
TGGAGGTACCA
>DJ054934.1 MN Gene and Protein
CCGAGGTGAGC
>DJ054933.1 MN Gene and Protein
CAGTCGTGAGG
>DJ054932.1 MN Gene and Protein
TGGAGGTGAGA
>DJ054931.1 MN Gene and Protein
AGAAGGTAAGT
>FB296093.1 Sequence 16 from Patent WO2007100412
TGGCTCATTCG
>CS813031.1 Sequence 55 from Patent WO2007106118
GTCTCCCGAGA
>EA356842.1 Sequence 8 from patent US 7288379
GATCGATCGAT
>EA356841.1 Sequence 7 from patent US 7288379
ATCGATCGATC
>EA356840.1 Sequence 6 from patent US 7288379
CATGCATCGAT
>EA356839.1 Sequence 5 from patent US 7288379
ATCGATGCATG
>EA354039.1 Sequence 39 from patent US 7306918
CTTATTTCCCT
>EA327543.1 Sequence 8 from patent US 7306903
CTAAACATAAC
>EA327542.1 Sequence 7 from patent US 7306903
TTAAACATAAA
>EA327541.1 Sequence 6 from patent US 7306903
CTAAAAATAAC
>EA323871.1 Sequence 5 from patent US 7303889
GGGGACTTTCC
>EA322500.1 Sequence 38 from patent US 7300922
ATGGGGAGGCA
>EA322394.1 Sequence 11 from patent US 7300791
ACTTAGTACGG
>EA318197.1 Sequence 22 from patent US 7297495
TTTTTTTTTTT
>EA318188.1 Sequence 13 from patent US 7297495
NAATTTAAAGA
>EA318182.1 Sequence 7 from patent US 7297495
GAATTTTGCTT
>EA318052.1 Sequence 22 from patent US 7297491
CGGGACACGGG
>EA318051.1 Sequence 21 from patent US 7297491
CGGGACATGTG
>EA318050.1 Sequence 20 from patent US 7297491
CGGGACACGTG
>EA318049.1 Sequence 19 from patent US 7297491
CGGGACACGGG
>EA318048.1 Sequence 18 from patent US 7297491
CGGGACATGTG
>EA318047.1 Sequence 17 from patent US 7297491
CGGGACACGTG
>EA318046.1 Sequence 16 from patent US 7297491
CGGGANNNNNG
>EA318045.1 Sequence 15 from patent US 7297491
CNGGACACGTN
>EA314412.1 Sequence 59 from patent US 7294500
GGGGGCCCCCG
>EA314411.1 Sequence 58 from patent US 7294500
GGGGGCCCCCC
>EA314404.1 Sequence 46 from patent US 7294500
CGGGTCCCCCC
>EA313622.1 Sequence 22 from patent US 7294487
CCANNNNNTGG
>EA313621.1 Sequence 21 from patent US 7294487
GCNNNNNNNGC
>EA313618.1 Sequence 18 from patent US 7294487
CCTNNNNNAGG
>EA313615.1 Sequence 15 from patent US 7294487
GCANNNNNTGC
>EA313614.1 Sequence 14 from patent US 7294487
CCNNNNNNNGG
>EA313612.1 Sequence 12 from patent US 7294487
GCCNNNNNGGC
>EA313609.1 Sequence 9 from patent US 7294487
GACNNNNNGTC
>EA307292.1 Sequence 3 from patent US 7291491
CTTTAGAGCAC
>EA307172.1 Sequence 42 from patent US 7291485
GGCGCGCCGCC
>EA307058.1 Sequence 8 from patent US 7291468
GATCGATCGAT
>EA307057.1 Sequence 7 from patent US 7291468
ATCGATCGATC
>EA307056.1 Sequence 6 from patent US 7291468
CATGCATCGAT
>EA307055.1 Sequence 5 from patent US 7291468
ATCGATGCATG
>EA307050.1 Sequence 8 from patent US 7291467
GATCGATCGAT
>EA307049.1 Sequence 7 from patent US 7291467
ATCGATCGATC
>EA307048.1 Sequence 6 from patent US 7291467
CATGCATCGAT
>EA307047.1 Sequence 5 from patent US 7291467
ATCGATGCATG
>EA306251.1 Sequence 23 from patent US 7285656
NNNWAAAGNNN
>EA306244.1 Sequence 16 from patent US 7285656
TACAATAAATA
>EA302660.1 Sequence 32 from patent US 7285416
GGATGGGAGAC
>EA302479.1 Sequence 628 from patent US 7285400
GTGGTGAAGAC
>DJ020769.1 NUCLEOTIDE SEQUENCE ENCODING THE ENZYME I-SceI AND THE USES THEREOF
AATGCTTTCCA
>DJ017951.1 ARRAY OLIGOMER SYNTHESIS AND USE
GGCCGATCCAA
>DJ020589.1 Double-Stranded RNA Structures and Constructs, and Methods For Generating and Using the Same
CCCCCCCCCCC
>DJ020586.1 Double-Stranded RNA Structures and Constructs, and Methods For Generating and Using the Same
GGGGGGGGGGG
>DJ022672.1 Recombinant Infectious Non-Segmented Negative Strand RNA Virus
ACGCTTAACAA
>DJ016463.1 Vaccine Composition
CGCCGCCGCCC
>CS803962.1 Sequence 186 from Patent WO2007095316
TCGACGTCGTT
>CS803961.1 Sequence 185 from Patent WO2007095316
TCGACGTCGTT
>FB295407.1 Sequence 4 from Patent WO2006135431
GGGTCTGGCCC
>FB294456.1 Sequence 88 from Patent EP1847611
NNNGTTTCCAN
>FB294455.1 Sequence 87 from Patent EP1847611
NNNGTTTATCN
>FB294449.1 Sequence 81 from Patent EP1847611
GCANNNNNTGC
>FB294447.1 Sequence 79 from Patent EP1847611
CCNNNNNNNGG
>FB294446.1 Sequence 78 from Patent EP1847611
GCTCTTCNNNN
>FB294444.1 Sequence 76 from Patent EP1847611
GCTCTTCNNNN
>FB294384.1 Sequence 16 from Patent EP1847611
NNNNGAAGAGC
>FB294382.1 Sequence 14 from Patent EP1847611
CCANNNNNTGG
>FB294380.1 Sequence 12 from Patent EP1847611
GCNNNNNNNGC
>FB294379.1 Sequence 11 from Patent EP1847611
CCNNNNNNNGG
>FB294377.1 Sequence 9 from Patent EP1847611
NNNNNGAGACC
>FB294375.1 Sequence 7 from Patent EP1847611
GCCNNNNNGGC
>FB294374.1 Sequence 6 from Patent EP1847611
NNNNNGAGACG
>FB294209.1 Sequence 213 from Patent EP1847605
GAGGGTGGCGG
>DJ052513.1 METHODS AND COMPOSITIONS FOR DIAGNOSIS AND TREATMENT OF B CELL CHRONIC LYMPHOCYTIC LEUKEMIA
ATTACTACTAC
>DJ052494.1 METHODS AND COMPOSITIONS FOR DIAGNOSIS AND TREATMENT OF B CELL CHRONIC LYMPHOCYTIC LEUKEMIA
ACTTTGACTAC
>DJ052484.1 METHODS AND COMPOSITIONS FOR DIAGNOSIS AND TREATMENT OF B CELL CHRONIC LYMPHOCYTIC LEUKEMIA
TGTGCGAGAGA
>DJ052478.1 METHODS AND COMPOSITIONS FOR DIAGNOSIS AND TREATMENT OF B CELL CHRONIC LYMPHOCYTIC LEUKEMIA
ATTACTACTAC
>DJ052476.1 METHODS AND COMPOSITIONS FOR DIAGNOSIS AND TREATMENT OF B CELL CHRONIC LYMPHOCYTIC LEUKEMIA
TGTGCGAGAGG
>DJ052467.1 METHODS AND COMPOSITIONS FOR DIAGNOSIS AND TREATMENT OF B CELL CHRONIC LYMPHOCYTIC LEUKEMIA
TGTGCGAGACA
>DJ052289.1 Synbiotic composition for infants
TTATCGCGCCA
>DJ051947.1 Vector
GTTGAACCTCG
>DJ046069.1 Gene Search vector
GAATTCAGATC
>DJ050847.1 Vectors for Directional Cloning
NNNGTTTCCAN
>DJ050846.1 Vectors for Directional Cloning
NNNGTTTATCN
>DJ050841.1 Vectors for Directional Cloning
GCANNNNNTGC
>DJ050839.1 Vectors for Directional Cloning
CCNNNNNNNGG
>DJ050838.1 Vectors for Directional Cloning
GCTCTTCNNNN
>DJ050836.1 Vectors for Directional Cloning
GCTCTTCNNNN
>DJ050818.1 Vectors for Directional Cloning
NNNNGAAGAGC
>DJ050816.1 Vectors for Directional Cloning
CCANNNNNTGG
>DJ050814.1 Vectors for Directional Cloning
GCNNNNNNNGC
>DJ050813.1 Vectors for Directional Cloning
CCNNNNNNNGG
>DJ050811.1 Vectors for Directional Cloning
NNNNNGAGACC
>DJ050809.1 Vectors for Directional Cloning
GCCNNNNNGGC
>DJ050808.1 Vectors for Directional Cloning
NNNNNGAGACG
>DJ050660.1 C-CLASS OLIGONUCLEOTIDE ANALOGS WITH ENHANCED IMMUNOSTIMULATORY POTENCY
TCGTCGTTTTA
>DJ050633.1 C-CLASS OLIGONUCLEOTIDE ANALOGS WITH ENHANCED IMMUNOSTIMULATORY POTENCY
GTCGAGGAGGT
>DJ050621.1 C-CLASS OLIGONUCLEOTIDE ANALOGS WITH ENHANCED IMMUNOSTIMULATORY POTENCY
CCGTTTTGTGG
>CS793388.1 Sequence 29 from Patent EP1832567
TGGTACGAATT
>CS793302.1 Sequence 86 from Patent EP1832653
ACACAGAAGGG
>CS793300.1 Sequence 84 from Patent EP1832653
CTCCAGTCCAG
>CS793299.1 Sequence 83 from Patent EP1832653
CCCTAGCTCCA
>CS793298.1 Sequence 82 from Patent EP1832653
TCACAGGCTCA
>CS793297.1 Sequence 81 from Patent EP1832653
CCCCAGGAGGG
>CS793296.1 Sequence 80 from Patent EP1832653
TTTCAGATCCA
>CS793295.1 Sequence 79 from Patent EP1832653
ACGCAGTGCAA
>CS793294.1 Sequence 78 from Patent EP1832653
CCCCAGGCGAC
>CS793293.1 Sequence 77 from Patent EP1832653
ATACAGGGGAT
>CS793292.1 Sequence 76 from Patent EP1832653
CACAGGTATTA
>CS793291.1 Sequence 75 from Patent EP1832653
TGCTGGTGAGT
>CS793290.1 Sequence 74 from Patent EP1832653
GCCAGGTACAG
>CS793289.1 Sequence 73 from Patent EP1832653
AGCAGGTGGGC
>CS793288.1 Sequence 72 from Patent EP1832653
GGAAGGTCAGT
>CS793287.1 Sequence 71 from Patent EP1832653
TGGAGGTACCA
>CS793286.1 Sequence 70 from Patent EP1832653
CCGAGGTGAGC
>CS793285.1 Sequence 69 from Patent EP1832653
CAGTCGTGAGG
>CS793284.1 Sequence 68 from Patent EP1832653
TGGAGGTGAGA
>CS793283.1 Sequence 67 from Patent EP1832653
AGAAGGTAAGT
>CS720935.1 Sequence 27 from Patent WO2007096275
GTAATGATTRC
>CS720933.1 Sequence 25 from Patent WO2007096275
GTAATGATTRC
>CS720164.1 Sequence 2 from Patent WO2006093892
CGCTGAACTGC
>CS706565.1 Sequence 16 from Patent WO2006091915
GTCGTTTTGAC
>CS806556.1 Sequence 281 from Patent WO2007093409
CCAATGTCGCC
>CS806530.1 Sequence 255 from Patent WO2007093409
GAGGGACGTGC
>DJ042925.1 NUCLEIC ACID-LIPOPHILIC CONJUGATES
TTCGACGTCGA
>DJ042870.1 NUCLEIC ACID-LIPOPHILIC CONJUGATES
TCGTCGACGTT
>DJ042868.1 NUCLEIC ACID-LIPOPHILIC CONJUGATES
GTCGACGTCGT
>DJ042867.1 NUCLEIC ACID-LIPOPHILIC CONJUGATES
TCGACGTCGTT
>DJ042866.1 NUCLEIC ACID-LIPOPHILIC CONJUGATES
TCGTCGACGTG
>DJ030486.1 A system for highly producing infectious Hepatits C virus particle
CTAGTACAGGG
>DJ030485.1 A system for highly producing infectious Hepatits C virus particle
TATTACCTGCC
>DJ028182.1 RNA aptamer inhibiting E. Coli termination factor RF1 and use thereof
AAAAAAAAAAA
>DJ044229.1 CONSENSUS/ANCESTRAL IMMUNOGENS
GCCACCATGGA
>DJ029408.1 Catalytic DNA molecules
ATAGGCCCGGT
>DJ029405.1 Catalytic DNA molecules
ATAGCGTATTA
>DJ026134.1 Method for screening an agent for modifying the transcription of ABCA1, and DNA and kit therefor
GTCTGGTGAGA
>DJ026133.1 Method for screening an agent for modifying the transcription of ABCA1, and DNA and kit therefor
TCTCAGCTGAG
>DJ026132.1 Method for screening an agent for modifying the transcription of ABCA1, and DNA and kit therefor
KATCACCCCAC
>DJ036235.1 RNA Interference Mediated Inhibition Of Vascular Endothelial Growth Factor And Vascular Endothelial Growth Factor Receptor Gene Expression Using Short Interfering Nucleic Acid (siNA)
GGAGGAGGAAG
>DJ036230.1 RNA Interference Mediated Inhibition Of Vascular Endothelial Growth Factor And Vascular Endothelial Growth Factor Receptor Gene Expression Using Short Interfering Nucleic Acid (siNA)
ACAAATGTGAA
>DJ036229.1 RNA Interference Mediated Inhibition Of Vascular Endothelial Growth Factor And Vascular Endothelial Growth Factor Receptor Gene Expression Using Short Interfering Nucleic Acid (siNA)
GGAGGAAGAGT
>DJ036222.1 RNA Interference Mediated Inhibition Of Vascular Endothelial Growth Factor And Vascular Endothelial Growth Factor Receptor Gene Expression Using Short Interfering Nucleic Acid (siNA)
AGGAAGAGGAG
>DJ036218.1 RNA Interference Mediated Inhibition Of Vascular Endothelial Growth Factor And Vascular Endothelial Growth Factor Receptor Gene Expression Using Short Interfering Nucleic Acid (siNA)
TACCCTGATGA
>EA296595.1 Sequence 8 from patent US 7279334
CCCATCTCTTT
>EA296222.1 Sequence 6 from patent US 7279310
CTTTAGAGCAC
>EA295931.1 Sequence 4 from patent US 7279280
GTCCAGGTACC
>EA295929.1 Sequence 2 from patent US 7279280
GCATCCATGTG
>EA294514.1 Sequence 62 from patent US 7276489
CTATCTGACGT
>EA294512.1 Sequence 60 from patent US 7276489
ACGTTCTCTGT
>EA294505.1 Sequence 53 from patent US 7276489
CCTACTAGCGT
>EA294502.1 Sequence 50 from patent US 7276489
GCGTTCTCATC
>EA294492.1 Sequence 40 from patent US 7276489
TCTGANGTTCT
>EA294491.1 Sequence 39 from patent US 7276489
TCTGTNGTTCT
>EA294490.1 Sequence 38 from patent US 7276489
TCTTTCNTTCT
>EA294489.1 Sequence 37 from patent US 7276489
TCTTTNGTTCT
>EA294485.1 Sequence 33 from patent US 7276489
TCTGTCGTTCT
>EA294479.1 Sequence 27 from patent US 7276489
TCTGANNTTCT
>EA294478.1 Sequence 26 from patent US 7276489
TCTGACNTTCT
>EA294476.1 Sequence 24 from patent US 7276489
TCTGACNTTCT
>EA294472.1 Sequence 20 from patent US 7276489
TCTGTNNTTCT
>EA294471.1 Sequence 19 from patent US 7276489
TCTGTCNTTCT
>EA294470.1 Sequence 18 from patent US 7276489
TCTGTCNTTCT
>EA294465.1 Sequence 13 from patent US 7276489
TCTGACGTTCT
>EA293870.1 Sequence 1 from patent US 7276337
NAAAATAAAAN
>EA292626.1 Sequence 40 from patent US 7273605
TAAGGCGCGCC
>EA291641.1 Sequence 1131 from patent US 7271156
GATGTATCGTC
>EA290573.1 Sequence 40 from patent US 7271139
CCGTTAAATTT
>EA290572.1 Sequence 39 from patent US 7271139
GTACTAAAACC
>EA290463.1 Sequence 6 from patent US 7271000
AATGCTTTCCA
>EA289537.1 Sequence 3 from patent US 7270969
GCCAGCCATGG
>EA289510.1 Sequence 90 from patent US 7270958
TACTATGGTTT
>EA289507.1 Sequence 87 from patent US 7270958
TACTATGGTTT
>EA289499.1 Sequence 79 from patent US 7270958
TACTATGTTTA
>EA289497.1 Sequence 77 from patent US 7270958
TACTATGTTTA
>EA289495.1 Sequence 75 from patent US 7270958
TACTATGGTTT
>EA289493.1 Sequence 73 from patent US 7270958
TACTATGGTTA
>EA289491.1 Sequence 71 from patent US 7270958
TACTATGGTTA
>EA289489.1 Sequence 69 from patent US 7270958
TACTATGGTTA
>EA289487.1 Sequence 67 from patent US 7270958
TACTATGTTTA
>EA289485.1 Sequence 65 from patent US 7270958
TACTATGTTTA
>EA289483.1 Sequence 63 from patent US 7270958
TACTATGGTTT
>EA289481.1 Sequence 61 from patent US 7270958
TACTATGGTTA
>EA289479.1 Sequence 59 from patent US 7270958
TACTATGGTTA
>EA289477.1 Sequence 57 from patent US 7270958
TACTATGGTTA
>EA289475.1 Sequence 55 from patent US 7270958
TACTATGTTTA
>EA289473.1 Sequence 53 from patent US 7270958
TACTATGTTTA
>EA289469.1 Sequence 49 from patent US 7270958
TACTTGGTTTA
>EA289465.1 Sequence 45 from patent US 7270958
TATATGGTTTA
>EA289463.1 Sequence 43 from patent US 7270958
TCTATGGTTTA
>EA289459.1 Sequence 39 from patent US 7270958
TACTAGGTTTA
>EA289457.1 Sequence 37 from patent US 7270958
TACTTGGTTTA
>EA289455.1 Sequence 35 from patent US 7270958
TACATGGTTTA
>EA289453.1 Sequence 33 from patent US 7270958
TATATGGTTTA
>EA289451.1 Sequence 31 from patent US 7270958
TCTATGGTTTA
>EA289449.1 Sequence 29 from patent US 7270958
ACTATGGTTTA
>EA289447.1 Sequence 27 from patent US 7270958
TACTAGGTTTA
>EA289445.1 Sequence 25 from patent US 7270958
TACTTGGTTTA
>EA289443.1 Sequence 23 from patent US 7270958
TACATGGTTTA
>EA289441.1 Sequence 21 from patent US 7270958
TATATGGTTTA
>EA289439.1 Sequence 19 from patent US 7270958
TCTATGGTTTA
>EA289437.1 Sequence 17 from patent US 7270958
ACTATGGTTTA
>EA288098.1 Sequence 33 from patent US 7267978
CCCTCGAGCGC
>EA287937.1 Sequence 2 from patent US 7267966
GAGAAGNNNNN
>EA287936.1 Sequence 1 from patent US 7267966
CTCTTCNNNNN
>EA287935.1 Sequence 1072 from patent US 7267965
GCCNNNNNCCC
>EA287917.1 Sequence 1048 from patent US 7267965
CGCNNNNNGGC
>EA287908.1 Sequence 1039 from patent US 7267965
CAGNNNNNGGG
>EA287898.1 Sequence 1027 from patent US 7267965
GCGNNNNNGCC
>EA287840.1 Sequence 954 from patent US 7267965
CGGNNNNNCCC
>EA287815.1 Sequence 923 from patent US 7267965
CCCNNNNNCCA
>EA287813.1 Sequence 921 from patent US 7267965
ACGNNNNNGCA
>EA287793.1 Sequence 899 from patent US 7267965
CACNNNNNGGG
>EA287772.1 Sequence 873 from patent US 7267965
CCGNNNNNTCC
>EA287754.1 Sequence 851 from patent US 7267965
GGCNNNNNGGA
>EA287753.1 Sequence 850 from patent US 7267965
CCCNNNNNAGC
>EA287751.1 Sequence 847 from patent US 7267965
CAGNNNNNCCC
>EA287748.1 Sequence 844 from patent US 7267965
GCCNNNNNGGA
>EA287742.1 Sequence 838 from patent US 7267965
CGGNNNNNACG
>EA287736.1 Sequence 831 from patent US 7267965
AGCNNNNNCAG
>EA287734.1 Sequence 827 from patent US 7267965
CCANNNNNCCG
>EA287721.1 Sequence 806 from patent US 7267965
ACCNNNNNCCC
>EA287704.1 Sequence 783 from patent US 7267965
CCANNNNNGGG
>EA287701.1 Sequence 779 from patent US 7267965
CTGNNNNNCCC
>EA287693.1 Sequence 770 from patent US 7267965
CGCNNNNNGAG
>EA287671.1 Sequence 742 from patent US 7267965
CGGNNNNNGGC
>EA287654.1 Sequence 721 from patent US 7267965
CCCNNNNNAGG
>EA287647.1 Sequence 710 from patent US 7267965
GAGNNNNNCCC
>EA287616.1 Sequence 664 from patent US 7267965
CCTNNNNNGCC
>EA287598.1 Sequence 641 from patent US 7267965
CCCNNNNNCGG
>EA287590.1 Sequence 632 from patent US 7267965
CCGNNNNNCCC
>EA287568.1 Sequence 604 from patent US 7267965
CTGNNNNNCGC
>EA287566.1 Sequence 602 from patent US 7267965
GCGNNNNNGAC
>EA287524.1 Sequence 548 from patent US 7267965
CTCNNNNNCGC
>EA287512.1 Sequence 533 from patent US 7267965
GACNNNNNCGC
>EA287508.1 Sequence 528 from patent US 7267965
CCCNNNNNCCG
>EA287496.1 Sequence 506 from patent US 7267965
CAGNNNNNCCG
>EA287461.1 Sequence 463 from patent US 7267965
CCGNNNNNGAC
>EA287451.1 Sequence 448 from patent US 7267965
GCGNNNNNGGA
>EA287445.1 Sequence 440 from patent US 7267965
CGGNNNNNCTC
>EA287421.1 Sequence 409 from patent US 7267965
GCCNNNNNCGC
>EA287400.1 Sequence 383 from patent US 7267965
GGGNNNNNGGA
>EA287396.1 Sequence 376 from patent US 7267965
CCTNNNNNGCG
>EA287393.1 Sequence 373 from patent US 7267965
CACNNNNNGCG
>EA287388.1 Sequence 360 from patent US 7267965
CCCNNNNNGCC
>EA287383.1 Sequence 355 from patent US 7267965
CGCNNNNNGCA
>EA284053.1 Sequence 107 from patent US 7262288
RGGGRMTYYCC
>EA284052.1 Sequence 106 from patent US 7262288
TGGGCTTCCCC
>EA283758.1 Sequence 32 from patent US 7262055
GGATGGGAGAC
>EA283558.1 Sequence 6 from patent US 7262039
CTTTAGAGCAC
>EA274168.1 Sequence 254 from patent US 7256020
CTCCTACTCCC
>EA273246.1 Sequence 130 from patent US 7255868
TNGAANGTTCG
>EA273245.1 Sequence 129 from patent US 7255868
TNGAANGTTCG
>EA273243.1 Sequence 127 from patent US 7255868
TCGAANGTTCG
>EA273235.1 Sequence 119 from patent US 7255868
TNGACCGTTCG
>EA273234.1 Sequence 118 from patent US 7255868
TNGAACGTTCG
>EA273228.1 Sequence 112 from patent US 7255868
TCGACCGTTCG
>EA273219.1 Sequence 103 from patent US 7255868
TCGAACGTTCG
>CS787553.1 Sequence 7 from Patent WO2007075836
CCTNNNNNAGG
>CS788263.1 Sequence 717 from Patent WO2007075836
TATCTTAATAT
>CS788262.1 Sequence 716 from Patent WO2007075836
TATCTTAATAC
>DJ004036.1 Expression vectors, transformed host cells and fermentation process for the production of recombinant polypeptides
TCGCCTTTGCG
>DJ004020.1 Process for the purification of recombinant polypeptides
TCGCCTTTGCG
>DJ003552.1 A novel loop sequence effective for shRNA expression
TCTATTTTCCA
>DD496053.1 Improved Nucleic Acid Cloning
TGGTTGGAACC
>DD495922.1 METHOD FOR POLYPEPTIDE PRODUCTION AND CONSTRUCTS USED THEREFOR
TGACGTACAGA
>DD495250.1 A nucleotide sequence having a function for suppressing gene expression
GGGAAGGGGAT
>CS673212.1 Sequence 14 from Patent EP1810978
CGATTCCCTCG
>DD463950.1 Method for Sowing CONTIG Map
GAACGCGAGAC
>DD463946.1 Method for Sowing CONTIG Map
GAACGCGAGAC
>DD463049.1 Method for Preparing Recombinat Enzyme Proteins Using Silkworm, Gene Recombinant Silkworm Used Therefor and Method for Preparing the Recombinant Silkworm
AATTGCTAGCA
>DD461876.1 Multiple shRNA expression vector
GCANNNNNTGC
>DD461875.1 Multiple shRNA expression vector
CCANNNNNTGG
>DD461873.1 Multiple shRNA expression vector
GCCNNNNNGCC
>DD461872.1 Multiple shRNA expression vector
CCTNNNNNAGG
>DD461870.1 Multiple shRNA expression vector
GACNNNNNGTC
>DD461720.1 Multiple shRNA expression vector
GTGTGCTGTCC
>DD460871.1 NUCLEOTIDE SEQUENCE ENCODING THE ENZYME I-SceI AND THE USES THEREOF
AATGCTTTCCA
>EA272391.1 Sequence 16 from patent US 7250252
ACCTGTGCATA
>EA271904.1 Sequence 24 from patent US 7247714
RGRACNNNGCT
>EA267713.1 Sequence 64 from patent US 7244560
TAGGCCAAGGG
>EA267712.1 Sequence 63 from patent US 7244560
CGGAACAAGGG
>EA267689.1 Sequence 40 from patent US 7244560
GAATAAGGGCG
>EA267684.1 Sequence 35 from patent US 7244560
AAGGGCGAGCT
>EA267629.1 Sequence 6 from patent US 7244558
GTTTTTTCTAA
>EA267110.1 Sequence 63 from patent US 7241882
GTTAGGGTTAG
>EA267105.1 Sequence 58 from patent US 7241882
TATTCCGTCAT
>EA267054.1 Sequence 6 from patent US 7241882
TATTCCGTCAT
>EA266724.1 Sequence 89 from patent US 7241876
TTCCGTTATGC
>EA264954.1 Sequence 14 from patent US 7241605
CTTTAGAGCAC
>EA251897.1 Sequence 51 from patent US 7232899
CGCGGATCCCG
>EA247046.1 Sequence 8 from patent US 7226998
TATGGACTTGC
>EA241412.1 Sequence 2 from patent US 7226606
TAAATAAATAA
>EA135353.1 Sequence 9 from patent US 7223850
GCTCCAATTCC
>EA135352.1 Sequence 8 from patent US 7223850
GCTCCAATTCC
>EA135351.1 Sequence 7 from patent US 7223850
GGAATTGGAGC
>EA133659.1 Sequence 29 from patent US 7223545
TGGTACGAATT
>EA130290.1 Sequence 2 from patent US 7217814
TTTTTTTTTTC
>EA128543.1 Sequence 5 from patent US 7217568
GCTTTGATCTT
>EA128155.1 Sequence 25 from patent US 7217522
TCGCCTTAACT
>EA128154.1 Sequence 24 from patent US 7217522
AGTCCTTAACT
>EA127962.1 Sequence 3 from patent US 7217509
CTAGACTTAAG
>EA127959.1 Sequence 2 from patent US 7217421
TAAATAAATAA
>EA127762.1 Sequence 13 from patent US 7211661
GGTGTTCCCTG
>EA127760.1 Sequence 11 from patent US 7211661
GAGGGTCATAT
>EA126989.1 Sequence 3 from patent US 7211435
GGCGCGAGTTT
>EA126355.1 Sequence 16 from patent US 7208659
CATCGATATGG
>EA125906.1 Sequence 48 from patent US 7208579
TCTTTCTCTCA
>EA125898.1 Sequence 40 from patent US 7208579
CTTTTGCAATA
>EA123586.1 Sequence 88 from patent US 7208293
CCANNNNNTGG
>EA123556.1 Sequence 13 from patent US 7208290
GGCGCGCCGCC
>EA123508.1 Sequence 15 from patent US 7208282
AGAGTGACTGA
>EA123174.1 Sequence 7 from patent US 7208274
CCTNNNNNAGG
>EA122941.1 Sequence 69 from patent US 7208161
TCACATGGCGA
>EA122940.1 Sequence 68 from patent US 7208161
TTACATGGCCA
>EA121047.1 Sequence 5232 from patent US 7205146
GTGGTGAAGAC
>EA112292.1 Sequence 13 from patent US 7202077
NNNNNTGANNN
>EA112291.1 Sequence 12 from patent US 7202077
NNNNNTAANNN
>EA112290.1 Sequence 11 from patent US 7202077
NNNNNTAGNNN
>EA112289.1 Sequence 10 from patent US 7202077
NNTGANNNNNN
>EA112288.1 Sequence 9 from patent US 7202077
NNTAANNNNNN
>EA112287.1 Sequence 8 from patent US 7202077
NNTAGNNNNNN
>EA110650.1 Sequence 10 from patent US 7201907
CAAAAATGTTG
>EA110133.1 Sequence 107 from patent US 7199234
RGGGRMTYYCC
>EA110132.1 Sequence 106 from patent US 7199234
TGGGCTTCCCC
>EA109375.1 Sequence 148 from patent US 7198924
GGCCTAAAGGG
>EA109372.1 Sequence 145 from patent US 7198924
GTTCCGAAGGG
>EA109364.1 Sequence 137 from patent US 7198924
GGCCTAAAGGG
>EA109363.1 Sequence 136 from patent US 7198924
GTTCCGAAGGG
>EA109362.1 Sequence 135 from patent US 7198924
GGCCATAAGGG
>EA109295.1 Sequence 64 from patent US 7198924
TAGGCCAAGGG
>EA109294.1 Sequence 63 from patent US 7198924
CGGAACAAGGG
>EA109271.1 Sequence 40 from patent US 7198924
GAATAAGGGCG
>EA109266.1 Sequence 35 from patent US 7198924
AAGGGCGAGCT
>DD457886.1 NUCLEOTIDES FOR PREVENTION AND TREATMENT OF BACTERIAL AND FUNGAL PATHOLOGIES
TGATGACCTTT
>DD457885.1 NUCLEOTIDES FOR PREVENTION AND TREATMENT OF BACTERIAL AND FUNGAL PATHOLOGIES
TTTTGATGACC
>DD457884.1 NUCLEOTIDES FOR PREVENTION AND TREATMENT OF BACTERIAL AND FUNGAL PATHOLOGIES
TTGCTGACCAT
>DD457883.1 NUCLEOTIDES FOR PREVENTION AND TREATMENT OF BACTERIAL AND FUNGAL PATHOLOGIES
TGGGGAGTGAG
>DD457865.1 NUCLEOTIDES FOR PREVENTION AND TREATMENT OF BACTERIAL AND FUNGAL PATHOLOGIES
CTTTCAACAGT
>DD457774.1 Recombinant Influenza Vectors with A PolII Promoter and Ribozymes for Vaccines and Gene Therapy
TATTAGTAGAA
>DD452988.1 Cold-inducible expression promoter and cold-inducible expression vector including the promoter
CCGGGGATCCG
>DD457003.1 Method of Inactivating Ribonucleases at High Temperature
GAAAGGCCCGG
>DD456999.1 Method of Inactivating Ribonucleases at High Temperature
GAAAGGCCCGG
>CS641509.1 Sequence 162 from Patent WO2007056153
GGATCTTATTT
>CS641506.1 Sequence 159 from Patent WO2007056153
GGATCTTATTT
>CS641503.1 Sequence 156 from Patent WO2007056153
GGATCTTATTT
>CS641500.1 Sequence 153 from Patent WO2007056153
GGATCTTATTT
>CS641499.1 Sequence 152 from Patent WO2007056153
ATAAGATCCTT
>CS641496.1 Sequence 149 from Patent WO2007056153
ATAAGATCCTT
>CS641491.1 Sequence 144 from Patent WO2007056153
GGATCTTATTT
>CS641488.1 Sequence 141 from Patent WO2007056153
GGATCTTATTT
>CS641485.1 Sequence 138 from Patent WO2007056153
GGATCTTATTT
>CS641482.1 Sequence 135 from Patent WO2007056153
GGATCTTATTT
>CS641469.1 Sequence 122 from Patent WO2007056153
CGGAGACAATG
>CS641457.1 Sequence 110 from Patent WO2007056153
CGGAGACAATG
>CS641445.1 Sequence 98 from Patent WO2007056153
CGGAGACAATG
>CS641387.1 Sequence 40 from Patent WO2007056153
ATAAGATCCTT
>CS641381.1 Sequence 34 from Patent WO2007056153
ATAAGATCCTT
>CS628283.1 Sequence 83 from Patent WO2006053571
TATCTACAGAG
>CS628222.1 Sequence 22 from Patent WO2006053571
TCTCGAGCATG
>CS623449.1 Sequence 59 from Patent WO2006060308
TTCAAAAACCA
>CS623448.1 Sequence 58 from Patent WO2006060308
TTTAAAAACCA
>CS623447.1 Sequence 57 from Patent WO2006060308
TTCGAAAACCA
>CS623446.1 Sequence 56 from Patent WO2006060308
TTTGAGGATTA
>CS623445.1 Sequence 55 from Patent WO2006060308
TTCGAGGATTA
>CS623444.1 Sequence 54 from Patent WO2006060308
TTCGAGGACCA
>CS623443.1 Sequence 53 from Patent WO2006060308
TTTGAGGACCA
>CS623442.1 Sequence 52 from Patent WO2006060308
TTCGAGGACCA
>CS623441.1 Sequence 51 from Patent WO2006060308
TTCGAGGACCA
>CS626804.1 Sequence 51 from Patent WO2007051626
ATGAACTCCAC
>CS626803.1 Sequence 50 from Patent WO2007051626
CTTTTGTTGTT
>CS626800.1 Sequence 47 from Patent WO2007051626
CTTCCCATAGA
>CS626799.1 Sequence 46 from Patent WO2007051626
AGAGGATTAGT
>CS626796.1 Sequence 43 from Patent WO2007051626
AGCGATAGAAG
>CS626791.1 Sequence 38 from Patent WO2007051626
ATCAGTGTGAA
>CS626788.1 Sequence 35 from Patent WO2007051626
AAGCAATCTAC
>CS626784.1 Sequence 31 from Patent WO2007051626
ACTGGGCTGAT
>CS626783.1 Sequence 30 from Patent WO2007051626
GGAAATCAAGA
>CS626776.1 Sequence 23 from Patent WO2007051626
GTCAACCTTCC
>CS626775.1 Sequence 22 from Patent WO2007051626
GGAAGATCATA
>CS626772.1 Sequence 19 from Patent WO2007051626
CGTGGAAAGTA
>CS626771.1 Sequence 18 from Patent WO2007051626
CTCATCTTGTT
>CS626768.1 Sequence 15 from Patent WO2007051626
AATGGTTGGAG
>CS626767.1 Sequence 14 from Patent WO2007051626
GCGAGAACACA
>CS623246.1 Sequence 40 from Patent WO2007051483
ATGAACTCCAC
>CS623245.1 Sequence 39 from Patent WO2007051483
CTTTTGTTGTT
>CS623242.1 Sequence 36 from Patent WO2007051483
CTTCCCATAGA
>CS623241.1 Sequence 35 from Patent WO2007051483
AGAGGATTAGT
>CS623238.1 Sequence 32 from Patent WO2007051483
AGCGATAGAAG
>CS623233.1 Sequence 27 from Patent WO2007051483
ATCAGTGTGAA
>CS623230.1 Sequence 24 from Patent WO2007051483
AAGCAATCTAC
>CS623226.1 Sequence 20 from Patent WO2007051483
ACTGGGCTGAT
>CS623225.1 Sequence 19 from Patent WO2007051483
GGAAATCAAGA
>CS623218.1 Sequence 12 from Patent WO2007051483
GTCAACCTTCC
>CS623217.1 Sequence 11 from Patent WO2007051483
GGAAGATCATA
>CS623214.1 Sequence 8 from Patent WO2007051483
CGTGGAAAGTA
>CS623213.1 Sequence 7 from Patent WO2007051483
CTCATCTTGTT
>CS623210.1 Sequence 4 from Patent WO2007051483
AATGGTTGGAG
>CS623209.1 Sequence 3 from Patent WO2007051483
GCGAGAACACA
>DD450559.1 METHODS FOR MODULATING ANGIOGENESIS WITH APELIN COMPOSITIONS
CAGACGTGACA
>DD438232.1 Inhibitors of STAT functions and their use
CGAATGGAAGA
>DD449063.1 RNA INTERFERENCE COMPOSITIONS AND METHODS
GTTCAAGACCC
>DD441267.1 RAPID ANALYSIS OF VARIATIONS IN A GENOME
CCTNNNNNAGG
>CS622551.1 Sequence 152 from Patent WO2003013537
CCCAGYGTCTC
>CS622550.1 Sequence 151 from Patent WO2003013537
CTCACRCTGGG
>CS622549.1 Sequence 150 from Patent WO2003013537
CCCAGCGTGAG
>CS622548.1 Sequence 149 from Patent WO2003013537
CTCACGCTGGG
>CS622547.1 Sequence 148 from Patent WO2003013537
GGAGGYGGGGC
>CS622546.1 Sequence 147 from Patent WO2003013537
GCCCCRCCTCC
>CS622545.1 Sequence 146 from Patent WO2003013537
GGAGGCGGGGC
>CS622544.1 Sequence 145 from Patent WO2003013537
GCCCCGCCTCC
>CS622543.1 Sequence 144 from Patent WO2003013537
TTGCAMGCCCA
>CS622542.1 Sequence 143 from Patent WO2003013537
TGGGCKTGCAA
>CS622541.1 Sequence 142 from Patent WO2003013537
TTGCACGCCCA
>CS622540.1 Sequence 141 from Patent WO2003013537
TGGGCGTGCAA
>CS622539.1 Sequence 140 from Patent WO2003013537
TAGAARTCCTT
>CS622538.1 Sequence 139 from Patent WO2003013537
AAGGAYTTCTA
>CS622537.1 Sequence 138 from Patent WO2003013537
TAGAAGTCCTT
>CS622536.1 Sequence 137 from Patent WO2003013537
AAGGACTTCTA
>CS614433.1 Sequence 26 from Patent WO2007047459
TGCGAATTGTT
>CS614431.1 Sequence 24 from Patent WO2007047459
ACGCTTAACAA
>CS600530.1 Sequence 40 from Patent WO2006055851
GTGACACAACC
>CS597600.1 Sequence 3 from Patent EP1793000
GATCGGTGGTA
>CS597124.1 Sequence 138 from Patent EP1793006
GGTAGNGGGNG
>CS598850.1 Sequence 37 from Patent WO2007038746
CTAGTCGCCAC
>CS583419.1 Sequence 246 from Patent WO2007031322
CAAGTTTCGAG
>CS588842.1 Sequence 1 from Patent EP1790736
ACGTACGACGT
>CS582061.1 Sequence 14 from Patent WO2006032039
CCAGCTCTTCG
>CS582060.1 Sequence 13 from Patent WO2006032039
CCAGATCTTCG
>CS575906.1 Sequence 21 from Patent WO2007026120
AGCTGTCANNA
>CS575904.1 Sequence 19 from Patent WO2007026120
RSTGACTMANN
>CS575902.1 Sequence 17 from Patent WO2007026120
TTGGTGTCACA
>CS575900.1 Sequence 15 from Patent WO2007026120
GAATGACAGTT
>CS575897.1 Sequence 12 from Patent WO2007026120
AGCTGTCAGTT
>CS575896.1 Sequence 11 from Patent WO2007026120
AAGCTGTCAGT
>CS575894.1 Sequence 9 from Patent WO2007026120
TTTTAGTCACT
>CS572111.1 Sequence 41 from Patent WO2006010619
CACAANTGAGA
>CS572083.1 Sequence 13 from Patent WO2006010619
CACAAATGAGA
>CS572082.1 Sequence 12 from Patent WO2006010619
CACAAGTGAGA
>CS581460.1 Sequence 14 from Patent WO2007030674
CCANNNNNTGG
>CS581459.1 Sequence 13 from Patent WO2007030674
CCTNNNNNAGG
>CS581456.1 Sequence 10 from Patent WO2007030674
GCANNNNNTGC
>CS581455.1 Sequence 9 from Patent WO2007030674
CCNNNNNNNGG
>CS581453.1 Sequence 7 from Patent WO2007030674
GCNNNNNNNGC
>CS581450.1 Sequence 4 from Patent WO2007030674
GCCNNNNNGGC
>CS581447.1 Sequence 1 from Patent WO2007030674
GACNNNNNGTC
>CS565901.1 Sequence 72 from Patent WO2006028742
TGCTTGCAAGC
>CS545386.1 Sequence 9 from Patent WO2006026667
AGCCCGGGACC
>CS566637.1 Sequence 107 from Patent EP1783139
RGGGRMTYYCC
>CS566636.1 Sequence 106 from Patent EP1783139
TGGGCTTCCCC
>CS544842.1 Sequence 38 from Patent WO2006037127
TGATGACCTTT
>CS544841.1 Sequence 37 from Patent WO2006037127
TTTTGATGACC
>CS544840.1 Sequence 36 from Patent WO2006037127
TTGCTGACCAT
>CS544839.1 Sequence 35 from Patent WO2006037127
TGGGGAGTGAG
>CS544810.1 Sequence 6 from Patent WO2006037127
CTTTCAACAGT
>DD433110.1 METHODS FOR DETECTION OF GENETIC DISORDERS
CCTNNNNNAGG
>DD434705.1 Polymerase Inhibitor and Method of Using Same
GTATAATAACN
>DD433820.1 METHODS FOR DETECTION OF GENETIC DISORDERS
TATCTTAATAT
>DD433819.1 METHODS FOR DETECTION OF GENETIC DISORDERS
TATCTTAATAC
>DD421378.1 A tripodic functional surfactant for fixing biomolecule and a gene-detection devise using the surfactant
GTTCTATGATC
>DD421377.1 A tripodic functional surfactant for fixing biomolecule and a gene-detection devise using the surfactant
CGTCCTCTGAG
>DD421376.1 A tripodic functional surfactant for fixing biomolecule and a gene-detection devise using the surfactant
CGTCCTCTGAA
>CS541239.1 Sequence 618 from Patent WO2007012576
GAAATGATTTG
>CS541238.1 Sequence 617 from Patent WO2007012576
CAAATCATTTC
>CS541237.1 Sequence 616 from Patent WO2007012576
GAAATGATTTG
>CS541211.1 Sequence 590 from Patent WO2007012576
ACCATTATTAT
>CS541208.1 Sequence 587 from Patent WO2007012576
TCAATAATTCT
>CS541207.1 Sequence 586 from Patent WO2007012576
AGAATTATTGA
>CS541192.1 Sequence 571 from Patent WO2007012576
AAAATAATTTA
>CS541191.1 Sequence 570 from Patent WO2007012576
TAAATTATTTT
>CS541189.1 Sequence 568 from Patent WO2007012576
TCAATTAATCA
>CS541178.1 Sequence 557 from Patent WO2007012576
TGTTTTTGTTT
>CS541158.1 Sequence 537 from Patent WO2007012576
ATGATGATTAG
>CS541157.1 Sequence 536 from Patent WO2007012576
ATATCTACTAA
>CS541152.1 Sequence 531 from Patent WO2007012576
AGCAACAGATA
>CS541146.1 Sequence 525 from Patent WO2007012576
TAATCTAAATG
>CS541141.1 Sequence 520 from Patent WO2007012576
ACAATTATTGG
>CS541140.1 Sequence 519 from Patent WO2007012576
CCAATAATTGT
>CS541137.1 Sequence 516 from Patent WO2007012576
CTATCTAAATC
>CS541135.1 Sequence 514 from Patent WO2007012576
TCTTTTTATTA
>CS541106.1 Sequence 485 from Patent WO2007012576
ATGATGATTAG
>CS541105.1 Sequence 484 from Patent WO2007012576
ATATCTACTAA
>CS541100.1 Sequence 479 from Patent WO2007012576
AGCAACAGATA
>CS541094.1 Sequence 473 from Patent WO2007012576
TAATCTAAATG
>CS541089.1 Sequence 468 from Patent WO2007012576
ACAATTATTGG
>CS541088.1 Sequence 467 from Patent WO2007012576
CCAATAATTGT
>CS541085.1 Sequence 464 from Patent WO2007012576
CTATCTAAATC
>CS541083.1 Sequence 462 from Patent WO2007012576
TCTTTTTATTA
>CS541065.1 Sequence 444 from Patent WO2007012576
GAGTTTAATCA
>CS541044.1 Sequence 423 from Patent WO2007012576
CGATCTATACA
>CS543385.1 Sequence 130 from Patent EP1775349
TGACCTCACCA
>CS541041.1 Sequence 420 from Patent WO2007012576
CTGATAATTAT
>CS541040.1 Sequence 419 from Patent WO2007012576
TTTATAATTAT
>CS541023.1 Sequence 402 from Patent WO2007012576
AGACGCGTTAG
>CS541022.1 Sequence 401 from Patent WO2007012576
TAACGCGTCTC
>CS541017.1 Sequence 396 from Patent WO2007012576
TCAATGATTGT
>CS541016.1 Sequence 395 from Patent WO2007012576
ACAATCATTGA
>CS541014.1 Sequence 393 from Patent WO2007012576
ACAATGATTTT
>CS541013.1 Sequence 392 from Patent WO2007012576
AAAATCATTGT
>CS541009.1 Sequence 388 from Patent WO2007012576
GTATCTAGAAG
>CS541004.1 Sequence 383 from Patent WO2007012576
TTATCTATACC
>CS541000.1 Sequence 379 from Patent WO2007012576
AACACCCTCAA
>CS540998.1 Sequence 377 from Patent WO2007012576
GTATCTAACTG
>CS540961.1 Sequence 340 from Patent WO2007012576
ACAATAATTTG
>CS540960.1 Sequence 339 from Patent WO2007012576
CAAATTATTGT
>CS540959.1 Sequence 338 from Patent WO2007012576
GAAATAATTTA
>CS540958.1 Sequence 337 from Patent WO2007012576
TAAATTATTTC
>CS540947.1 Sequence 326 from Patent WO2007012576
GTAATGAATAC
>CS540925.1 Sequence 304 from Patent WO2007012576
TAAATCATTGA
>CS540924.1 Sequence 303 from Patent WO2007012576
TCAATGATTTA
>CS540908.1 Sequence 287 from Patent WO2007012576
AAAAAGTTTGA
>CS540906.1 Sequence 285 from Patent WO2007012576
GCTATTATTCG
>CS540905.1 Sequence 284 from Patent WO2007012576
AATCTTAATCT
>CS540904.1 Sequence 283 from Patent WO2007012576
AAAAAGATTAA
>CS540899.1 Sequence 278 from Patent WO2007012576
AGCATAATTAA
>CS540896.1 Sequence 275 from Patent WO2007012576
TAAAAGATACT
>CS540894.1 Sequence 273 from Patent WO2007012576
ATGCTTAATGG
>CS540887.1 Sequence 266 from Patent WO2007012576
TAAATTAATGT
>CS540884.1 Sequence 263 from Patent WO2007012576
AAATCTACATT
>CS540858.1 Sequence 237 from Patent WO2007012576
CACATTATTAA
>CS540854.1 Sequence 233 from Patent WO2007012576
TACACTTGTCA
>CS540846.1 Sequence 225 from Patent WO2007012576
GCCACCATTCA
>CS539044.1 Sequence 52 from Patent WO2006029485
GTTGGCCTTTT
>CS540839.1 Sequence 218 from Patent WO2007012576
TGGATAATTAA
>CS540808.1 Sequence 187 from Patent WO2007012576
GAATCTATAAA
>CS540806.1 Sequence 185 from Patent WO2007012576
AAAATGATAGT
>CS540802.1 Sequence 181 from Patent WO2007012576
TAAAAGATTGT
>CS540794.1 Sequence 173 from Patent WO2007012576
TAATCTAAAAA
>CS540793.1 Sequence 172 from Patent WO2007012576
AACATTAATGA
>CS540792.1 Sequence 171 from Patent WO2007012576
CTCATTAATGT
>CS540779.1 Sequence 158 from Patent WO2007012576
TAAATGTTTAT
>CS540765.1 Sequence 144 from Patent WO2007012576
GNATATTCCNN
>CS540760.1 Sequence 139 from Patent WO2007012576
NNTTTTTRNYW
>CS540751.1 Sequence 130 from Patent WO2007012576
NGCAACAKAWN
>CS540742.1 Sequence 121 from Patent WO2007012576
GGTWGGTGAGA
>CS540731.1 Sequence 110 from Patent WO2007012576
GNCACCYYYNA
>CS540726.1 Sequence 105 from Patent WO2007012576
NNAGTTAGTTA
>CS540724.1 Sequence 103 from Patent WO2007012576
NWGGTAGKTRN
>CS540707.1 Sequence 86 from Patent WO2007012576
AMNGTTACNNT
>CS540692.1 Sequence 71 from Patent WO2007012576
NACACNYGNCC
>CS540685.1 Sequence 64 from Patent WO2007012576
NGCTCAGCGCN
>CS540671.1 Sequence 50 from Patent WO2007012576
NNGACRGTTAS
>CS540668.1 Sequence 47 from Patent WO2007012576
GTAATGATTRC
>CS540659.1 Sequence 38 from Patent WO2007012576
NNAGATCTANN
>CS538028.1 Sequence 53 from Patent WO2006135434
TCGTCGTTTTA
>CS538021.1 Sequence 46 from Patent WO2006135434
GTCGAGGAGGT
>CS538011.1 Sequence 36 from Patent WO2006135434
CCGTTTTGTGG
>EA103661.1 Sequence 107 from patent US 7195911
RGGGRMTYYCC
>EA103660.1 Sequence 106 from patent US 7195911
TGGGCTTCCCC
>EA103629.1 Sequence 16 from patent US 7195910
CTGGCATTTGG
>EA103623.1 Sequence 10 from patent US 7195910
GCGTGGTGGCG
>EA103092.1 Sequence 1 from patent US 7195874
AAAAAAGGGGG
>EA103089.1 Sequence 269 from patent US 7195871
CGCGCCGAGGA
>EA096052.1 Sequence 1079 from patent US 7192741
GCCNNNNNCCC
>EA096034.1 Sequence 1055 from patent US 7192741
CGCNNNNNGGC
>EA096025.1 Sequence 1046 from patent US 7192741
CAGNNNNNGGG
>EA096015.1 Sequence 1034 from patent US 7192741
GCGNNNNNGCC
>EA095957.1 Sequence 961 from patent US 7192741
CGGNNNNNCCC
>EA095932.1 Sequence 930 from patent US 7192741
CCCNNNNNCCA
>EA095930.1 Sequence 928 from patent US 7192741
ACGNNNNNGCA
>EA095910.1 Sequence 906 from patent US 7192741
CACNNNNNGGG
>EA095889.1 Sequence 880 from patent US 7192741
CCGNNNNNTCC
>EA095871.1 Sequence 858 from patent US 7192741
GGCNNNNNGGA
>EA095870.1 Sequence 857 from patent US 7192741
CCCNNNNNAGC
>EA095868.1 Sequence 854 from patent US 7192741
CAGNNNNNCCC
>EA095865.1 Sequence 851 from patent US 7192741
GCCNNNNNGGA
>EA095859.1 Sequence 845 from patent US 7192741
CGGNNNNNACG
>EA095853.1 Sequence 838 from patent US 7192741
AGCNNNNNCAG
>EA095851.1 Sequence 834 from patent US 7192741
CCANNNNNCCG
>EA095838.1 Sequence 813 from patent US 7192741
ACCNNNNNCCC
>EA095821.1 Sequence 790 from patent US 7192741
CCANNNNNGGG
>EA095818.1 Sequence 786 from patent US 7192741
CTGNNNNNCCC
>EA095810.1 Sequence 777 from patent US 7192741
CGCNNNNNGAG
>EA095788.1 Sequence 749 from patent US 7192741
CGGNNNNNGGC
>EA095771.1 Sequence 728 from patent US 7192741
CCCNNNNNAGG
>EA095764.1 Sequence 717 from patent US 7192741
GAGNNNNNCCC
>EA095733.1 Sequence 671 from patent US 7192741
CCTNNNNNGCC
>EA095715.1 Sequence 648 from patent US 7192741
CCCNNNNNCGG
>EA095707.1 Sequence 639 from patent US 7192741
CCGNNNNNCCC
>EA095685.1 Sequence 611 from patent US 7192741
CTGNNNNNCGC
>EA095683.1 Sequence 609 from patent US 7192741
GCGNNNNNGAC
>EA095641.1 Sequence 555 from patent US 7192741
CTCNNNNNCGC
>EA095629.1 Sequence 540 from patent US 7192741
GACNNNNNCGC
>EA095625.1 Sequence 535 from patent US 7192741
CCCNNNNNCCG
>EA095613.1 Sequence 513 from patent US 7192741
CAGNNNNNCCG
>EA095578.1 Sequence 470 from patent US 7192741
CCGNNNNNGAC
>EA095568.1 Sequence 455 from patent US 7192741
GCGNNNNNGGA
>EA095562.1 Sequence 447 from patent US 7192741
CGGNNNNNCTC
>EA095538.1 Sequence 416 from patent US 7192741
GCCNNNNNCGC
>EA095517.1 Sequence 390 from patent US 7192741
GGGNNNNNGGA
>EA095513.1 Sequence 383 from patent US 7192741
CCTNNNNNGCG
>EA095510.1 Sequence 380 from patent US 7192741
CACNNNNNGCG
>EA095505.1 Sequence 367 from patent US 7192741
CCCNNNNNGCC
>EA095500.1 Sequence 362 from patent US 7192741
CGCNNNNNGCA
>EA094569.1 Sequence 10 from patent US 7192593
GCTTAGCGATG
>EA090406.1 Sequence 392 from patent US 7189690
CCGCCACCATG
>EA087670.1 Sequence 48 from patent US 7189510
TAGGTAGCTAG
>EA087471.1 Sequence 18 from patent US 7189506
TGTTCGCACTT
>EA087459.1 Sequence 1 from patent US 7189506
CGTTCGCACTT
>EA087049.1 Sequence 44 from patent US 7186884
NNNCTTTWNNT
>EA087048.1 Sequence 43 from patent US 7186884
NCNCTTTWNWN
>EA087046.1 Sequence 41 from patent US 7186884
NWNWAAAGNGN
>EA087044.1 Sequence 39 from patent US 7186884
ANNWAAAGNNN
>EA085935.1 Sequence 41 from patent US 7186536
ACCGCCCTCCG
>EA085667.1 Sequence 86 from patent US 7186514
ACACAGAAGGG
>EA085665.1 Sequence 84 from patent US 7186514
CTCCAGTCCAG
>EA085664.1 Sequence 83 from patent US 7186514
CCCTAGCTCCA
>EA085663.1 Sequence 82 from patent US 7186514
TCACAGGCTCA
>EA085662.1 Sequence 81 from patent US 7186514
CCCCAGGAGGG
>EA085661.1 Sequence 80 from patent US 7186514
TTTCAGATCCA
>EA085660.1 Sequence 79 from patent US 7186514
ACGCAGTGCAA
>EA085659.1 Sequence 78 from patent US 7186514
CCCCAGGCGAC
>EA085658.1 Sequence 77 from patent US 7186514
ATACAGGGGAT
>EA085657.1 Sequence 76 from patent US 7186514
CACAGGTATTA
>EA085656.1 Sequence 75 from patent US 7186514
TGCTGGTGAGT
>EA085655.1 Sequence 74 from patent US 7186514
GCCAGGTACAG
>EA085654.1 Sequence 73 from patent US 7186514
AGCAGGTGGGC
>EA085653.1 Sequence 72 from patent US 7186514
GGAAGGTCAGT
>EA085652.1 Sequence 71 from patent US 7186514
TGGAGGTACCA
>EA085651.1 Sequence 70 from patent US 7186514
CCGAGGTGAGC
>EA085650.1 Sequence 69 from patent US 7186514
CAGTCGTGAGG
>EA085649.1 Sequence 68 from patent US 7186514
TGGAGGTGAGA
>EA085648.1 Sequence 67 from patent US 7186514
AGAAGGTAAGT
>EA077324.1 Sequence 7 from patent US 7183395
GGGAATTCCCC
>EA077318.1 Sequence 5 from patent US 7183394
AAAGAGGAAAA
>EA077317.1 Sequence 4 from patent US 7183394
AAAAGGAGAAA
>EA077316.1 Sequence 3 from patent US 7183394
AAAGGAGGAAA
>EA077007.1 Sequence 12 from patent US 7183111
TCGAGCGTTCT
>EA076416.1 Sequence 7546 from patent US 7183083
GTGGTGAAGAC
>EA071688.1 Sequence 5 from patent US 7179903
ATTGCGGCAAT
>EA070644.1 Sequence 44 from patent US 7179621
GTAAAGTTAAC
>EA070291.1 Sequence 13 from patent US 7179593
TGGTCCTGTGA
>CS510531.1 Sequence 1 from Patent EP1767629
GCCAGCCATGG
>CS503936.1 Sequence 20 from Patent WO2007011733
GAATAGGAACT
>CS503935.1 Sequence 19 from Patent WO2007011733
AGTTCCTATAC
>CS502933.1 Sequence 55 from Patent WO2007010221
TCCCTCCGCAA
>CS500278.1 Sequence 31 from Patent WO2006107317
TTGAGGCGCGA
>CS496121.1 Sequence 20 from Patent WO2007018601
CCTNNNNNAGG
>CS495299.1 Sequence 246 from Patent EP1764108
CAAGTTTCGAG
>DD418512.1 METHOD FOR ISOLATING INTRACELLULAR ANTIBODIES ABLE TO NEUTRALIZE PROTEIN INTERACTIONS
GCGCGCATGCC
>DD412058.1 Oligonucleotide derivative, probe for detecting gene, and DNA chip
CGGCNGAGGAG
>CS493067.1 Sequence 19 from Patent EP1762623
CTAGACGCTCA
>CS493066.1 Sequence 18 from Patent EP1762623
AGCTTGAGCGT
>CS484408.1 Sequence 6 from Patent WO2007002890
NNNNNNNNNNC
>DD404565.1 A method for detecting single nucleotide polymorphisms in a nucleic acid
GTTGACATGGA
>DD404563.1 A method for detecting single nucleotide polymorphisms in a nucleic acid
GTTGGCATGGA
>DD404562.1 A method for detecting single nucleotide polymorphisms in a nucleic acid
GTTGTCATGGA
>DD406939.1 ANTIBODIES DIRECTED TO PHOSPHOLIPASE A2 AND USES THEREOF
TGGGACCTACT
>DD406735.1 LECTIN COMPOSITIONS AND METHODS FOR MODULATING AN IMMUNE RESPONSE TO AN ANTIGEN
CGAAAATTTCC
>DD402570.1 Method for regulating transcription of a gene
AAAAAAGGAAA
>DD406118.1 Agent for gene sensing and use thereof
AGCCACCATGG
>DD409257.1 Improved method for bisulfite treatment
TTTTTTTTTTT
>DD409256.1 Improved method for bisulfite treatment
TTTTTNTTTTT
>DD409255.1 Improved method for bisulfite treatment
TTTTTCTTTTT
>DD409254.1 Improved method for bisulfite treatment
TTTTTCTTTTT
>EA065282.1 Sequence 8 from patent US 7172997
CCGTTAAATTT
>EA065281.1 Sequence 7 from patent US 7172997
GTACTAAAACC
>EA057957.1 Sequence 29 from patent US 7166468
TGAAANNNNNN
>EA056333.1 Sequence 9 from patent US 7164992
TCTCCTGTCAG
>EA056332.1 Sequence 8 from patent US 7164992
CCTGAGAGGAC
>EA055341.1 Sequence 5 from patent US 7163791
CTTTAGAGCAC
>EA050717.1 Sequence 82 from patent US 7157436
GGTTTTGTTTG
>EA050716.1 Sequence 81 from patent US 7157436
GTGTGTTTGGT
>EA050548.1 Sequence 12 from patent US 7157272
GACNNANNGTC
>EA050547.1 Sequence 11 from patent US 7157272
GACNNTNNGTC
>EA050546.1 Sequence 10 from patent US 7157272
GACNNNNNGTC
>EA049782.1 Sequence 39 from patent US 7157228
CTTATTTCCCT
>EA049614.1 Sequence 36 from patent US 7157224
CGCTTGGCTAT
>EA049223.1 Sequence 7 from patent US 7154024
CAATCCATTAA
>EA048091.1 Sequence 5324 from patent US 7153952
GTGGTGAAGAC
>EA045267.1 Sequence 94 from patent US 7153948
GGTAGNGGGNG
>EA044290.1 Sequence 3 from patent US 7153700
TGCCGAAGCTC
>EA043291.1 Sequence 37 from patent US 7153510
TATGAAAAAAA
>EA043290.1 Sequence 36 from patent US 7153510
TTTTTTTCATA
>EA043289.1 Sequence 35 from patent US 7153510
TATGAAAAAAA
>EA043269.1 Sequence 15 from patent US 7153510
TCAGGAGAAAC
>EA043126.1 Sequence 5324 from patent US 7151171
GTGGTGAAGAC
>EA040328.1 Sequence 36 from patent US 7151161
GTGGTGAAGAC
>EA039454.1 Sequence 3614 from patent US 7150982
GCCTCCCTCCA
>EA039397.1 Sequence 3557 from patent US 7150982
GTGGCAGCCCG
>EA039367.1 Sequence 3527 from patent US 7150982
GCGCGCCCTCT
>EA039204.1 Sequence 3364 from patent US 7150982
GCACCCCGGGC
>EA039174.1 Sequence 3334 from patent US 7150982
GCCCCAGCAGG
>EA037742.1 Sequence 1794 from patent US 7150982
ATTCTCTCAGA
>EA036696.1 Sequence 748 from patent US 7150982
GGGCCAGAGGG
>EA036663.1 Sequence 715 from patent US 7150982
GGGCCAGAGGG
>EA036232.1 Sequence 196 from patent US 7150982
GGGCCAGAGGG
>EA035501.1 Sequence 4 from patent US 7148325
AATTTCCTCGG
>EA035218.1 Sequence 63 from patent US 7148049
TGAGCTTGAGA
>EA035216.1 Sequence 61 from patent US 7148049
TGAGCTTGAGA
>EA035214.1 Sequence 59 from patent US 7148049
TGAGCTGGATA
>EA035212.1 Sequence 57 from patent US 7148049
TGACCTGGATA
>EA035210.1 Sequence 55 from patent US 7148049
TGASCTGGATA
>EA035208.1 Sequence 53 from patent US 7148049
CGATCATGAAA
>EA035206.1 Sequence 51 from patent US 7148049
CGATAATGAAA
>EA035204.1 Sequence 49 from patent US 7148049
CGATMATGAAA
>EA035202.1 Sequence 47 from patent US 7148049
TGATCAGGAAA
>EA035200.1 Sequence 45 from patent US 7148049
TGATAAGGAAA
>EA035198.1 Sequence 43 from patent US 7148049
TGATMAGGAAA
>EA035196.1 Sequence 41 from patent US 7148049
CGACGATGAGA
>EA035194.1 Sequence 39 from patent US 7148049
CGACGAAGAGA
>EA035192.1 Sequence 37 from patent US 7148049
CGACGANGAGA
>EA035146.1 Sequence 60 from patent US 7148044
GGGCGGCTGGG
>EA035110.1 Sequence 24 from patent US 7148044
GGGCGGGACGG
>EA035109.1 Sequence 23 from patent US 7148044
GGGCGGCTCGG
>EA035108.1 Sequence 22 from patent US 7148044
GGGCGGGTCGT
>EA035107.1 Sequence 21 from patent US 7148044
GGGCGGGTCTG
>EA035106.1 Sequence 20 from patent US 7148044
GGGCGGGTTGG
>EA035105.1 Sequence 19 from patent US 7148044
GGGCGGGTAGG
>EA035104.1 Sequence 18 from patent US 7148044
GGGCGGGGCGG
>EA035103.1 Sequence 17 from patent US 7148044
GGGCGGGCCGG
>EA035102.1 Sequence 16 from patent US 7148044
GGGCGGTTCGG
>EA035101.1 Sequence 15 from patent US 7148044
GGGCGGATCGG
>EA035100.1 Sequence 14 from patent US 7148044
GGGCGTGTCGG
>EA035099.1 Sequence 13 from patent US 7148044
GGGCGAGTCGG
>EA035098.1 Sequence 12 from patent US 7148044
GGGCCGGTCGG
>EA035097.1 Sequence 11 from patent US 7148044
GGGCAGGTCGG
>EA035095.1 Sequence 9 from patent US 7148044
GGGCGGGTCGG
>EA035094.1 Sequence 8 from patent US 7148044
YHRHGNNHNNN
>EA035093.1 Sequence 7 from patent US 7148044
AAACGNNTNNN
>EA035091.1 Sequence 5 from patent US 7148044
GGGTGNNTNNN
>EA035090.1 Sequence 4 from patent US 7148044
GGGCGNNHNNN
>EA035089.1 Sequence 3 from patent US 7148044
GGGCGNNTNNN
>EA035088.1 Sequence 2 from patent US 7148044
RRRHGNNHNNN
>EA035087.1 Sequence 1 from patent US 7148044
NNRHGNNHNNN
>CS467424.1 Sequence 1346 from Patent WO2006116156
GCAGAGTCCAC
>CS467422.1 Sequence 1344 from Patent WO2006116156
GGGTCGAGACG
>CS466767.1 Sequence 689 from Patent WO2006116156
GCAGAGTCCAC
>CS466766.1 Sequence 688 from Patent WO2006116156
TTATTGTATAC
>CS466765.1 Sequence 687 from Patent WO2006116156
TATGCGAGACG
>CS466764.1 Sequence 686 from Patent WO2006116156
GCAGAGAATTC
>CS466761.1 Sequence 683 from Patent WO2006116156
TGGTTGAGACG
>CS465033.1 Sequence 14 from Patent EP1743901
GGCTGTCTGCG
>DD384935.1 Probe unit, apparatus for identifying a nucleotide region, and method for identifying a nucleotide region
CATCTATATTG
>DD384934.1 Probe unit, apparatus for identifying a nucleotide region, and method for identifying a nucleotide region
CATCTGTATTG
>DD384933.1 Probe unit, apparatus for identifying a nucleotide region, and method for identifying a nucleotide region
NTAGACATNAC
>DD384159.1 Integral role of transcription factor IRF-5 in gene induction program activated by Toll-like receptors
CAGGAGAAACC
>DD389852.1 VASCULAR-PREFERRED PROMOTERS
ATCAAGCTGAT
>DD389851.1 VASCULAR-PREFERRED PROMOTERS
TGAGGAGAAGA
>DD383422.1 Body weight modulator, correspondent nucleic acid or protein and their diagnostic or therapeutic use
AGCAGTCGGTA
>DD400314.1 BRANCHED IMMUNOMODULATORY COMPOUNDS AND METHODS OF USING THE SAME
TBGAABGTTCG
>DD400313.1 BRANCHED IMMUNOMODULATORY COMPOUNDS AND METHODS OF USING THE SAME
TBGAABGTTCG
>DD400311.1 BRANCHED IMMUNOMODULATORY COMPOUNDS AND METHODS OF USING THE SAME
TCGAABGTTCG
>DD400303.1 BRANCHED IMMUNOMODULATORY COMPOUNDS AND METHODS OF USING THE SAME
TBGACCGTTCG
>DD400302.1 BRANCHED IMMUNOMODULATORY COMPOUNDS AND METHODS OF USING THE SAME
TBGAACGTTCG
>DD400296.1 BRANCHED IMMUNOMODULATORY COMPOUNDS AND METHODS OF USING THE SAME
TCGACCGTTCG
>DD400287.1 BRANCHED IMMUNOMODULATORY COMPOUNDS AND METHODS OF USING THE SAME
TCGAACGTTCG
>DD394250.1 Methods for Treating Cancer by Inhibiting Wnt Signaling
AGTCNGGACCT
>DD382157.1 Albumin Fusion Proteins
CCGCCACCATG
>CS463588.1 Sequence 271 from Patent EP1741780
GGAAYGAYGAY
>CS462027.1 Sequence 136 from Patent WO2006120197
CCACGCGTGCC
>CS462026.1 Sequence 135 from Patent WO2006120197
GCACGCGTGGT
>CS462021.1 Sequence 130 from Patent WO2006120197
GAATCTACAAG
>CS462020.1 Sequence 129 from Patent WO2006120197
GCATCTATACA
>CS461991.1 Sequence 100 from Patent WO2006120197
ATTTTTTATTA
>DD364270.1 Probe for detecting nucleic acid and method for detecting nucleic acid
GGTTGGTGAGA
>DD366793.1 DNA catalytic molecules
ATAGGCCCGGT
>DD366790.1 DNA catalytic molecules
ATAGCGTATTA
>DD362941.1 DNA Conjugate and,method for determining DNA
TTTTTACCAGC
>DD361958.1 Method for analyzing polynucleotide
CCGCACACGTC
>CS456736.1 Sequence 7 from Patent WO2006122242
GGGGTATTTCC
>CS457432.1 Sequence 25 from Patent WO2006119780
ATACTGAACCA
>CS456469.1 Sequence 41 from Patent EP1728863
TCGTCGTTTTA
>CS456442.1 Sequence 14 from Patent EP1728863
GTCGAGGAGGT
>CS456430.1 Sequence 2 from Patent EP1728863
CCGTTTTGTGG
>CS455887.1 Sequence 6 from Patent EP1728799
AGTAAGTCCAT
>CS455886.1 Sequence 5 from Patent EP1728799
ATGGACTTACT
>EA033841.1 Sequence 101 from patent US 7144731
GATACCTTCCA
>EA033839.1 Sequence 99 from patent US 7144731
GATCTCCTGCA
>EA032963.1 Sequence 150 from patent US 7141665
GGAAGGACAGA
>EA032862.1 Sequence 47 from patent US 7141665
ATAGGCCCGGT
>EA032859.1 Sequence 44 from patent US 7141665
ATAGCGTATTA
>EA032615.1 Sequence 31 from patent US 7141659
AGATAATGCAG
>EA031341.1 Sequence 1107 from patent US 7141547
CCGCCACCATG
>EA030009.1 Sequence 64 from patent US 7141417
AACCAAAAAAG
>EA030008.1 Sequence 63 from patent US 7141417
AACCAAAAAAC
>EA030007.1 Sequence 62 from patent US 7141417
AACCAAAAAAT
>EA030006.1 Sequence 61 from patent US 7141417
AACCAAAAAAA
>EA028542.1 Sequence 9 from patent US 7138383
GATTGGGATTG
>EA028536.1 Sequence 3 from patent US 7138383
GTTGAGTGTAG
>EA028534.1 Sequence 1 from patent US 7138383
GTTAGGGTTAG
>EA027172.1 Sequence 5324 from patent US 7135560
GTGGTGAAGAC
>EA022713.1 Sequence 27 from patent US 7135312
TTTTCTTTCTT
>EA022548.1 Sequence 79 from patent US 7135310
CTAGCTGANNN
>EA019697.1 Sequence 5324 from patent US 7129340
GTGGTGAAGAC
>EA017034.1 Sequence 5324 from patent US 7129339
GTGGTGAAGAC
>EA012597.1 Sequence 14 from patent US 7128919
CGATTCCCTCG
>EA012068.1 Sequence 9 from patent US 7125975
GGCTGACTGCG
>EA012041.1 Sequence 23 from patent US 7125970
GTTGGCCTTTT
>EA010747.1 Sequence 13 from patent US 7125695
GTGACCGCTTG
>EA010744.1 Sequence 10 from patent US 7125695
GTGCCGCTGTG
>EA010742.1 Sequence 8 from patent US 7125695
TTGACGCTTTG
>EA010343.1 Sequence 17 from patent US 7125674
AATTACATTCA
>EA010336.1 Sequence 10 from patent US 7125674
ACTCATTTATA
>EA008630.1 Sequence 165 from patent US 7122652
TGTCATCCAAG
>EA008629.1 Sequence 164 from patent US 7122652
CTTGGATGACA
>EA008628.1 Sequence 163 from patent US 7122652
TGTCACCCAAG
>EA008627.1 Sequence 162 from patent US 7122652
CTTGGGTGACA
>EA008626.1 Sequence 161 from patent US 7122652
GCAGCTGCTCA
>EA008625.1 Sequence 160 from patent US 7122652
TGAGCAGCTGC
>EA008624.1 Sequence 159 from patent US 7122652
GCAGCCGCTCA
>EA008623.1 Sequence 158 from patent US 7122652
TGAGCGGCTGC
>EA008622.1 Sequence 157 from patent US 7122652
GGCTCTCTCAC
>EA008621.1 Sequence 156 from patent US 7122652
GTGAGAGAGCC
>EA008620.1 Sequence 155 from patent US 7122652
GGCTCCCTCAC
>EA008619.1 Sequence 154 from patent US 7122652
GTGAGGGAGCC
>EA008618.1 Sequence 153 from patent US 7122652
AATGGTGAATT
>EA008617.1 Sequence 152 from patent US 7122652
AATTCACCATT
>EA008616.1 Sequence 151 from patent US 7122652
AATGGCGAATT
>EA008615.1 Sequence 150 from patent US 7122652
AATTCGCCATT
>EA008614.1 Sequence 149 from patent US 7122652
AGGCTAGGGGG
>EA008613.1 Sequence 148 from patent US 7122652
CCCCCTAGCCT
>EA008612.1 Sequence 147 from patent US 7122652
AGGCTGGGGGG
>EA008611.1 Sequence 146 from patent US 7122652
CCCCCCAGCCT
>EA008610.1 Sequence 145 from patent US 7122652
AGCATATAGTG
>EA008609.1 Sequence 144 from patent US 7122652
CACTATATGCT
>EA008608.1 Sequence 143 from patent US 7122652
AGCATGTAGTG
>EA008607.1 Sequence 142 from patent US 7122652
CACTACATGCT
>EA008606.1 Sequence 141 from patent US 7122652
AACAGAATGGA
>EA008605.1 Sequence 140 from patent US 7122652
TCCATTCTGTT
>EA008604.1 Sequence 139 from patent US 7122652
AACAGGATGGA
>EA008603.1 Sequence 138 from patent US 7122652
TCCATCCTGTT
>EA008602.1 Sequence 137 from patent US 7122652
CAATACCTTGT
>EA008601.1 Sequence 136 from patent US 7122652
ACAAGGTATTG
>EA008600.1 Sequence 135 from patent US 7122652
CAATATCTTGT
>EA008599.1 Sequence 134 from patent US 7122652
ACAAGATATTG
>EA008598.1 Sequence 133 from patent US 7122652
CTGCCTTGCCA
>EA008597.1 Sequence 132 from patent US 7122652
TGGCAAGGCAG
>EA008596.1 Sequence 131 from patent US 7122652
CTGCCCTGCCA
>EA008595.1 Sequence 130 from patent US 7122652
TGGCAGGGCAG
>EA008594.1 Sequence 129 from patent US 7122652
GCGGCTCCCTT
>EA008593.1 Sequence 128 from patent US 7122652
AAGGGAGCCGC
>EA008592.1 Sequence 127 from patent US 7122652
GCGGCCCCCTT
>EA008591.1 Sequence 126 from patent US 7122652
AAGGGGGCCGC
>EA008590.1 Sequence 125 from patent US 7122652
TTCCCACCACT
>EA008589.1 Sequence 124 from patent US 7122652
AGTGGTGGGAA
>EA008588.1 Sequence 123 from patent US 7122652
TTCCCGCCACT
>EA008587.1 Sequence 122 from patent US 7122652
AGTGGCGGGAA
>EA008586.1 Sequence 121 from patent US 7122652
TCGCAACCACT
>EA008585.1 Sequence 120 from patent US 7122652
AGTGGTTGCGA
>EA008584.1 Sequence 119 from patent US 7122652
TCGCAGCCACT
>EA008583.1 Sequence 118 from patent US 7122652
AGTGGCTGCGA
>EA008582.1 Sequence 117 from patent US 7122652
AAGGTGGTGTC
>EA008581.1 Sequence 116 from patent US 7122652
GACACCACCTT
>EA008580.1 Sequence 115 from patent US 7122652
AAGGTAGTGTC
>EA008579.1 Sequence 114 from patent US 7122652
GACACTACCTT
>EA008578.1 Sequence 113 from patent US 7122652
TAGTGCCAAAG
>EA008577.1 Sequence 112 from patent US 7122652
CTTTGGCACTA
>EA008576.1 Sequence 111 from patent US 7122652
TAGTGTCAAAG
>EA008575.1 Sequence 110 from patent US 7122652
CTTTGACACTA
>EA008574.1 Sequence 109 from patent US 7122652
CTGCATTCCCA
>EA008573.1 Sequence 108 from patent US 7122652
TGGGAATGCAG
>EA008572.1 Sequence 107 from patent US 7122652
CTGCACTCCCA
>EA008571.1 Sequence 106 from patent US 7122652
TGGGAGTGCAG
>EA008570.1 Sequence 105 from patent US 7122652
CATGCCCACAC
>EA008569.1 Sequence 104 from patent US 7122652
GTGTGGGCATG
>EA008568.1 Sequence 103 from patent US 7122652
CATGCACACAC
>EA008567.1 Sequence 102 from patent US 7122652
GTGTGTGCATG
>EA008566.1 Sequence 101 from patent US 7122652
ATGCCACTCTC
>EA008565.1 Sequence 100 from patent US 7122652
GAGAGTGGCAT
>EA008564.1 Sequence 99 from patent US 7122652
ATGCCGCTCTC
>EA008563.1 Sequence 98 from patent US 7122652
GAGAGCGGCAT
>EA008562.1 Sequence 97 from patent US 7122652
CACCTGAGCCG
>EA008561.1 Sequence 96 from patent US 7122652
CGGCTCAGGTG
>EA008560.1 Sequence 95 from patent US 7122652
CACCTCAGCCG
>EA008559.1 Sequence 94 from patent US 7122652
CGGCTGAGGTG
>EA008558.1 Sequence 93 from patent US 7122652
GGGGGAATGCA
>EA008557.1 Sequence 92 from patent US 7122652
TGCATTCCCCC
>EA008556.1 Sequence 91 from patent US 7122652
GGGGGGATGCA
>EA008555.1 Sequence 90 from patent US 7122652
TGCATCCCCCC
>EA008554.1 Sequence 89 from patent US 7122652
ACCTCTGACTT
>EA008553.1 Sequence 88 from patent US 7122652
AAGTCAGAGGT
>EA008552.1 Sequence 87 from patent US 7122652
ACCTCCGACTT
>EA008551.1 Sequence 86 from patent US 7122652
AAGTCGGAGGT
>EA008550.1 Sequence 85 from patent US 7122652
ACTGGACTTTC
>EA008549.1 Sequence 84 from patent US 7122652
GAAAGTCCAGT
>EA008548.1 Sequence 83 from patent US 7122652
ACTGGGCTTTC
>EA008547.1 Sequence 82 from patent US 7122652
GAAAGCCCAGT
>EA008546.1 Sequence 81 from patent US 7122652
GTCCTTACAGT
>EA008545.1 Sequence 80 from patent US 7122652
ACTGTAAGGAC
>EA008544.1 Sequence 79 from patent US 7122652
GTCCTCACAGT
>EA008543.1 Sequence 78 from patent US 7122652
ACTGTGAGGAC
>EA008542.1 Sequence 77 from patent US 7122652
ACCACGGAGAA
>EA008541.1 Sequence 76 from patent US 7122652
TTCTCCGTGGT
>EA008540.1 Sequence 75 from patent US 7122652
ACCACAGAGAA
>EA008539.1 Sequence 74 from patent US 7122652
TTCTCTGTGGT
>EA008536.1 Sequence 71 from patent US 7122652
CCTCAGGGGGG
>EA008535.1 Sequence 70 from patent US 7122652
CCCCCCTGAGG
>EA008534.1 Sequence 69 from patent US 7122652
CTCCCCCAGTC
>EA008533.1 Sequence 68 from patent US 7122652
GACTGGGGGAG
>EA008532.1 Sequence 67 from patent US 7122652
CTCCCACAGTC
>EA008531.1 Sequence 66 from patent US 7122652
GACTGTGGGAG
>EA008530.1 Sequence 65 from patent US 7122652
TTCTCACCTGG
>EA008529.1 Sequence 64 from patent US 7122652
CCAGGTGAGAA
>EA008528.1 Sequence 63 from patent US 7122652
TTCTCCCCTGG
>EA008527.1 Sequence 62 from patent US 7122652
CCAGGGGAGAA
>EA008526.1 Sequence 61 from patent US 7122652
GCCTTTTTCAG
>EA008525.1 Sequence 60 from patent US 7122652
CTGAAAAAGGC
>EA008524.1 Sequence 59 from patent US 7122652
GCCTTGTTCAG
>EA008523.1 Sequence 58 from patent US 7122652
CTGAACAAGGC
>EA008522.1 Sequence 57 from patent US 7122652
GAGGCTGAGAT
>EA008521.1 Sequence 56 from patent US 7122652
ATCTCAGCCTC
>EA008520.1 Sequence 55 from patent US 7122652
GAGGCCGAGAT
>EA008519.1 Sequence 54 from patent US 7122652
ATCTCGGCCTC
>EA008441.1 Sequence 7 from patent US 7122649
GGCTGACTGCG
>EA004706.1 Sequence 5324 from patent US 7122368
GTGGTGAAGAC
>EA001043.1 Sequence 62 from patent US 7122339
AAGGGAAGCAC
>EA001023.1 Sequence 42 from patent US 7122339
CGCCACCCCCA
>EA001007.1 Sequence 26 from patent US 7122339
CGGAGACTGCC
>EA001002.1 Sequence 21 from patent US 7122339
AGCCCAGGGAA
>EA001001.1 Sequence 20 from patent US 7122339
CCGCCACCCCA
>AR987833.1 Sequence 14 from patent US 7119184
GGCTGTCTGCG
>AR987205.1 Sequence 15 from patent US 7119167
AAAAGAGAGGA
>AR987204.1 Sequence 14 from patent US 7119167
AGAAAGGAGGA
>AR986659.1 Sequence 88 from patent US 7118879
CCANNNNNTGG
>CS452416.1 Sequence 5 from Patent EP1724348
ACCAGCTGATC
>DD360835.1 MODULATION OF IMMUNOSTIMULATORY PROPERTIES OF OLIGONUCLEOTIDE-BASED COMPOUNDS BY UTILIZING MODIFIED IMMUNOSTIMULATORY DINUCLEOTIDES
TCTGTNGTTCT
>DD360834.1 MODULATION OF IMMUNOSTIMULATORY PROPERTIES OF OLIGONUCLEOTIDE-BASED COMPOUNDS BY UTILIZING MODIFIED IMMUNOSTIMULATORY DINUCLEOTIDES
TCTGANGTTCT
>DD360827.1 MODULATION OF IMMUNOSTIMULATORY PROPERTIES OF OLIGONUCLEOTIDE-BASED COMPOUNDS BY UTILIZING MODIFIED IMMUNOSTIMULATORY DINUCLEOTIDES
TNNTNNTTCTG
>DD360826.1 MODULATION OF IMMUNOSTIMULATORY PROPERTIES OF OLIGONUCLEOTIDE-BASED COMPOUNDS BY UTILIZING MODIFIED IMMUNOSTIMULATORY DINUCLEOTIDES
TNGTNGTTCTG
>DD360825.1 MODULATION OF IMMUNOSTIMULATORY PROPERTIES OF OLIGONUCLEOTIDE-BASED COMPOUNDS BY UTILIZING MODIFIED IMMUNOSTIMULATORY DINUCLEOTIDES
TNGTNGTTCTG
>DD360824.1 MODULATION OF IMMUNOSTIMULATORY PROPERTIES OF OLIGONUCLEOTIDE-BASED COMPOUNDS BY UTILIZING MODIFIED IMMUNOSTIMULATORY DINUCLEOTIDES
TNGTNGTTCTG
>DD360823.1 MODULATION OF IMMUNOSTIMULATORY PROPERTIES OF OLIGONUCLEOTIDE-BASED COMPOUNDS BY UTILIZING MODIFIED IMMUNOSTIMULATORY DINUCLEOTIDES
TCNTCNTTCTG
>DD360822.1 MODULATION OF IMMUNOSTIMULATORY PROPERTIES OF OLIGONUCLEOTIDE-BASED COMPOUNDS BY UTILIZING MODIFIED IMMUNOSTIMULATORY DINUCLEOTIDES
CTGTNGTTCTC
>DD360821.1 MODULATION OF IMMUNOSTIMULATORY PROPERTIES OF OLIGONUCLEOTIDE-BASED COMPOUNDS BY UTILIZING MODIFIED IMMUNOSTIMULATORY DINUCLEOTIDES
CTGTNGTTCTC
>DD360820.1 MODULATION OF IMMUNOSTIMULATORY PROPERTIES OF OLIGONUCLEOTIDE-BASED COMPOUNDS BY UTILIZING MODIFIED IMMUNOSTIMULATORY DINUCLEOTIDES
CTGTNGTTCTC
>DD360819.1 MODULATION OF IMMUNOSTIMULATORY PROPERTIES OF OLIGONUCLEOTIDE-BASED COMPOUNDS BY UTILIZING MODIFIED IMMUNOSTIMULATORY DINUCLEOTIDES
CTGTCNTTCTC
>DD360818.1 MODULATION OF IMMUNOSTIMULATORY PROPERTIES OF OLIGONUCLEOTIDE-BASED COMPOUNDS BY UTILIZING MODIFIED IMMUNOSTIMULATORY DINUCLEOTIDES
TCTGTNGTTCT
>DD360817.1 MODULATION OF IMMUNOSTIMULATORY PROPERTIES OF OLIGONUCLEOTIDE-BASED COMPOUNDS BY UTILIZING MODIFIED IMMUNOSTIMULATORY DINUCLEOTIDES
TCTGTNGTTCT
>DD360816.1 MODULATION OF IMMUNOSTIMULATORY PROPERTIES OF OLIGONUCLEOTIDE-BASED COMPOUNDS BY UTILIZING MODIFIED IMMUNOSTIMULATORY DINUCLEOTIDES
TCTGTCNTTCT
>DD360815.1 MODULATION OF IMMUNOSTIMULATORY PROPERTIES OF OLIGONUCLEOTIDE-BASED COMPOUNDS BY UTILIZING MODIFIED IMMUNOSTIMULATORY DINUCLEOTIDES
TCNTCNTTCTG
>DD360814.1 MODULATION OF IMMUNOSTIMULATORY PROPERTIES OF OLIGONUCLEOTIDE-BASED COMPOUNDS BY UTILIZING MODIFIED IMMUNOSTIMULATORY DINUCLEOTIDES
CTGTCNTTCTC
>DD360813.1 MODULATION OF IMMUNOSTIMULATORY PROPERTIES OF OLIGONUCLEOTIDE-BASED COMPOUNDS BY UTILIZING MODIFIED IMMUNOSTIMULATORY DINUCLEOTIDES
TCTGTNGTTCT
>DD360802.1 MODULATION OF IMMUNOSTIMULATORY PROPERTIES OF OLIGONUCLEOTIDE-BASED COMPOUNDS BY UTILIZING MODIFIED IMMUNOSTIMULATORY DINUCLEOTIDES
TCTGTCGTTCT
>DD360801.1 MODULATION OF IMMUNOSTIMULATORY PROPERTIES OF OLIGONUCLEOTIDE-BASED COMPOUNDS BY UTILIZING MODIFIED IMMUNOSTIMULATORY DINUCLEOTIDES
TCTGACGTTCT
>DD360796.1 MODULATION OF IMMUNOSTIMULATORY PROPERTIES OF OLIGONUCLEOTIDE-BASED COMPOUNDS BY UTILIZING MODIFIED IMMUNOSTIMULATORY DINUCLEOTIDES
CTATCTGACGT
>DD360794.1 MODULATION OF IMMUNOSTIMULATORY PROPERTIES OF OLIGONUCLEOTIDE-BASED COMPOUNDS BY UTILIZING MODIFIED IMMUNOSTIMULATORY DINUCLEOTIDES
ACGTTCTCTGT
>DD360790.1 MODULATION OF IMMUNOSTIMULATORY PROPERTIES OF OLIGONUCLEOTIDE-BASED COMPOUNDS BY UTILIZING MODIFIED IMMUNOSTIMULATORY DINUCLEOTIDES
CTATCTGACGT
>DD360785.1 MODULATION OF IMMUNOSTIMULATORY PROPERTIES OF OLIGONUCLEOTIDE-BASED COMPOUNDS BY UTILIZING MODIFIED IMMUNOSTIMULATORY DINUCLEOTIDES
ACGTTCTCTGT
>DD360751.1 MODULATION OF IMMUNOSTIMULATORY PROPERTIES OF OLIGONUCLEOTIDE-BASED COMPOUNDS BY UTILIZING MODIFIED IMMUNOSTIMULATORY DINUCLEOTIDES
CCTACTAGCGT
>DD360747.1 MODULATION OF IMMUNOSTIMULATORY PROPERTIES OF OLIGONUCLEOTIDE-BASED COMPOUNDS BY UTILIZING MODIFIED IMMUNOSTIMULATORY DINUCLEOTIDES
GCGTTCTCATC
>DD360714.1 MODULATION OF IMMUNOSTIMULATORY PROPERTIES OF OLIGONUCLEOTIDE-BASED COMPOUNDS BY UTILIZING MODIFIED IMMUNOSTIMULATORY DINUCLEOTIDES
TCTGACNTTCT
>DD360713.1 MODULATION OF IMMUNOSTIMULATORY PROPERTIES OF OLIGONUCLEOTIDE-BASED COMPOUNDS BY UTILIZING MODIFIED IMMUNOSTIMULATORY DINUCLEOTIDES
TCTGANGTTCT
>DD360706.1 MODULATION OF IMMUNOSTIMULATORY PROPERTIES OF OLIGONUCLEOTIDE-BASED COMPOUNDS BY UTILIZING MODIFIED IMMUNOSTIMULATORY DINUCLEOTIDES
TCTGTCNTTCT
>DD360705.1 MODULATION OF IMMUNOSTIMULATORY PROPERTIES OF OLIGONUCLEOTIDE-BASED COMPOUNDS BY UTILIZING MODIFIED IMMUNOSTIMULATORY DINUCLEOTIDES
TCTGTNGTTCT
>DD360702.1 MODULATION OF IMMUNOSTIMULATORY PROPERTIES OF OLIGONUCLEOTIDE-BASED COMPOUNDS BY UTILIZING MODIFIED IMMUNOSTIMULATORY DINUCLEOTIDES
TCTTTCNTTCT
>DD360701.1 MODULATION OF IMMUNOSTIMULATORY PROPERTIES OF OLIGONUCLEOTIDE-BASED COMPOUNDS BY UTILIZING MODIFIED IMMUNOSTIMULATORY DINUCLEOTIDES
TCTTTNGTTCT
>DD360690.1 MODULATION OF IMMUNOSTIMULATORY PROPERTIES OF OLIGONUCLEOTIDE-BASED COMPOUNDS BY UTILIZING MODIFIED IMMUNOSTIMULATORY DINUCLEOTIDES
TCTGTCGTTCT
>DD360685.1 MODULATION OF IMMUNOSTIMULATORY PROPERTIES OF OLIGONUCLEOTIDE-BASED COMPOUNDS BY UTILIZING MODIFIED IMMUNOSTIMULATORY DINUCLEOTIDES
TCTGACGTTCT
>DD360679.1 MODULATION OF IMMUNOSTIMULATORY PROPERTIES OF OLIGONUCLEOTIDE-BASED COMPOUNDS BY UTILIZING MODIFIED IMMUNOSTIMULATORY DINUCLEOTIDES
TCTGANNTTCT
>DD360678.1 MODULATION OF IMMUNOSTIMULATORY PROPERTIES OF OLIGONUCLEOTIDE-BASED COMPOUNDS BY UTILIZING MODIFIED IMMUNOSTIMULATORY DINUCLEOTIDES
TCTGACNTTCT
>DD360676.1 MODULATION OF IMMUNOSTIMULATORY PROPERTIES OF OLIGONUCLEOTIDE-BASED COMPOUNDS BY UTILIZING MODIFIED IMMUNOSTIMULATORY DINUCLEOTIDES
TCTGACNTTCT
>DD360672.1 MODULATION OF IMMUNOSTIMULATORY PROPERTIES OF OLIGONUCLEOTIDE-BASED COMPOUNDS BY UTILIZING MODIFIED IMMUNOSTIMULATORY DINUCLEOTIDES
TCTGTNNTTCT
>DD360671.1 MODULATION OF IMMUNOSTIMULATORY PROPERTIES OF OLIGONUCLEOTIDE-BASED COMPOUNDS BY UTILIZING MODIFIED IMMUNOSTIMULATORY DINUCLEOTIDES
TCTGTCNTTCT
>DD360670.1 MODULATION OF IMMUNOSTIMULATORY PROPERTIES OF OLIGONUCLEOTIDE-BASED COMPOUNDS BY UTILIZING MODIFIED IMMUNOSTIMULATORY DINUCLEOTIDES
TCTGTCGTTCT
>DD360665.1 MODULATION OF IMMUNOSTIMULATORY PROPERTIES OF OLIGONUCLEOTIDE-BASED COMPOUNDS BY UTILIZING MODIFIED IMMUNOSTIMULATORY DINUCLEOTIDES
TCTGACGTTCT
>DD360450.1 IMMUNOSTIMULATORY SEQUENCE OLIGONUCLEOTIDES AND METHODS OF USING THE SAME
TCGAACGTTCG
>DD354012.1 Use of DNase gamma and its function
GAATTCAGATC
>DD359795.1 LNA-CpG conjugates
CTCTCTCTCTC
>DD359793.1 LNA-CpG conjugates
CTCTCTCTCTC
>DD356829.1 Probe for detecting nucleic acid and method for detecting nucleic acid
GGTTGGTGAGA
>CS448778.1 Sequence 252 from Patent WO2006111541
TGCCGCGTACA
>CS448777.1 Sequence 251 from Patent WO2006111541
TGCCGCGTACA
>CS448774.1 Sequence 248 from Patent WO2006111541
GGTTTTTGATA
>CS448773.1 Sequence 247 from Patent WO2006111541
GGTTTTTGATA
>CS448730.1 Sequence 204 from Patent WO2006111541
TTATCTACTTG
>CS448669.1 Sequence 143 from Patent WO2006111541
TNNGTTACNNT
>CS448631.1 Sequence 105 from Patent WO2006111541
TTATCTACTTG
>CS448611.1 Sequence 85 from Patent WO2006111541
GNACACGTAGC
>Y17526.1 Artificial DNA sequence synthesized ab initio by DNA polymerase of Thermococcus litoralis, clone pTL842
TCCGGATATCC
>X63633.1 H.sapiens pml gene, exon 6(5'portion)
TGCAGGATGTC
>X63632.1 H.sapiens pml gene, exon 4
GACCTGGTGAG
>X63635.1 H.sapiens pml gene, exon 3(3'portion)
GGGAAAGGTAA
>CS445024.1 Sequence 389 from Patent WO2006116127
TCCACCCTCAA
>CS444580.1 Sequence 18 from Patent WO2006110680
TCCTGAGCTCA
>CS446284.1 Sequence 44 from Patent WO2006110607
GTCGTTTTGAC
>CS445993.1 Sequence 1358 from Patent WO2006116127
TATTCTTCGTT
>CS445992.1 Sequence 1357 from Patent WO2006116127
TACTCATGCCA
>CS440757.1 Sequence 24 from Patent EP1715046
GATCCAGCATG
>CS435984.1 Sequence 128 from Patent WO2006085973
GCGTTCTTCCG
>CS435983.1 Sequence 127 from Patent WO2006085973
ATAGTGCTCAT
>CS435982.1 Sequence 126 from Patent WO2006085973
TGCTCATACTC
>CS435981.1 Sequence 125 from Patent WO2006085973
CTCTCGCAAGG
>CS435974.1 Sequence 118 from Patent WO2006085973
TCTCAGATGGT
>CS435965.1 Sequence 109 from Patent WO2006085973
CTTCGATAGTG
>CS435957.1 Sequence 101 from Patent WO2006085973
TTTGCAACCCC
>CS435956.1 Sequence 100 from Patent WO2006085973
AATAGGGTTGG
>CS435935.1 Sequence 79 from Patent WO2006085973
GGCATCGTCGC
>CS435919.1 Sequence 63 from Patent WO2006085973
ACGTTGAGGGG
>DD349270.1 CHIMERIC ANTAGONIST ANTH1
CCCATATGATG
>DD334558.1 Staphylococcus aureus bacteriophage faiMR11 integrase, and site-specific recombination system using nucleotide sequences recognized by it
TAGGWWGTATA
>DD349143.1 IMMUNOSTIMULATORY NUCLEIC ACIDS
TCGTCGTTTTG
>DD349129.1 IMMUNOSTIMULATORY NUCLEIC ACIDS
GTTTTGTCGTT
>DD349128.1 IMMUNOSTIMULATORY NUCLEIC ACIDS
GTTTTGTCGTT
>DD348384.1 Method for In Vitro Selection of 2'-Substituted Nucleic Acids
GGAGCAGCACC
>DD348376.1 Method for In Vitro Selection of 2'-Substituted Nucleic Acids
GGNGCNGCNCC
>DD346250.1 Method to generate or determine nucleic acid tages correponding to the terminal ends of DNA molecules using sequences analysis of gene expression (terminal sage)
AAAAAAAAAGC
>DD331632.1 Molecules for detecting mismatch and methods for detecting mismatch and the use
CATTCNGTTAG
>DD331631.1 Molecules for detecting mismatch and methods for detecting mismatch and the use
CTAACNGAATG
>DD331036.1 A metod of detecting mismatched base pair
CATTCNGTTAG
>DD331035.1 A metod of detecting mismatched base pair
CTAACNGAATG
>DD352875.1 METHODS FOR DETECTION OF GENETIC DISORDERS
CCTNNNNNAGG
>DD345286.1 Oligonucleotide Conjugates
GATTGGGATTG
>DD345285.1 Oligonucleotide Conjugates
GTTAGGGTTAG
>DD345275.1 Oligonucleotide Conjugates
GTTAGGGTTAG
>DD345273.1 Oligonucleotide Conjugates
CYAACCCYAAC
>DD345195.1 Strand-Specific Detection and Quantification
CACGGTGACAC
>DD347710.1 Methods for Identifying Functionally Related Genes and Drug Targets
NNTTTATTTNN
>DD346173.1 Method to generate or determine nucleic acid tages correponding to the terminal ends of DNA molecules using sequences analysis of gene expression (terminal sage)
GCTCTTCNNNN
>DD346168.1 Method to generate or determine nucleic acid tages correponding to the terminal ends of DNA molecules using sequences analysis of gene expression (terminal sage)
CCTCNNNNNNN
>DD346163.1 Method to generate or determine nucleic acid tages correponding to the terminal ends of DNA molecules using sequences analysis of gene expression (terminal sage)
CCTTCNNNNNN
>DD346156.1 Method to generate or determine nucleic acid tages correponding to the terminal ends of DNA molecules using sequences analysis of gene expression (terminal sage)
CCCGCNNNNNN
>DD346154.1 Method to generate or determine nucleic acid tages correponding to the terminal ends of DNA molecules using sequences analysis of gene expression (terminal sage)
CGTCTCNNNNN
>DD346151.1 Method to generate or determine nucleic acid tages correponding to the terminal ends of DNA molecules using sequences analysis of gene expression (terminal sage)
GGTCTCNNNNN
>DD346139.1 Method to generate or determine nucleic acid tages correponding to the terminal ends of DNA molecules using sequences analysis of gene expression (terminal sage)
GCATCNNNNNN
>DD346135.1 Method to generate or determine nucleic acid tages correponding to the terminal ends of DNA molecules using sequences analysis of gene expression (terminal sage)
ACTGGGNNNNN
>CS430751.1 Sequence 2 from Patent WO2006028889
ATTGGNCCACG
>AR983086.1 Sequence 86 from patent US 7115715
ACACAGAAGGG
>AR983084.1 Sequence 84 from patent US 7115715
CTCCAGTCCAG
>AR983083.1 Sequence 83 from patent US 7115715
CCCTAGCTCCA
>AR983082.1 Sequence 82 from patent US 7115715
TCACAGGCTCA
>AR983081.1 Sequence 81 from patent US 7115715
CCCCAGGAGGG
>AR983080.1 Sequence 80 from patent US 7115715
TTTCAGATCCA
>AR983079.1 Sequence 79 from patent US 7115715
ACGCAGTGCAA
>AR983078.1 Sequence 78 from patent US 7115715
CCCCAGGCGAC
>AR983077.1 Sequence 77 from patent US 7115715
ATACAGGGGAT
>AR983076.1 Sequence 76 from patent US 7115715
CACAGGTATTA
>AR983075.1 Sequence 75 from patent US 7115715
TGCTGGTGAGT
>AR983074.1 Sequence 74 from patent US 7115715
GCCAGGTACAG
>AR983073.1 Sequence 73 from patent US 7115715
AGCAGGTGGGC
>AR983072.1 Sequence 72 from patent US 7115715
GGAAGGTCAGT
>AR983071.1 Sequence 71 from patent US 7115715
TGGAGGTACCA
>AR983070.1 Sequence 70 from patent US 7115715
CCGAGGTGAGC
>AR983069.1 Sequence 69 from patent US 7115715
CAGTCGTGAGG
>AR983068.1 Sequence 68 from patent US 7115715
TGGAGGTGAGA
>AR983067.1 Sequence 67 from patent US 7115715
AGAAGGTAAGT
>AR982633.1 Sequence 86 from patent US 7115580
GCTCCCCGTAC
>AR982390.1 Sequence 35 from patent US 7115555
GAATTCAGATC
>AR948646.1 Sequence 22 from patent US 7115370
CCANNNNNTGG
>AR948645.1 Sequence 21 from patent US 7115370
GCNNNNNNNGC
>AR948642.1 Sequence 18 from patent US 7115370
CCTNNNNNAGG
>AR948639.1 Sequence 15 from patent US 7115370
GCANNNNNTGC
>AR948638.1 Sequence 14 from patent US 7115370
CCNNNNNNNGG
>AR948636.1 Sequence 12 from patent US 7115370
GCCNNNNNGGC
>AR948633.1 Sequence 9 from patent US 7115370
GACNNNNNGTC
>AR948271.1 Sequence 493 from patent US 7115364
GGGNCCCTTAA
>AR948148.1 Sequence 370 from patent US 7115364
GGAGGGGGTTT
>AR948125.1 Sequence 347 from patent US 7115364
CATGGGGAGGG
>AR948110.1 Sequence 332 from patent US 7115364
GGTGAGGGGTG
>AR948109.1 Sequence 331 from patent US 7115364
AGGGGTGGCAT
>AR948101.1 Sequence 323 from patent US 7115364
AGGGACCCCTA
>AR948098.1 Sequence 320 from patent US 7115364
AGGGGGGTCAT
>AR948081.1 Sequence 303 from patent US 7115364
TTATGGGCCCG
>AR948079.1 Sequence 301 from patent US 7115364
CGGAGCGAGGA
>AR948056.1 Sequence 278 from patent US 7115364
GTGCTCCGGCT
>AR948055.1 Sequence 277 from patent US 7115364
TCCGGCTCCAG
>AR948048.1 Sequence 270 from patent US 7115364
TGCATACCCCC
>AR948047.1 Sequence 269 from patent US 7115364
TACCCCCCAGA
>AR948046.1 Sequence 268 from patent US 7115364
CCCAGACGAAA
>AR948001.1 Sequence 223 from patent US 7115364
GGGGTTTGGCA
>AR947994.1 Sequence 216 from patent US 7115364
CAGAAGCGGGG
>AR947992.1 Sequence 214 from patent US 7115364
GAGGGGGGGTT
>AR947991.1 Sequence 213 from patent US 7115364
GGTTTGGTGGA
>AR947984.1 Sequence 206 from patent US 7115364
AGTTGGGGGGT
>AR947979.1 Sequence 201 from patent US 7115364
CATACCGCCAA
>AR947978.1 Sequence 200 from patent US 7115364
CGCCAAAAAGA
>AR947963.1 Sequence 185 from patent US 7115364
TAGGATGGGCG
>AR947955.1 Sequence 177 from patent US 7115364
GAGTGGGAGGG
>AR947938.1 Sequence 160 from patent US 7115364
GGTTGGTTCGG
>AR947936.1 Sequence 158 from patent US 7115364
AGCGGGGGAGG
>AR945503.1 Sequence 13 from patent US 7112654
ACCGGCCCCGT
>AR945296.1 Sequence 3 from patent US 7112407
GTCGGGGGGAA
>AR944708.1 Sequence 4 from patent US 7105661
TACGTAAGGCS
>AR943706.1 Sequence 1 from patent US 7105576
GGGGACTTTCC
>AR941997.1 Sequence 6 from patent US 7102158
CGCATATAGCA
>AR935376.1 Sequence 44 from patent US 7101850
ACCGCCCTCCG
>AR934795.1 Sequence 5 from patent US 7101685
AGGGTCAAAGT
>AR934632.1 Sequence 19 from patent US 7101672
CCGCAAGACCG
>AR934631.1 Sequence 18 from patent US 7101672
CCGCGAGACCG
>AR934630.1 Sequence 17 from patent US 7101672
TGTTGGGTCGC
>AR934628.1 Sequence 15 from patent US 7101672
CCGCGAGACTG
>AR934627.1 Sequence 14 from patent US 7101672
GGAGATTTGGG
>AR934626.1 Sequence 13 from patent US 7101672
GGACGACCGGG
>AR934625.1 Sequence 12 from patent US 7101672
TGGTCTGCGGA
>AR934585.1 Sequence 12 from patent US 7101669
ATCTCGCGTCT
>AR934481.1 Sequence 1 from patent US 7101662
GCCAGCCATGG
>AR934210.1 Sequence 32 from patent US 7098324
WTTTATRTTTW
>AR932932.1 Sequence 5324 from patent US 7098023
GTGGTGAAGAC
>AR929423.1 Sequence 3 from patent US 7097978
CTAGACTTAAG
>AR928747.1 Sequence 37 from patent US 7094953
TGGCGCCGTTG
>AR928251.1 Sequence 10 from patent US 7094766
GATCGATCGAT
>AR928250.1 Sequence 9 from patent US 7094766
CTAACCCTAAC
>AR928248.1 Sequence 5 from patent US 7094766
GTTAGGGTTAG
>AR926929.1 Sequence 5 from patent US 7094530
CTTTAGAGCAC
>AR925593.1 Sequence 170 from patent US 7091311
TTACTTAGTTA
>AR925592.1 Sequence 169 from patent US 7091311
ACCACCTCCGG
>AR925570.1 Sequence 23 from patent US 7091178
ACCGCCCTCCG
>AR924977.1 Sequence 20 from patent US 7091023
CCGTTAAATTT
>AR924976.1 Sequence 19 from patent US 7091023
GTACTAAAACC
>AR919295.1 Sequence 90 from patent US 7090844
GAGATGGCTAC
>AR919293.1 Sequence 88 from patent US 7090844
GAGATGGCTAC
>AR919292.1 Sequence 87 from patent US 7090844
CAGTGGCTGGT
>AR919052.1 Sequence 20 from patent US 7057027
NNNNANNNNNN
>AR917703.1 Sequence 14 from patent US 7056730
CACGGGAATAA
>AR916446.1 Sequence 8 from patent US 7056501
AAGTCAACGCG
>AR916445.1 Sequence 7 from patent US 7056501
AGTCAAACGCG
>CS419007.1 Sequence 89 from Patent WO2006048459
GAATTCATGGG
>CS419001.1 Sequence 83 from Patent WO2006048459
AAACCATGGCC
>CS414245.1 Sequence 1131 from Patent EP1700603
GATGTATCGTC
>CS416918.1 Sequence 3 from Patent WO2006094704
GGGGACTTTCC
>CS412703.1 Sequence 54 from Patent WO2006032859
ATATATACACC
>CS412699.1 Sequence 50 from Patent WO2006032859
TATATAAAATA
>CS412660.1 Sequence 11 from Patent WO2006032859
ATATATGATAT
>CS410905.1 Sequence 103 from Patent WO2006043271
CTGCCAGACAT
>CS414811.1 Sequence 47 from Patent EP1700915
ATAGGCCCGGT
>CS414808.1 Sequence 44 from Patent EP1700915
ATAGCGTATTA
>CS410244.1 Sequence 16 from Patent WO2006030174
GGCGCCCGCGG
>CS410153.1 Sequence 29 from Patent WO2005074350
TAAGGAYCGGA
>CS410152.1 Sequence 28 from Patent WO2005074350
GTGAATRCAAC
>CS410151.1 Sequence 27 from Patent WO2005074350
CTAAAGWGACA
>DD329832.1 Methods And Compositions For DNA Manipulation
CAACCGGCGAT
>DD329831.1 Methods And Compositions For DNA Manipulation
GTCCCGGCGAT
>DD329828.1 Methods And Compositions For DNA Manipulation
ACATATGAGTN
>DD329827.1 Methods And Compositions For DNA Manipulation
ACATATGAGTT
>DD329817.1 Methods And Compositions For DNA Manipulation
GGAGACANNNN
>DD329813.1 Methods And Compositions For DNA Manipulation
GCTGAGGGGGG
>DD329811.1 Methods And Compositions For DNA Manipulation
GCTGAGGGGGG
>DD326729.1 IMMUNOMODULATORY COMPOSITIONS, METHODS OF MAKING, AND METHODS OF USE THEREOF
TCGAGCGTTCT
>CS400249.1 Sequence 89 from Patent EP1696028
TTCCGTTATGC
>CS399945.1 Sequence 353 from Patent EP1695978
GAGGATTACCC
>CS389220.1 Sequence 128 from Patent WO2005069724
GTGGTTTGAAA
>CS399083.1 Sequence 31 from Patent WO2006089192
TTGAGGCGCGA
>CS401278.1 Sequence 5 from Patent EP1693059
GGAAATTCCCC
>CS405768.1 Sequence 31 from Patent WO2006086737
TTCTCAGTGCG
>CS409738.1 Sequence 124 from Patent WO2006089950
CATTTTTATCA
>CS409729.1 Sequence 115 from Patent WO2006089950
ATTTTTTATTA
>CS403236.1 Sequence 9 from Patent WO2006084754
ACCGAAACGGT
>CS402427.1 Sequence 61 from Patent WO2006017833
GTGACACAACC
>DD308912.1 ELECTRICAL DETECTION OF DNA HYBRIDIZATION AND SPECIFIC BINDING EVENTS
CTCGCTGAGAG
>DD308909.1 ELECTRICAL DETECTION OF DNA HYBRIDIZATION AND SPECIFIC BINDING EVENTS
GGCGAGGAATA
>DD292619.1 METHODS AND SYSTEMS FOR ESTIMATING THE MELTING TEMPERATURE (Tm) FOR POLYNUCLEOTIDE MOLECULES
CCATTGCTACC
>DD292618.1 METHODS AND SYSTEMS FOR ESTIMATING THE MELTING TEMPERATURE (Tm) FOR POLYNUCLEOTIDE MOLECULES
CGTACACATGC
>DD292070.1 Gene and Polypeptide Sequences
TTAGGCTTATA
>DD313073.1 ASSAYS FOR DNA METHYLATION CHANGES
CGACTCAGGAC
>DD290066.1 LIGAND FOR G-PROTEIN COUPLED RECEPTOR FPRL2 AND USES THEREOF
GGGGACTTTCC
>DD289936.1 GENOMIC PROFILING OF REGULATORY FACTOR BINDING SITES
TGTTTATTTCA
>DD289930.1 GENOMIC PROFILING OF REGULATORY FACTOR BINDING SITES
TATTTGTTTAT
>DD289929.1 GENOMIC PROFILING OF REGULATORY FACTOR BINDING SITES
TATTTGTTTAT
>CS370808.1 Sequence 2282 from Patent WO2005028649
GGAGGAGGAAG
>CS370803.1 Sequence 2277 from Patent WO2005028649
ACAAATGTGAA
>CS370802.1 Sequence 2276 from Patent WO2005028649
GGAGGAAGAGT
>CS370795.1 Sequence 2269 from Patent WO2005028649
AGGAAGAGGAG
>CS370791.1 Sequence 2265 from Patent WO2005028649
TACCCTGATGA
>CS363991.1 Sequence 86 from Patent WO2006077411
CATCTTACGGA
>CS363990.1 Sequence 85 from Patent WO2006077411
CCGGAGCTGAA
>CS363989.1 Sequence 84 from Patent WO2006077411
ACGACGGGCAG
>CS363988.1 Sequence 83 from Patent WO2006077411
CATCTTACGGA
>CS363987.1 Sequence 82 from Patent WO2006077411
AAACTATTAAC
>CS363986.1 Sequence 81 from Patent WO2006077411
GAAAAGCATCT
>CS375783.1 Sequence 35 from Patent WO2006034061
CCANNNNNTGG
>CS362834.1 Sequence 17 from Patent WO2006021724
AATTTTTGGAG
>CS362833.1 Sequence 16 from Patent WO2006021724
AATTTGTCTAG
>AR912962.1 Sequence 5324 from patent US 7081530
GTGGTGAAGAC
>AR910174.1 Sequence 4 from patent US 7081526
TACGTAAGGCS
>AR908828.1 Sequence 159 from patent US 7081341
TCAAGAGGTTA
>AR908827.1 Sequence 158 from patent US 7081341
CATATACCTCG
>AR908826.1 Sequence 157 from patent US 7081341
TCATGAGGTTA
>AR908825.1 Sequence 156 from patent US 7081341
CAACTACCTCG
>AR908824.1 Sequence 155 from patent US 7081341
TCATGGGGTTA
>AR908823.1 Sequence 154 from patent US 7081341
CATATCCCTCG
>AR908822.1 Sequence 153 from patent US 7081341
TCAAGAGGTTA
>AR908821.1 Sequence 152 from patent US 7081341
CACCGACCTCG
>AR908820.1 Sequence 151 from patent US 7081341
TCATGAGGTTA
>AR908819.1 Sequence 150 from patent US 7081341
CACATACCTCG
>AR908818.1 Sequence 149 from patent US 7081341
TCATGAGGTTA
>AR908817.1 Sequence 148 from patent US 7081341
CAAATACCTCG
>AR908816.1 Sequence 147 from patent US 7081341
TCAAGAGATTA
>AR908815.1 Sequence 146 from patent US 7081341
CATATAACTCG
>AR908814.1 Sequence 145 from patent US 7081341
TCATGAGGTTA
>AR908813.1 Sequence 144 from patent US 7081341
CATACCTCTCG
>AR908812.1 Sequence 143 from patent US 7081341
TCAGGAGATTA
>AR908811.1 Sequence 142 from patent US 7081341
CATCTATCTCG
>AR908810.1 Sequence 141 from patent US 7081341
TCAGAGTGTTA
>AR908809.1 Sequence 140 from patent US 7081341
CAACGAACTCG
>AR908808.1 Sequence 139 from patent US 7081341
TCAAGAGGTTA
>AR908807.1 Sequence 138 from patent US 7081341
CAAACACCTCG
>AR908806.1 Sequence 137 from patent US 7081341
TCAGGGATTTA
>AR908805.1 Sequence 136 from patent US 7081341
CATATCCCTCG
>AR908804.1 Sequence 135 from patent US 7081341
TCAGAGGATTA
>AR908803.1 Sequence 134 from patent US 7081341
CACTGATCTCG
>AR908802.1 Sequence 133 from patent US 7081341
TCAGGGTATTA
>AR908801.1 Sequence 132 from patent US 7081341
CATCCCACTCG
>AR908800.1 Sequence 131 from patent US 7081341
TCAAGATGTTA
>AR908799.1 Sequence 130 from patent US 7081341
CAAACATCTCG
>AR908798.1 Sequence 129 from patent US 7081341
TCAGAGGGTTA
>AR908797.1 Sequence 128 from patent US 7081341
CAACCCCCTCG
>AR908796.1 Sequence 127 from patent US 7081341
TCAGGAGATTA
>AR908795.1 Sequence 126 from patent US 7081341
CAATCCACTCG
>AR908794.1 Sequence 125 from patent US 7081341
TCAGGAGATTA
>AR908793.1 Sequence 124 from patent US 7081341
CAACCTACTCG
>AR908792.1 Sequence 123 from patent US 7081341
TCATGGAATTA
>AR908791.1 Sequence 122 from patent US 7081341
CATATTCCTCG
>AR908790.1 Sequence 121 from patent US 7081341
TCAGAGGATTA
>AR908789.1 Sequence 120 from patent US 7081341
CACTCCTCTCG
>AR908788.1 Sequence 119 from patent US 7081341
TCAGGAGATTA
>AR908787.1 Sequence 118 from patent US 7081341
CAAATATCTCG
>AR908786.1 Sequence 117 from patent US 7081341
TCAAGGTATTA
>AR908785.1 Sequence 116 from patent US 7081341
CAAATATCTCG
>AR908784.1 Sequence 115 from patent US 7081341
TCATAGTGTTA
>AR908783.1 Sequence 114 from patent US 7081341
CAACTAACTCG
>AR908782.1 Sequence 113 from patent US 7081341
TCATGCTATTA
>AR908781.1 Sequence 112 from patent US 7081341
CATAGCACTCG
>AR908780.1 Sequence 111 from patent US 7081341
TCAGGCTTTTA
>AR908779.1 Sequence 110 from patent US 7081341
CACAGATCTCG
>AR908778.1 Sequence 109 from patent US 7081341
TCAGTGGATTA
>AR908777.1 Sequence 108 from patent US 7081341
CAATCCACTCG
>AR908776.1 Sequence 107 from patent US 7081341
TCATGGATTTA
>AR908775.1 Sequence 106 from patent US 7081341
CATAGTACTCG
>AR908774.1 Sequence 105 from patent US 7081341
TCATGAGGTTA
>AR908773.1 Sequence 104 from patent US 7081341
CATACCTCTCG
>AR908772.1 Sequence 103 from patent US 7081341
TCAGAGATTTA
>AR908771.1 Sequence 102 from patent US 7081341
CAAATATCTCG
>AR908770.1 Sequence 101 from patent US 7081341
TCAGGAGATTA
>AR908769.1 Sequence 100 from patent US 7081341
CAACTCTCTCG
>AR908768.1 Sequence 99 from patent US 7081341
TCAAGAGTTTA
>AR908767.1 Sequence 98 from patent US 7081341
CATACATCTCG
>AR908766.1 Sequence 97 from patent US 7081341
TCATACTATTA
>AR908765.1 Sequence 96 from patent US 7081341
CAAACTCCTCG
>AR908764.1 Sequence 95 from patent US 7081341
TCAAGGGGTTA
>AR908763.1 Sequence 94 from patent US 7081341
CATCCCACTCG
>AR908762.1 Sequence 93 from patent US 7081341
TCAAAGGGTTA
>AR908761.1 Sequence 92 from patent US 7081341
CACCCACCTCG
>AR908760.1 Sequence 91 from patent US 7081341
TCATGGTTTTA
>AR908759.1 Sequence 90 from patent US 7081341
CACACCACTCG
>AR908758.1 Sequence 89 from patent US 7081341
TCAAAGAGTTA
>AR908757.1 Sequence 88 from patent US 7081341
CATCGTTCTCG
>AR908756.1 Sequence 87 from patent US 7081341
TCATGGGATTA
>AR908755.1 Sequence 86 from patent US 7081341
CAACCCACTCG
>AR908754.1 Sequence 85 from patent US 7081341
TCAGAGTGTTA
>AR908753.1 Sequence 84 from patent US 7081341
CAACTCACTCG
>AR908752.1 Sequence 83 from patent US 7081341
TCAGTGAATTA
>AR908751.1 Sequence 82 from patent US 7081341
CAATTCACTCG
>AR908750.1 Sequence 81 from patent US 7081341
TCAATGAGTTA
>AR908749.1 Sequence 80 from patent US 7081341
CAAAGTTCTCG
>AR908748.1 Sequence 79 from patent US 7081341
TCAATCAGTTA
>AR908747.1 Sequence 78 from patent US 7081341
CACAGAACTCG
>AR908746.1 Sequence 77 from patent US 7081341
TCAGAATTTTA
>AR908745.1 Sequence 76 from patent US 7081341
CAATTATCTCG
>AR908744.1 Sequence 75 from patent US 7081341
TCAGGAGGTTA
>AR908743.1 Sequence 74 from patent US 7081341
CATCTTCCTCG
>AR908742.1 Sequence 73 from patent US 7081341
TCATTGGGTTA
>AR908741.1 Sequence 72 from patent US 7081341
CATAGCCCTCG
>AR908740.1 Sequence 71 from patent US 7081341
TCAGTGATTTA
>AR908739.1 Sequence 70 from patent US 7081341
CAAACCACTCG
>AR908738.1 Sequence 69 from patent US 7081341
TCAGACGATTA
>AR908737.1 Sequence 68 from patent US 7081341
CACAGTCCTCG
>AR908736.1 Sequence 67 from patent US 7081341
TCAATGGGTTA
>AR908735.1 Sequence 66 from patent US 7081341
CATACCTCTCG
>AR908734.1 Sequence 65 from patent US 7081341
TCAAGGGATTA
>AR908733.1 Sequence 64 from patent US 7081341
CAATCCCCTCG
>AR908732.1 Sequence 63 from patent US 7081341
TCACCTCCTTA
>AR908731.1 Sequence 62 from patent US 7081341
CAGGAGGCTCG
>AR908716.1 Sequence 47 from patent US 7081341
TCAAGAGGTTA
>AR908715.1 Sequence 46 from patent US 7081341
CATATACCTCG
>AR908714.1 Sequence 45 from patent US 7081341
TCATGAGGTTA
>AR908713.1 Sequence 44 from patent US 7081341
CAACTACCTCG
>AR908712.1 Sequence 43 from patent US 7081341
TCATGGGATTA
>AR908711.1 Sequence 42 from patent US 7081341
CATATCCCTCG
>AR908710.1 Sequence 41 from patent US 7081341
TCAAGAGGTTA
>AR908709.1 Sequence 40 from patent US 7081341
CACCGACCTCG
>AR908708.1 Sequence 39 from patent US 7081341
TCATGAGGTTA
>AR908707.1 Sequence 38 from patent US 7081341
CACATACCTCG
>AR908706.1 Sequence 37 from patent US 7081341
TCATGAGGTTA
>AR908705.1 Sequence 36 from patent US 7081341
CAAATACCTCG
>AR908704.1 Sequence 35 from patent US 7081341
TCAGAGGATTA
>AR908703.1 Sequence 34 from patent US 7081341
CATAATCCTCG
>AR908702.1 Sequence 33 from patent US 7081341
TCATGAGGTTA
>AR908701.1 Sequence 32 from patent US 7081341
CATACCTCTCG
>AR908700.1 Sequence 31 from patent US 7081341
TCAAGAGGTTA
>AR908699.1 Sequence 30 from patent US 7081341
CAAACACCTCG
>AR908698.1 Sequence 29 from patent US 7081341
TCAGGGATTTA
>AR908697.1 Sequence 28 from patent US 7081341
CATATCCCTCG
>AR908696.1 Sequence 27 from patent US 7081341
TCACACACTTA
>AR908695.1 Sequence 26 from patent US 7081341
CAGTGTGCTCG
>AR908694.1 Sequence 25 from patent US 7081341
TCACCTCCTTA
>AR908693.1 Sequence 24 from patent US 7081341
CAGGAGGCTCG
>AR907164.1 Sequence 5 from patent US 7078389
NGGGGGAAGGA
>AR907161.1 Sequence 1 from patent US 7078389
NAGGAAGGGGG
>AR907046.1 Sequence 127 from patent US 7078383
CCANNNNNTGG
>AR906778.1 Sequence 17 from patent US 7078197
AAAAAAAAAAA
>AR906133.1 Sequence 26 from patent US 7078028
AGATCAAAGGG
>AR906017.1 Sequence 5324 from patent US 7074914
GTGGTGAAGAC
>AR900211.1 Sequence 40 from patent US 7074590
AATGGGCGGTC
>AR900209.1 Sequence 38 from patent US 7074590
GACGCCGGAGG
>AR896672.1 Sequence 5 from patent US 7070932
CCAACCACACA
>AR896670.1 Sequence 3 from patent US 7070932
GGTTGGTGTGT
>AR896597.1 Sequence 29 from patent US 7070928
TGGTACGAATT
>AR896570.1 Sequence 10 from patent US 7070927
AAAAAATTTTT
>AR894355.1 Sequence 10 from patent US 7067497
TCTAATTCTAA
>AR894354.1 Sequence 9 from patent US 7067497
TCTAACCCTAA
>AR893487.1 Sequence 90 from patent US 7067131
GAGATGGCTAC
>AR893485.1 Sequence 88 from patent US 7067131
GAGATGGCTAC
>AR893484.1 Sequence 87 from patent US 7067131
CAGTGGCTGGT
>AR893296.1 Sequence 49 from patent US 7064244
ACTAACTACCC
>AR892670.1 Sequence 4 from patent US 7063962
CCGTTAAATTT
>AR892669.1 Sequence 3 from patent US 7063962
GTACTAAAACC
>AR892434.1 Sequence 15 from patent US 7063945
TAGGTCATACT
>AR892431.1 Sequence 12 from patent US 7063945
AGTATTGCCTA
>AR892387.1 Sequence 213 from patent US 7063943
GAGGGTGGCGG
>AR891017.1 Sequence 41 from patent US 7060690
TCTCCCAGCGT
>AR885936.1 Sequence 25 from patent US 7060438
AGGGGACCGCA
>AR885839.1 Sequence 293 from patent US 7060436
TGCCTGGCCGT
>AR885568.1 Sequence 19 from patent US 7060436
CCGCAAGACCG
>AR885567.1 Sequence 18 from patent US 7060436
CCGCGAGACCG
>AR885566.1 Sequence 17 from patent US 7060436
TGTTGGGTCGC
>AR885564.1 Sequence 15 from patent US 7060436
CCGCGAGACTG
>AR885563.1 Sequence 14 from patent US 7060436
GGAGATTTGGG
>AR885562.1 Sequence 13 from patent US 7060436
GGACGACCGGG
>AR885561.1 Sequence 12 from patent US 7060436
TGGTCTGCGGA
>AR885442.1 Sequence 1 from patent US 7060282
TAATGARATTC
>AR884986.1 Sequence 43 from patent US 7053268
GTCGACCATGG
>AR883298.1 Sequence 8 from patent US 7052867
GAGGTGATTTT
>AR882974.1 Sequence 25 from patent US 7052845
TTTTTTTTTTT
>AR882920.1 Sequence 33 from patent US 7052838
AAAAAAAAGGA
>AR882919.1 Sequence 32 from patent US 7052838
TTTTTTTTCCT
>AR882907.1 Sequence 15 from patent US 7052838
AGGAGCGGGAG
>AR882906.1 Sequence 14 from patent US 7052838
TCCTCTCCCTC
>AR882619.1 Sequence 26 from patent US 7052693
CTTGGTGGAGG
>AR881883.1 Sequence 18 from patent US 7049143
ATCGAATTCCC
>AR880693.1 Sequence 30 from patent US 7049061
WGWCCWWWWWW
>AR880692.1 Sequence 29 from patent US 7049061
WWWWWWGGWCW
>AR880689.1 Sequence 26 from patent US 7049061
TAACAATAACA
>AR880688.1 Sequence 25 from patent US 7049061
TGTTATTGTTA
>AR880679.1 Sequence 16 from patent US 7049061
TGGCGTAATCA
>AR880678.1 Sequence 15 from patent US 7049061
TGATTACGCCA
>AR880677.1 Sequence 14 from patent US 7049061
CACAGGAAACA
>AR880676.1 Sequence 13 from patent US 7049061
TGTTTCCTGTG
>AR880675.1 Sequence 12 from patent US 7049061
TGTCATTGTCA
>AR880674.1 Sequence 11 from patent US 7049061
TGACAATGACA
>AR880673.1 Sequence 10 from patent US 7049061
AACATATAACA
>AR880672.1 Sequence 9 from patent US 7049061
TGTTATATGTT
>AR880671.1 Sequence 8 from patent US 7049061
CTAACATAACA
>AR880670.1 Sequence 7 from patent US 7049061
TGTTATGTTAG
>AR880669.1 Sequence 6 from patent US 7049061
TAACAATAACA
>AR880665.1 Sequence 2 from patent US 7049061
TGTCATTGTCA
>AR880664.1 Sequence 1 from patent US 7049061
TGTTATTGTTA
>AR877553.1 Sequence 1794 from patent US 7045289
ATTCTCTCAGA
>AR876507.1 Sequence 748 from patent US 7045289
GGGCCAGAGGG
>AR876474.1 Sequence 715 from patent US 7045289
GGGCCAGAGGG
>AR876043.1 Sequence 196 from patent US 7045289
GGGCCAGAGGG
>AR875827.1 Sequence 13 from patent US 7043371
TTGACATAGCA
>AR875824.1 Sequence 6 from patent US 7043371
TTGACATAGCA
>AR875339.1 Sequence 1 from patent US 7041817
NNNNTHNNNNN
>AR875328.1 Sequence 11326 from patent US 7041814
GTGGTGAAGAC
>AR863573.1 Sequence 11 from patent US 7041483
GCCAGCCATGA
>AR863267.1 Sequence 42 from patent US 7041457
GGCGCGCCGCC
>AR862686.1 Sequence 12 from patent US 7035738
TGCGTACGGCA
>AR862685.1 Sequence 11 from patent US 7035738
TGCGTACGGCA
>AR862587.1 Sequence 15 from patent US 7034145
GCNNNNNNNGC
>AR862586.1 Sequence 14 from patent US 7034145
CCANNNNNTGG
>AR862585.1 Sequence 13 from patent US 7034145
GCANNNNNTGC
>AR862578.1 Sequence 6 from patent US 7034145
CCGCCTCGGCC
>AR860503.1 Sequence 20806 from patent US 7034009
NNNNTHNNNNN
>AR839452.1 Sequence 15 from patent US 7033829
CGGGCTTATTG
>AR839451.1 Sequence 14 from patent US 7033829
TAGATGTGGTG
>AR839449.1 Sequence 10 from patent US 7033829
GATCGATCGAT
>AR839448.1 Sequence 9 from patent US 7033829
CTAACCCTAAC
>AR839446.1 Sequence 5 from patent US 7033829
GTTAGGGTTAG
>AR838101.1 Sequence 43 from patent US 7033801
GGCCATAAGGG
>AR838100.1 Sequence 42 from patent US 7033801
GCCTTGTTCCC
>AR838099.1 Sequence 41 from patent US 7033801
ATCCGGTTCCC
>AR838098.1 Sequence 40 from patent US 7033801
GGCCTAAAGGG
>AR838097.1 Sequence 39 from patent US 7033801
TAGGCCAAGGG
>AR838096.1 Sequence 38 from patent US 7033801
CGGAACAAGGG
>AR838095.1 Sequence 37 from patent US 7033801
GTTCCGAAGGG
>AR838094.1 Sequence 34 from patent US 7033801
CGGAACAAGGG
>AR838093.1 Sequence 33 from patent US 7033801
GTTCCGAAGGG
>AR833375.1 Sequence 22 from patent US 7029847
CGGGACACGGG
>AR833374.1 Sequence 21 from patent US 7029847
CGGGACATGTG
>AR833373.1 Sequence 20 from patent US 7029847
CGGGACACGTG
>AR833372.1 Sequence 19 from patent US 7029847
CGGGACACGGG
>AR833371.1 Sequence 18 from patent US 7029847
CGGGACATGTG
>AR833370.1 Sequence 17 from patent US 7029847
CGGGACACGTG
>AR833369.1 Sequence 16 from patent US 7029847
CGGGANNNNNG
>AR833368.1 Sequence 15 from patent US 7029847
CNGGACACGTN
>AR830836.1 Sequence 13 from patent US 7026141
GCCCTTNNNNN
>AR821328.1 Sequence 25 from patent US 7026116
TTTTTTTTTTT
>AX810142.1 Sequence 107 from Patent EP1333094
RGGGRMTYYCC
>AX810141.1 Sequence 106 from Patent EP1333094
TGGGCTTCCCC
>BD269366.1 Gene showing enhanced expression in association with aging of cells and final differentiation of cells and utilization thereof
TATTTATTTAA
>BD269252.1 Expression and transport of antiobestic protein as Fc-fused protein
TTAAGATATCG
>BD269251.1 Expression and transport of antiobestic protein as Fc-fused protein
AATTCGATATC
>BD269105.1 Directed evolution of microorganisms
GTGACCGCTTG
>BD269102.1 Directed evolution of microorganisms
GTGCCGCTGTG
>BD269100.1 Directed evolution of microorganisms
TTGACGCTTTG
>BD268240.1 Adenovirus vector, packaging cell line, composition and method for production and use
CGCGGATCCCG
>BD267685.1 Fixed address analysis of sequence tags
CGTGAATCATG
>BD263766.1 Production of attenuated negative stranded RNA virus vaccines from cloned nucleotide sequences
AAAAAAGGGGG
>BD263271.1 Compositions and methods for use in recombinational cloning of nucleic acids
GAAAGCTGGGT
>BD263270.1 Compositions and methods for use in recombinational cloning of nucleic acids
AAAAGCAGGCT
>BD263252.1 Compositions and methods for use in recombinational cloning of nucleic acids
AAAGCTGGGTN
>BD263251.1 Compositions and methods for use in recombinational cloning of nucleic acids
AAAGCAGGCTN
>BD263219.1 Method of treating cancer by restoration of pp32 function
AAAACATAAAT
>BD263216.1 Method of treating cancer by restoration of pp32 function
AAGATAAAACC
>BD262814.1 Diagnostic sequencing method comprising specific cleavage combined with mass spectrometry
CACAGAGAAAT
>BD262080.1 Antineoplastic viral agent containing toxin gene under regulation by oncotyte-inducible transcriptional factor
AGATCAAAGGG
>BD260535.1 Polymorphic loci that differentiate Escherichia coli O157:H7 from other strains
AGCTTGCCCTG
>BD252106.1 Antiproliferative activity of G-rich oligonucleotides and method of using same to bind to nuclbolin
GGTGGTGGTGG
>BD251953.1 Artificial matrix attachment region for increasing expression of genes introduced in plant cells
AAGATTATATA
>BD251949.1 Artificial matrix attachment region for increasing expression of genes introduced in plant cells
TTCTAATATAT
>BD251943.1 Artificial matrix attachment region for increasing expression of genes introduced in plant cells
TGACGTCCATG
>BD250407.1 Methods for determination of single nucleic acid polymorphisms using a bioelectric microchip
TGCCTGTCCAG
>BD250406.1 Methods for determination of single nucleic acid polymorphisms using a bioelectric microchip
CGCCTGTCCAG
>BD250402.1 Methods for determination of single nucleic acid polymorphisms using a bioelectric microchip
TACGTATATCT
>BD250401.1 Methods for determination of single nucleic acid polymorphisms using a bioelectric microchip
CACGTATATCT
>BD250395.1 Methods for determination of single nucleic acid polymorphisms using a bioelectric microchip
AAGGAATACAG
>BD250394.1 Methods for determination of single nucleic acid polymorphisms using a bioelectric microchip
GAGGAATACAG
>BD249580.1 Novel apoptosis proteins
GCTCCAATTCC
>BD249579.1 Novel apoptosis proteins
GCTCCAATTCC
>BD249578.1 Novel apoptosis proteins
GGAATTGGAGC
>BD244969.1 Complexity management and analysis of genomic DNA
CTCTTCNNNNN
>BD244871.1 Oligonucleotide primer capable of making the non-specific double strand formation unstable
GGGGGGGGGGG
>BD244759.1 Isolation method of primer extension products by modular oligonucleotide
ACGGGGCCCTC
>BD244756.1 Isolation method of primer extension products by modular oligonucleotide
CGGGGCCCTCC
>BD244728.1 Isolation method of primer extension products by modular oligonucleotide
NNAAGCTTACT
>BD244488.1 New triplex forming oligonucleotides and their use in anti-HBV
AGAGGAGGGGG
>BD244487.1 New triplex forming oligonucleotides and their use in anti-HBV
AAGGAGGAGGA
>BD243356.1 Protection probes
TGCGTCTTGAG
>BD243220.1 MN gene and protein
ACACAGAAGGG
>BD243218.1 MN gene and protein
CTCCAGTCCAG
>BD243217.1 MN gene and protein
CCCTAGCTCCA
>BD243216.1 MN gene and protein
TCACAGGCTCA
>BD243215.1 MN gene and protein
CCCCAGGAGGG
>BD243214.1 MN gene and protein
TTTCAGATCCA
>BD243213.1 MN gene and protein
ACGCAGTGCAA
>BD243212.1 MN gene and protein
CCCCAGGCGAC
>BD243211.1 MN gene and protein
ATACAGGGGAT
>BD243210.1 MN gene and protein
ATACAGGGGAT
>BD243209.1 MN gene and protein
TGCTGGTGAGT
>BD243208.1 MN gene and protein
GCCAGGTACAG
>BD243207.1 MN gene and protein
AGCAGGTGGGC
>BD243206.1 MN gene and protein
GGAAGGTCAGT
>BD243205.1 MN gene and protein
TGGAGGTACCA
>BD243204.1 MN gene and protein
CCGAGGTGAGC
>BD243203.1 MN gene and protein
CAGTCGTGAGG
>BD243202.1 MN gene and protein
TGGAGGTGAGA
>BD243201.1 MN gene and protein
AGAAGGTAAGT
>BD242995.1 Method for assaying the presence of target nucleic acid sequence and its application
TGCCGAGACGT
>BD242969.1 Method for assaying the presence of target nucleic acid sequence and its application
AGTGACTGGGG
>BD242389.1 Compound and method for the prevention and/or the treatment of allergy
TAGGCGGCCGC
>BD241065.1 Methods and products related to genotyping and DNA analysis
AAATTAAATGT
>BD241064.1 Methods and products related to genotyping and DNA analysis
AAATTCAATGT
>BD241063.1 Methods and products related to genotyping and DNA analysis
AATTGTTTCCC
>BD241062.1 Methods and products related to genotyping and DNA analysis
AATTGCTTCCC
>BD241061.1 Methods and products related to genotyping and DNA analysis
CCCACAGAGAA
>BD241060.1 Methods and products related to genotyping and DNA analysis
CCCACGGAGAA
>BD241059.1 Methods and products related to genotyping and DNA analysis
TAAGTATACAA
>BD241058.1 Methods and products related to genotyping and DNA analysis
TAAGTGTACAA
>BD240914.1 Expression and export of angiogenesis inhibitors as immunofusins
TTAAGCCGGAG
>BD240913.1 Expression and export of angiogenesis inhibitors as immunofusins
TCGACTCCGGC
>BD240724.1 Replication-deficient recombinant adenovirus having mutation major late promoter
TTGTCAGTTTC
>BD238189.1 Accelerated identification of polymorphism of single nucleotide in genome sequencing and alignment of clones
CCANNNNNTGG
>BD238187.1 Accelerated identification of polymorphism of single nucleotide in genome sequencing and alignment of clones
GCCNNNNNGGC
>BD238186.1 Accelerated identification of polymorphism of single nucleotide in genome sequencing and alignment of clones
GCCNNNNNGGC
>BD235381.1 Translational regulatory element for high-level expression of protein in higher plant plastid and method of using the same
TAAGGAGGTGA
>BD234603.1 Thymidine kinase mutants and fusion proteins having thymidine kinase and guanylate kinase activities
ATGAGGTACCG
>BD234262.1 Method for separating nucleic acids into populations
CTACCAGTAAA
>BD234260.1 Method for separating nucleic acids into populations
GATCCAGTAAA
>BD234258.1 Method for separating nucleic acids into populations
TTTACTGGTAG
>BD233001.1 Method of detecting mutation selected by drug in HIV protease gene
AAAATAAAAAT
>BD232342.1 Method and apparatus for detecting sequence length polymorphism in DNA
AATGAATGTTT
>BD232329.1 Method and apparatus for detecting sequence length polymorphism in DNA
CATTCATTCAC
>BD232295.1 Production and utilization of recombinant protein polymer having modified biological activity
GCGGCAGTACT
>BD227148.1 Protease inhibitor peptide
GGCCGCAATTC
>BD227146.1 Protease inhibitor peptide
AAAGGAAGAGC
>BD226182.1 Glaucoma therapeutics and diagnostics based on a novel human transcription factor
GCACGCCGAGC
>BD225301.1 Strains isolated from equine Neospora species and utilization thereof
AATTAATGTGT
>BD225300.1 Strains isolated from equine Neospora species and utilization thereof
AATTAACGTCT
>BD218252.1 Newcastle disease virus infectious clones, vaccines and diagnostic assays
CGCGAGSCTCG
>BD194750.1 Homogeneous diagnostic assay method utilizing simultaneous target and signal amplification
CCTNNNNNAGG
>BD194742.1 Homogeneous diagnostic assay method utilizing simultaneous target and signal amplification
GCCNNNNNGGC
>DD283470.1 GENETIC ANALYSIS AND AUTHENTICATION
CTTATTTCCCT
>DD287671.1 ALBUMIN-FUSED KUNITZ DOMAIN PEPTIDES
CCANNNNNTGG
>DD286731.1 Evolving New Molecular Function
TATCTACAGAG
>DD286726.1 Evolving New Molecular Function
TGTACGAATTC
>DD286724.1 Evolving New Molecular Function
GAATTCGTACC
>DD286722.1 Evolving New Molecular Function
TGTACGAATTC
>DD286720.1 Evolving New Molecular Function
GAATTCGTACC
>DD286718.1 Evolving New Molecular Function
TGTACGAATTC
>DD286717.1 Evolving New Molecular Function
GAATTCGTACA
>DD286716.1 Evolving New Molecular Function
GAATTCGTACC
>DD286715.1 Evolving New Molecular Function
GGTACGAATTC
>DD286710.1 Evolving New Molecular Function
TGTACGAATTC
>DD286707.1 Evolving New Molecular Function
GAATTCGTACC
>DD286649.1 Evolving New Molecular Function
TAAGATCTGCT
>DD286648.1 Evolving New Molecular Function
TCCTGATGTAA
>DD286647.1 Evolving New Molecular Function
TATCTACAGAG
>DD286646.1 Evolving New Molecular Function
TTAACGAGAGA
>DD286645.1 Evolving New Molecular Function
TATAGATCAGC
>DD286639.1 Evolving New Molecular Function
TGGTACGAATT
>DD286631.1 Evolving New Molecular Function
TGGTACGAATT
>DD286560.1 METHODS OF TREATING INFECTION BY DRUG RESISTANT BACTERIA
TGACAATTAAT
>DD279223.1 Method for identifying base polymorphism
TTCCCAGGAAC
>DD279222.1 Method for identifying base polymorphism
TTCCCGGGAAC
>DD279215.1 Method for identifying base polymorphism
TTCCCAGGAAC
>DD279214.1 Method for identifying base polymorphism
TTCCCGGGAAC
>DD279206.1 Method for identifying base polymorphism
TTCCCAGGAAC
>DD279205.1 Method for identifying base polymorphism
TTCCCGGGAAC
>DD278957.1 Gene Group of circadian rhythm control, DNAchip, and the methods of using DNAchip
WAWNTDGGTCA
>DD278955.1 Method for identifying base polymorphism
TTCCCAGGAAC
>DD278954.1 Method for identifying base polymorphism
TTCCCGGGAAC
>DD278937.1 Method for identifying base polymorphism
TTCCCAGGAAC
>CS284610.1 Sequence 20 from Patent EP1650219
TAAGCTTAACG
>CS278211.1 Sequence 52 from Patent EP1637595
GTTGGCCTTTT
>CS276926.1 Sequence 32 from Patent WO2004108840
TGATGACCTTT
>CS276925.1 Sequence 31 from Patent WO2004108840
TTTTGATGACC
>CS276924.1 Sequence 30 from Patent WO2004108840
TTGCTGACCAT
>CS276923.1 Sequence 29 from Patent WO2004108840
TGGGGAGTGAG
>CS276905.1 Sequence 11 from Patent WO2004108840
CTTTCAACAGT
>CS276879.1 Sequence 44 from Patent WO2005116213
TTTTTTTTGCC
>CS276867.1 Sequence 32 from Patent WO2005116213
TTTTTTTTGCC
>CS275849.1 Sequence 36 from Patent EP1632778
GGGGACTTTCC
>CS255226.1 Sequence 5 from Patent WO1998010085
TTATTTATATA
>CS247168.1 Sequence 1 from Patent EP1602725
NNNNTHNNNNN
>CS246936.1 Sequence 31 from Patent WO2005121358
CTGCCNCTTTC
>CS246934.1 Sequence 29 from Patent WO2005121358
CTGCCTCNTTC
>CS246932.1 Sequence 27 from Patent WO2005121358
CTGCCTCTTTC
>CS246930.1 Sequence 25 from Patent WO2005121358
CTGCCTCTTTC
>CS245571.1 Sequence 19 from Patent WO2005121362
GAAAATCCCTG
>CS245889.1 Sequence 5 from Patent WO2005118852
TGGGTTGAGAG
>CS245888.1 Sequence 4 from Patent WO2005118852
TGGGTYGAGAG
>CS244864.1 Sequence 4 from Patent WO2005118617
ATTGCATCTGA
>CS239400.1 Sequence 13 from Patent EP1607745
GGGGACTTTCC
>CS231690.1 Sequence 10 from Patent WO2005108618
GTCCGCCCCAC
>CS231687.1 Sequence 7 from Patent WO2005108618
CGCCCCACATA
>CS231685.1 Sequence 5 from Patent WO2005108618
CCGCCCCACAT
>CS231683.1 Sequence 3 from Patent WO2005108618
GTCCGCCCCAC
>CS200716.1 Sequence 86 from Patent EP1595947
ACACAGAAGGG
>CS200714.1 Sequence 84 from Patent EP1595947
CTCCAGTCCAG
>CS200713.1 Sequence 83 from Patent EP1595947
CCCTAGCTCCA
>CS200712.1 Sequence 82 from Patent EP1595947
TCACAGGCTCA
>CS200711.1 Sequence 81 from Patent EP1595947
CCCCAGGAGGG
>CS200710.1 Sequence 80 from Patent EP1595947
TTTCAGATCCA
>CS200709.1 Sequence 79 from Patent EP1595947
ACGCAGTGCAA
>CS200708.1 Sequence 78 from Patent EP1595947
CCCCAGGCGAC
>CS200707.1 Sequence 77 from Patent EP1595947
ATACAGGGGAT
>CS200706.1 Sequence 76 from Patent EP1595947
CACAGGTATTA
>CS200705.1 Sequence 75 from Patent EP1595947
TGCTGGTGAGT
>CS200704.1 Sequence 74 from Patent EP1595947
GCCAGGTACAG
>CS200703.1 Sequence 73 from Patent EP1595947
AGCAGGTGGGC
>CS200702.1 Sequence 72 from Patent EP1595947
GGAAGGTCAGT
>CS200701.1 Sequence 71 from Patent EP1595947
TGGAGGTACCA
>CS200700.1 Sequence 70 from Patent EP1595947
CCGAGGTGAGC
>CS200699.1 Sequence 69 from Patent EP1595947
CAGTCGTGAGG
>CS200698.1 Sequence 68 from Patent EP1595947
TGGAGGTGAGA
>CS200697.1 Sequence 67 from Patent EP1595947
AGAAGGTAAGT
>CS226838.1 Sequence 46 from Patent WO2005108625
GGCGAGGAATA
>CS226831.1 Sequence 39 from Patent WO2005108625
AGGCAAGGAAT
>CS226830.1 Sequence 38 from Patent WO2005108625
GGCGAGGAATA
>CS209916.1 Sequence 1079 from Patent EP1600510
GCCNNNNNCCC
>CS209892.1 Sequence 1055 from Patent EP1600510
CGCNNNNNGGC
>CS209883.1 Sequence 1046 from Patent EP1600510
CAGNNNNNGGG
>CS209871.1 Sequence 1034 from Patent EP1600510
GCGNNNNNGCC
>CS209798.1 Sequence 961 from Patent EP1600510
CGGNNNNNCCC
>CS209767.1 Sequence 930 from Patent EP1600510
CCCNNNNNCCA
>CS209765.1 Sequence 928 from Patent EP1600510
ACGNNNNNGCA
>CS209743.1 Sequence 906 from Patent EP1600510
CACNNNNNGGG
>CS209717.1 Sequence 880 from Patent EP1600510
CCGNNNNNTCC
>CS209695.1 Sequence 858 from Patent EP1600510
GGCNNNNNGGA
>CS209694.1 Sequence 857 from Patent EP1600510
CCCNNNNNAGC
>CS209691.1 Sequence 854 from Patent EP1600510
CAGNNNNNCCC
>CS209688.1 Sequence 851 from Patent EP1600510
GCCNNNNNGGA
>CS209682.1 Sequence 845 from Patent EP1600510
CGGNNNNNACG
>CS209675.1 Sequence 838 from Patent EP1600510
AGCNNNNNCAG
>CS209671.1 Sequence 834 from Patent EP1600510
CCANNNNNCCG
>CS209650.1 Sequence 813 from Patent EP1600510
ACCNNNNNCCC
>CS209627.1 Sequence 790 from Patent EP1600510
CCANNNNNGGG
>CS209623.1 Sequence 786 from Patent EP1600510
CTGNNNNNCCC
>CS209614.1 Sequence 777 from Patent EP1600510
CGCNNNNNGAG
>CS209586.1 Sequence 749 from Patent EP1600510
CGGNNNNNGGC
>CS209565.1 Sequence 728 from Patent EP1600510
CCCNNNNNAGG
>CS209554.1 Sequence 717 from Patent EP1600510
GAGNNNNNCCC
>CS209508.1 Sequence 671 from Patent EP1600510
CCTNNNNNGCC
>CS209485.1 Sequence 648 from Patent EP1600510
CCCNNNNNCGG
>CS209476.1 Sequence 639 from Patent EP1600510
CCGNNNNNCCC
>CS209448.1 Sequence 611 from Patent EP1600510
CTGNNNNNCGC
>CS209446.1 Sequence 609 from Patent EP1600510
GCGNNNNNGAC
>CS209392.1 Sequence 555 from Patent EP1600510
CTCNNNNNCGC
>CS209377.1 Sequence 540 from Patent EP1600510
GACNNNNNCGC
>CS209372.1 Sequence 535 from Patent EP1600510
CCCNNNNNCCG
>CS209350.1 Sequence 513 from Patent EP1600510
CAGNNNNNCCG
>CS209307.1 Sequence 470 from Patent EP1600510
CCGNNNNNGAC
>CS209292.1 Sequence 455 from Patent EP1600510
GCGNNNNNGGA
>CS209284.1 Sequence 447 from Patent EP1600510
CGGNNNNNCTC
>CS209253.1 Sequence 416 from Patent EP1600510
GCCNNNNNCGC
>CS209227.1 Sequence 390 from Patent EP1600510
GGGNNNNNGGA
>CS209220.1 Sequence 383 from Patent EP1600510
CCTNNNNNGCG
>CS209217.1 Sequence 380 from Patent EP1600510
CACNNNNNGCG
>CS209204.1 Sequence 367 from Patent EP1600510
CCCNNNNNGCC
>CS209199.1 Sequence 362 from Patent EP1600510
CGCNNNNNGCA
>CS208147.1 Sequence 95 from Patent WO2005080581
GGGGGGAGTCT
>CS208145.1 Sequence 93 from Patent WO2005080581
AAGGGGTCTCT
>CS208143.1 Sequence 91 from Patent WO2005080581
GGGACGGCGGG
>CS208137.1 Sequence 85 from Patent WO2005080581
GGGAGGGGGAC
>CS208133.1 Sequence 81 from Patent WO2005080581
CTCCCGTCCCC
>CS208131.1 Sequence 79 from Patent WO2005080581
GCGGACCGCCC
>CS208119.1 Sequence 67 from Patent WO2005080581
GCGGGCGGTCC
>CS208114.1 Sequence 62 from Patent WO2005080581
CCCCCCCGTCG
>CS208108.1 Sequence 56 from Patent WO2005080581
GCCCGACCCCC
>CS208077.1 Sequence 25 from Patent WO2005080581
ACGCACCCCCA
>CS189408.1 Sequence 639 from Patent WO2005078139
AAANNNNNNNN
>CS177981.1 Sequence 38 from Patent WO2005093095
CATACACTACG
>CS177974.1 Sequence 31 from Patent WO2005093095
AAAAACTAACG
>CS174901.1 Sequence 22 from Patent WO2005090595
GGCCGGTCCTG
>CS174893.1 Sequence 14 from Patent WO2005090595
GGCCGGTCCTG
>CS174891.1 Sequence 12 from Patent WO2005090595
SWNSWRTCCCA
>CS174890.1 Sequence 11 from Patent WO2005090595
GGNGGSARNCC
>CS174889.1 Sequence 10 from Patent WO2005090595
GGNYTSCCNCC
>CS174888.1 Sequence 9 from Patent WO2005090595
GCNTGGRYNGA
>CS174887.1 Sequence 8 from Patent WO2005090595
GWNGWRTCCCA
>CS174886.1 Sequence 7 from Patent WO2005090595
GGNGGNARNCC
>CS174885.1 Sequence 6 from Patent WO2005090595
GGNYTNCCNCC
>CS174883.1 Sequence 4 from Patent WO2005090595
GGNCGCWBSGG
>CS174882.1 Sequence 3 from Patent WO2005090595
GGSGGSAGSCC
>CS174881.1 Sequence 2 from Patent WO2005090595
GGSCTSCCSCC
>CS174117.1 Sequence 3 from Patent EP1583016
CATGCATCATG
>CS173090.1 Sequence 48 from Patent WO2005088306
YGGCGCTAYCA
>CS173076.1 Sequence 34 from Patent WO2005088306
SGTGCGSYGYG
>CS173066.1 Sequence 24 from Patent WO2005088306
AAKGAAANKWA
>CS173060.1 Sequence 18 from Patent WO2005088306
GGNNATANCGS
>CS173059.1 Sequence 17 from Patent WO2005088306
GATAAGATAAG
>CS172981.1 Sequence 88 from Patent WO2005087932
NNNGTTTCCAN
>CS172980.1 Sequence 87 from Patent WO2005087932
NNNGTTTATCN
>CS172974.1 Sequence 81 from Patent WO2005087932
GCANNNNNTGC
>CS172972.1 Sequence 79 from Patent WO2005087932
CCNNNNNNNGG
>CS172971.1 Sequence 78 from Patent WO2005087932
GCTCTTCNNNN
>CS172969.1 Sequence 76 from Patent WO2005087932
GCTCTTCNNNN
>CS172909.1 Sequence 16 from Patent WO2005087932
NNNNGAAGAGC
>CS172907.1 Sequence 14 from Patent WO2005087932
CCANNNNNTGG
>CS172905.1 Sequence 12 from Patent WO2005087932
GCNNNNNNNGC
>CS172904.1 Sequence 11 from Patent WO2005087932
CCNNNNNNNGG
>CS172902.1 Sequence 9 from Patent WO2005087932
NNNNNGAGACC
>CS172900.1 Sequence 7 from Patent WO2005087932
GCCNNNNNGGC
>CS172899.1 Sequence 6 from Patent WO2005087932
NNNNNGAGACG
>CS173091.1 Sequence 49 from Patent WO2005088306
YMTGTMTYTAW
>CS173094.1 Sequence 52 from Patent WO2005088306
GYGWCASWAAW
>CS141779.1 Sequence 24 from Patent WO2005068638
ACGCTACTTCT
>CS141759.1 Sequence 4 from Patent WO2005068638
ACGCTACTTCT
>CS140231.1 Sequence 21 from Patent WO2005071077
ACTGGGNNNNN
>CS140226.1 Sequence 16 from Patent WO2005071077
CGTCTCNNNNN
>CS140225.1 Sequence 15 from Patent WO2005071077
GGTCTCNNNNN
>CS140223.1 Sequence 13 from Patent WO2005071077
GCTCTTCNNNN
>CS140218.1 Sequence 8 from Patent WO2005071077
ACTGGGNNNNN
>CS140212.1 Sequence 2 from Patent WO2005071077
GGTCTCNNNNN
>CS140211.1 Sequence 1 from Patent WO2005071077
CGTCTCNNNNN
>CS128812.1 Sequence 21 from Patent EP1557464
ACTGGGNNNNN
>CS128807.1 Sequence 16 from Patent EP1557464
CGTCTCNNNNN
>CS128806.1 Sequence 15 from Patent EP1557464
GGTCTCNNNNN
>CS128804.1 Sequence 13 from Patent EP1557464
GCTCTTCNNNN
>CS128799.1 Sequence 8 from Patent EP1557464
ACTGGGNNNNN
>CS128793.1 Sequence 2 from Patent EP1557464
GGTCTCNNNNN
>CS128792.1 Sequence 1 from Patent EP1557464
CGTCTCNNNNN
>CS131565.1 Sequence 12 from Patent WO2005063994
TATCCAGCTAT
>CS131564.1 Sequence 11 from Patent WO2005063994
TATCCATCCAT
>CS106213.1 Sequence 203 from Patent WO2005049652
CCANNNNNTGG
>CS106212.1 Sequence 202 from Patent WO2005049652
CCTNNNNNAGG
>CQ977033.1 Sequence 81 from Patent WO2005000875
GGGGACTTTCC
>CS182116.1 Sequence 8 from Patent WO2004067545
TTTTTTTTTTT
>CS182115.1 Sequence 7 from Patent WO2004067545
TTTTTNTTTTT
>CS182114.1 Sequence 6 from Patent WO2004067545
TTTTTCTTTTT
>CS182113.1 Sequence 5 from Patent WO2004067545
TTTTTCTTTTT
>CS181560.1 Sequence 5 from Patent WO2005090599
GATCGCGTCAG
>CS323548.1 Sequence 16 from Patent WO2006045591
GCCCTGAAAAA
>DD271436.1 Ligand for G-protein coupled receptor GPR43 and uses thereof
GGGGACTTTCC
>DD271082.1 TRANSGENIC NON-HUMAN MAMMALS EXPRESSING A REPORTER NUCLEIC ACID UNDER THE REGULATION OF ANDROGEN RESPONSE ELEMENTS
GGAACGGAACA
>DD261127.1 Single Promoter System for Making siRNA Expression Cassettes and Expression Libraries Using a Polymerase Primer Hairpin Linker
TTTTTNNNNGC
>DD260341.1 DNA Amplification and Sequencing Using DNA Molecules Generated by Random Fragmentation
TCTCCTTCCTC
>DD260339.1 DNA Amplification and Sequencing Using DNA Molecules Generated by Random Fragmentation
TCTCCTTCCTC
>DD260338.1 DNA Amplification and Sequencing Using DNA Molecules Generated by Random Fragmentation
TCTCCTTCCTC
>DD259476.1 Method of screening for compound inhibiting the formation of STAT3,NF-kappa-B p65 and p300complex
GGGACTTGTAC
>DD266115.1 Genes
GGAAANGAAAC
>DD272461.1 METHODS FOR INDUCING TARGETED STIMULATION OF MEIOTIC RECOMBINATION AND KITS FOR PERFORMING SAID METHODS
CCCATCTCTTT
>DD272277.1 MN/CA IX-SPECIFIC MONOCLONAL ANTIBODIES GENERATED FROM MN/CA IX-DEFICIENT MICE AND METHODS OF USE
ACACAGAAGGG
>DD272275.1 MN/CA IX-SPECIFIC MONOCLONAL ANTIBODIES GENERATED FROM MN/CA IX-DEFICIENT MICE AND METHODS OF USE
CTCCAGTCCAG
>DD272274.1 MN/CA IX-SPECIFIC MONOCLONAL ANTIBODIES GENERATED FROM MN/CA IX-DEFICIENT MICE AND METHODS OF USE
CCCTAGCTCCA
>DD272273.1 MN/CA IX-SPECIFIC MONOCLONAL ANTIBODIES GENERATED FROM MN/CA IX-DEFICIENT MICE AND METHODS OF USE
TCACAGGCTCA
>DD272272.1 MN/CA IX-SPECIFIC MONOCLONAL ANTIBODIES GENERATED FROM MN/CA IX-DEFICIENT MICE AND METHODS OF USE
CCCCAGGAGGG
>DD272271.1 MN/CA IX-SPECIFIC MONOCLONAL ANTIBODIES GENERATED FROM MN/CA IX-DEFICIENT MICE AND METHODS OF USE
TTTCAGATCCA
>DD272270.1 MN/CA IX-SPECIFIC MONOCLONAL ANTIBODIES GENERATED FROM MN/CA IX-DEFICIENT MICE AND METHODS OF USE
ACGCAGTGCAA
>DD272269.1 MN/CA IX-SPECIFIC MONOCLONAL ANTIBODIES GENERATED FROM MN/CA IX-DEFICIENT MICE AND METHODS OF USE
CCCCAGGCGAC
>DD272268.1 MN/CA IX-SPECIFIC MONOCLONAL ANTIBODIES GENERATED FROM MN/CA IX-DEFICIENT MICE AND METHODS OF USE
ATACAGGGGAT
>DD272267.1 MN/CA IX-SPECIFIC MONOCLONAL ANTIBODIES GENERATED FROM MN/CA IX-DEFICIENT MICE AND METHODS OF USE
CACAGGTATTA
>DD272266.1 MN/CA IX-SPECIFIC MONOCLONAL ANTIBODIES GENERATED FROM MN/CA IX-DEFICIENT MICE AND METHODS OF USE
TGCTGGTGAGT
>DD272265.1 MN/CA IX-SPECIFIC MONOCLONAL ANTIBODIES GENERATED FROM MN/CA IX-DEFICIENT MICE AND METHODS OF USE
GCCAGGTACAG
>DD272264.1 MN/CA IX-SPECIFIC MONOCLONAL ANTIBODIES GENERATED FROM MN/CA IX-DEFICIENT MICE AND METHODS OF USE
AGCAGGTGGGC
>DD272263.1 MN/CA IX-SPECIFIC MONOCLONAL ANTIBODIES GENERATED FROM MN/CA IX-DEFICIENT MICE AND METHODS OF USE
GGAAGGTCAGT
>DD272262.1 MN/CA IX-SPECIFIC MONOCLONAL ANTIBODIES GENERATED FROM MN/CA IX-DEFICIENT MICE AND METHODS OF USE
TGGAGGTACCA
>DD272261.1 MN/CA IX-SPECIFIC MONOCLONAL ANTIBODIES GENERATED FROM MN/CA IX-DEFICIENT MICE AND METHODS OF USE
CCGAGGTGAGC
>DD272260.1 MN/CA IX-SPECIFIC MONOCLONAL ANTIBODIES GENERATED FROM MN/CA IX-DEFICIENT MICE AND METHODS OF USE
CAGTCGTGAGG
>DD272259.1 MN/CA IX-SPECIFIC MONOCLONAL ANTIBODIES GENERATED FROM MN/CA IX-DEFICIENT MICE AND METHODS OF USE
TGGAGGTGAGA
>DD272258.1 MN/CA IX-SPECIFIC MONOCLONAL ANTIBODIES GENERATED FROM MN/CA IX-DEFICIENT MICE AND METHODS OF USE
AGAAGGTAAGT
>DD253161.1 A method for simultaneous production of multiple proteins; vectors and cells for use therein
GCCNNNNNCCC
>DD253137.1 A method for simultaneous production of multiple proteins; vectors and cells for use therein
CGCNNNNNGGC
>DD253128.1 A method for simultaneous production of multiple proteins; vectors and cells for use therein
CAGNNNNNGGG
>DD253116.1 A method for simultaneous production of multiple proteins; vectors and cells for use therein
GCGNNNNNGCC
>DD253043.1 A method for simultaneous production of multiple proteins; vectors and cells for use therein
CGGNNNNNCCC
>DD253012.1 A method for simultaneous production of multiple proteins; vectors and cells for use therein
CCCNNNNNCCA
>DD253010.1 A method for simultaneous production of multiple proteins; vectors and cells for use therein
ACGNNNNNGCA
>DD252988.1 A method for simultaneous production of multiple proteins; vectors and cells for use therein
CACNNNNNGGG
>DD252962.1 A method for simultaneous production of multiple proteins; vectors and cells for use therein
CCGNNNNNTCC
>DD252940.1 A method for simultaneous production of multiple proteins; vectors and cells for use therein
GGCNNNNNGGA
>DD252939.1 A method for simultaneous production of multiple proteins; vectors and cells for use therein
CCCNNNNNAGC
>DD252936.1 A method for simultaneous production of multiple proteins; vectors and cells for use therein
CAGNNNNNCCC
>DD252933.1 A method for simultaneous production of multiple proteins; vectors and cells for use therein
GCCNNNNNGGA
>DD252927.1 A method for simultaneous production of multiple proteins; vectors and cells for use therein
CGGNNNNNACG
>DD252920.1 A method for simultaneous production of multiple proteins; vectors and cells for use therein
AGCNNNNNCAG
>DD252916.1 A method for simultaneous production of multiple proteins; vectors and cells for use therein
CCANNNNNCCG
>DD252895.1 A method for simultaneous production of multiple proteins; vectors and cells for use therein
ACCNNNNNCCC
>DD252872.1 A method for simultaneous production of multiple proteins; vectors and cells for use therein
CCANNNNNGGG
>DD252868.1 A method for simultaneous production of multiple proteins; vectors and cells for use therein
CTGNNNNNCCC
>DD252859.1 A method for simultaneous production of multiple proteins; vectors and cells for use therein
CGCNNNNNGAG
>DD252831.1 A method for simultaneous production of multiple proteins; vectors and cells for use therein
CGGNNNNNGGC
>DD252810.1 A method for simultaneous production of multiple proteins; vectors and cells for use therein
CCCNNNNNAGG
>DD252799.1 A method for simultaneous production of multiple proteins; vectors and cells for use therein
GAGNNNNNCCC
>DD252753.1 A method for simultaneous production of multiple proteins; vectors and cells for use therein
CCTNNNNNGCC
>DD252730.1 A method for simultaneous production of multiple proteins; vectors and cells for use therein
CCCNNNNNCGG
>DD252721.1 A method for simultaneous production of multiple proteins; vectors and cells for use therein
CCGNNNNNCCC
>DD252693.1 A method for simultaneous production of multiple proteins; vectors and cells for use therein
CTGNNNNNCGC
>DD252691.1 A method for simultaneous production of multiple proteins; vectors and cells for use therein
GCGNNNNNGAC
>DD252637.1 A method for simultaneous production of multiple proteins; vectors and cells for use therein
CTCNNNNNCGC
>DD252622.1 A method for simultaneous production of multiple proteins; vectors and cells for use therein
GACNNNNNCGC
>DD252617.1 A method for simultaneous production of multiple proteins; vectors and cells for use therein
CCCNNNNNCCG
>DD252595.1 A method for simultaneous production of multiple proteins; vectors and cells for use therein
CAGNNNNNCCG
>DD252552.1 A method for simultaneous production of multiple proteins; vectors and cells for use therein
CCGNNNNNGAC
>DD252537.1 A method for simultaneous production of multiple proteins; vectors and cells for use therein
GCGNNNNNGGA
>DD252529.1 A method for simultaneous production of multiple proteins; vectors and cells for use therein
CGGNNNNNCTC
>DD252498.1 A method for simultaneous production of multiple proteins; vectors and cells for use therein
GCCNNNNNCGC
>DD252472.1 A method for simultaneous production of multiple proteins; vectors and cells for use therein
GGGNNNNNGGA
>DD252465.1 A method for simultaneous production of multiple proteins; vectors and cells for use therein
CCTNNNNNGCG
>DD252462.1 A method for simultaneous production of multiple proteins; vectors and cells for use therein
CACNNNNNGCG
>DD252449.1 A method for simultaneous production of multiple proteins; vectors and cells for use therein
CCCNNNNNGCC
>DD252444.1 A method for simultaneous production of multiple proteins; vectors and cells for use therein
CGCNNNNNGCA
>DD252008.1 DENGUE TETRAVALENT VACCINE CONTAINING A COMMON 30 NUCLEOTIDE DELETION IN THE 3'-UTR OF DENGUE TYPES 1, 2, 3, AND 4, OR ANTIGENIC CHIMERIC DENGUE VIRUSES 1, 2, 3, AND 4
AGAGCTCTCTC
>DD251121.1 A METHOD FOR THE DETECTION OF APOPTOSIS
GCGGTTTGCGG
>DD251105.1 A METHOD FOR THE DETECTION OF APOPTOSIS
GGTGGTGGTGG
>DD248604.1 Method for analyzing splicing patterns of biomolecular sequences
TGAATGTTATC
>DD248547.1 Method for analysing expression of markers involved autoimmune diseases, and use thereof
GAATTCAGATC
>DD258609.1 The IL-1 Gene Cluster and Associated Inflammatory Polymorphisms and Haplotypes
TGCATAGGGTT
>DD258608.1 The IL-1 Gene Cluster and Associated Inflammatory Polymorphisms and Haplotypes
TGCATAGGGCC
>DD258607.1 The IL-1 Gene Cluster and Associated Inflammatory Polymorphisms and Haplotypes
TGCATAGGCTC
>DD258606.1 The IL-1 Gene Cluster and Associated Inflammatory Polymorphisms and Haplotypes
TGCATAGAGTC
>DD258605.1 The IL-1 Gene Cluster and Associated Inflammatory Polymorphisms and Haplotypes
TGCATAAGGTC
>DD258604.1 The IL-1 Gene Cluster and Associated Inflammatory Polymorphisms and Haplotypes
TGCATGGGGTC
>DD258603.1 The IL-1 Gene Cluster and Associated Inflammatory Polymorphisms and Haplotypes
TGCACAGGGTC
>DD258602.1 The IL-1 Gene Cluster and Associated Inflammatory Polymorphisms and Haplotypes
TGCGTAGGGTC
>DD258601.1 The IL-1 Gene Cluster and Associated Inflammatory Polymorphisms and Haplotypes
TGTATAGGGTC
>DD258600.1 The IL-1 Gene Cluster and Associated Inflammatory Polymorphisms and Haplotypes
TACATAGGGTC
>DD258599.1 The IL-1 Gene Cluster and Associated Inflammatory Polymorphisms and Haplotypes
CGCATAGGGTC
>DD258598.1 The IL-1 Gene Cluster and Associated Inflammatory Polymorphisms and Haplotypes
TGCATAGGGTC
>DD258593.1 The IL-1 Gene Cluster and Associated Inflammatory Polymorphisms and Haplotypes
TGCATAGGGCC
>DD258592.1 The IL-1 Gene Cluster and Associated Inflammatory Polymorphisms and Haplotypes
TGCATAGGGTT
>DD258591.1 The IL-1 Gene Cluster and Associated Inflammatory Polymorphisms and Haplotypes
TGCATAGGCCT
>DD258590.1 The IL-1 Gene Cluster and Associated Inflammatory Polymorphisms and Haplotypes
TGCATAGAGCT
>DD258588.1 The IL-1 Gene Cluster and Associated Inflammatory Polymorphisms and Haplotypes
TGCATGGGGCT
>DD258587.1 The IL-1 Gene Cluster and Associated Inflammatory Polymorphisms and Haplotypes
TGCACAGGGCT
>DD258586.1 The IL-1 Gene Cluster and Associated Inflammatory Polymorphisms and Haplotypes
TGCGTAGGGCT
>DD258585.1 The IL-1 Gene Cluster and Associated Inflammatory Polymorphisms and Haplotypes
TGTATAGGGCT
>DD258584.1 The IL-1 Gene Cluster and Associated Inflammatory Polymorphisms and Haplotypes
TACATAGGGCT
>DD258583.1 The IL-1 Gene Cluster and Associated Inflammatory Polymorphisms and Haplotypes
CGCATAGGGCT
>DD258582.1 The IL-1 Gene Cluster and Associated Inflammatory Polymorphisms and Haplotypes
TGCATAGGGCT
>DD257920.1 NUCLEIC ACID COMPOSITIONS FOR STIMULATING IMMUNE RESPONSES
GTTTTTTTCGA
>DD257823.1 NUCLEIC ACID COMPOSITIONS FOR STIMULATING IMMUNE RESPONSES
TCGGTCGTTTT
>DD253732.1 Randomised DNA libraries and double-stranded RNA libraries, use and method of production thereof
TTTTTGGATCC
>DD241033.1 Parallel Stranded Duplexes of Deoxyribonucleic Acid and Methods of Use
GAAGNNGNNGA
>DD241030.1 Parallel Stranded Duplexes of Deoxyribonucleic Acid and Methods of Use
TCTCCTACTTC
>DD241029.1 Parallel Stranded Duplexes of Deoxyribonucleic Acid and Methods of Use
TCTCCTGCTTC
>DD241024.1 Parallel Stranded Duplexes of Deoxyribonucleic Acid and Methods of Use
GAAGTNGGNGA
>DD241023.1 Parallel Stranded Duplexes of Deoxyribonucleic Acid and Methods of Use
CTTCATCCTCT
>DD241022.1 Parallel Stranded Duplexes of Deoxyribonucleic Acid and Methods of Use
CTTCGTCCTCT
>DD241021.1 Parallel Stranded Duplexes of Deoxyribonucleic Acid and Methods of Use
CTTCTTCCTCT
>DD241020.1 Parallel Stranded Duplexes of Deoxyribonucleic Acid and Methods of Use
GAAGCNGGNGA
>DD241015.1 Parallel Stranded Duplexes of Deoxyribonucleic Acid and Methods of Use
TCTCCTCCTTC
>DD241014.1 Parallel Stranded Duplexes of Deoxyribonucleic Acid and Methods of Use
TGTGGTGGTTG
>DD241013.1 Parallel Stranded Duplexes of Deoxyribonucleic Acid and Methods of Use
AGAGGAGGAAG
>DD241007.1 Parallel Stranded Duplexes of Deoxyribonucleic Acid and Methods of Use
CCCCCTTTTTT
>DD241006.1 Parallel Stranded Duplexes of Deoxyribonucleic Acid and Methods of Use
TTTTTTTTTTT
>DD241005.1 Parallel Stranded Duplexes of Deoxyribonucleic Acid and Methods of Use
AAAAAAAAAAA
>DD241004.1 Parallel Stranded Duplexes of Deoxyribonucleic Acid and Methods of Use
GAAGNAGNAGA
>DD241003.1 Parallel Stranded Duplexes of Deoxyribonucleic Acid and Methods of Use
GAAGNAGNAGA
>DD241002.1 Parallel Stranded Duplexes of Deoxyribonucleic Acid and Methods of Use
GAAGGNGGNGA
>DD241001.1 Parallel Stranded Duplexes of Deoxyribonucleic Acid and Methods of Use
CTTCCTCCTCT
>DD241000.1 Parallel Stranded Duplexes of Deoxyribonucleic Acid and Methods of Use
GAAGGAGGAGA
>DD240964.1 A NEW METHOD FOR THE DIAGNOSIS AND PROGNOSIS OF MALIGNANT DISEASES
GCGGTTTGCGG
>DD240948.1 A NEW METHOD FOR THE DIAGNOSIS AND PROGNOSIS OF MALIGNANT DISEASES
GGTGGTGGTGG
>DD240879.1 CARDIAC-SPECIFIC 11BETA HYDROXYSTEROID DEHYDROGENASE TYPE 2 TRANSGENIC MICE
CATGGCCCTGC
>DD240878.1 CARDIAC-SPECIFIC 11BETA HYDROXYSTEROID DEHYDROGENASE TYPE 2 TRANSGENIC MICE
CCCAGCCCTAC
>DD240877.1 CARDIAC-SPECIFIC 11BETA HYDROXYSTEROID DEHYDROGENASE TYPE 2 TRANSGENIC MICE
CCTGGCGCTAC
>DD240876.1 CARDIAC-SPECIFIC 11BETA HYDROXYSTEROID DEHYDROGENASE TYPE 2 TRANSGENIC MICE
CCTGGCCCTGT
>DD240875.1 CARDIAC-SPECIFIC 11BETA HYDROXYSTEROID DEHYDROGENASE TYPE 2 TRANSGENIC MICE
CCTGGCCTTAC
>DD240874.1 CARDIAC-SPECIFIC 11BETA HYDROXYSTEROID DEHYDROGENASE TYPE 2 TRANSGENIC MICE
CCTGGCACTAC
>DD240555.1 METHODS OF IDENTIFYING AND ISOLATING STEM CELLS AND CANCER STEM CELLS
GCTTTGATCTT
>DD238129.1 Decoy nucleic acid against syobiolin promoter
GCCGGAAGTGA
>DD235484.1 DATA PROCESSING AND DISPLAY METHOD FOR GENE EXPRESSION ANALYSIS SYSTEM AND GENE EXPRESSION ANALYSIS SYSTEM
CATGCATCATG
>DD247408.1 IMPROVEMENTS FOR COMBINATORIAL OLIGONUCLEOTIDE PCR
CCANNNNNTGG
>DD247407.1 IMPROVEMENTS FOR COMBINATORIAL OLIGONUCLEOTIDE PCR
GCNNNNNNNGC
>DD247404.1 IMPROVEMENTS FOR COMBINATORIAL OLIGONUCLEOTIDE PCR
CCTNNNNNAGG
>DD247401.1 IMPROVEMENTS FOR COMBINATORIAL OLIGONUCLEOTIDE PCR
GCANNNNNTGC
>DD247400.1 IMPROVEMENTS FOR COMBINATORIAL OLIGONUCLEOTIDE PCR
CCNNNNNNNGG
>DD247398.1 IMPROVEMENTS FOR COMBINATORIAL OLIGONUCLEOTIDE PCR
GCCNNNNNGGC
>DD247395.1 IMPROVEMENTS FOR COMBINATORIAL OLIGONUCLEOTIDE PCR
GACNNNNNGTC
>E09846.1 Primer
GTGCTCCCTCT
>E09845.1 Primer
GTGCTCCCTCC
>E09842.1 Primer
GAGGGAAGAGC
>E09841.1 Primer
GAGGGAAGAGG
>E09260.1 Synthetic oligonucleotide for gaining N38
GGCATATGCCC
>E11691.1 Probe for screening novel deoxyribonuclease(DNase) gamma
GAYGTNTTYTC
>E41629.1 Antibody against human VEGF receptor KDR having novel complementarity determining region
CTTGGTGGAGG
>E38431.1 Novel polypeptide
CTTTAGAGCAC
>E37972.1 Method for analyzing gene expression frequency
CTGCCAAGTTC
>E37971.1 Method for analyzing gene expression frequency
CACTACAGCAC
>E37970.1 Method for analyzing gene expression frequency
TGCATGCCCTG
>E37969.1 Method for analyzing gene expression frequency
ACCAGTGTCGC
>E37968.1 Method for analyzing gene expression frequency
TTCCAGGCCCG
>E37967.1 Method for analyzing gene expression frequency
ACCTCGGATGA
>E37966.1 Method for analyzing gene expression frequency
GGGAAGTACGC
>E37965.1 Method for analyzing gene expression frequency
TGCTCTCCACC
>E37964.1 Method for analyzing gene expression frequency
CCTGGTGGAAA
>E37963.1 Method for analyzing gene expression frequency
TGCATTCCATC
>E38191.1 Expression system regulated by oncogene or virus
TAATGATGGCG
